The influence of age on the cellular immune response in patients with tuberculosis and healthy controls by Schölvinck, Elisabeth Henriëtte
The influence of age on the cellular immune 
response in patients with tuberculosis and healthy 
controls 
Elisabeth Henriette SchOivinck 
Dissertation presented for the Degree of Doctor ofPhilosphy at the 
Faculty of Medicine 
Department of Paediatrics and Child Health 
University of Stellenbosch 
Promotor: 
Prof. N. Beyers 
Co-Promotors: 
Prof. A.D. Beyers 
Prof. M. Levin 
/ 
Declaration: 
I, Elisabeth Henriette Scholvinck, hereby declare that the work contained in this 
dissertation is my own original work and that I have not previously in its entity or in its 
part submitted it at any university for a degree 
Signature 
Date 
Stellenbosch University http://scholar.sun.ac.za
" •.... Every age has a kind of universal genius, 
which inclines those that live in it to do particular studies .•. " 
J. Dryden 1633-1700 
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Abstract 
Children and adults may differ in their immune function. An adequate function of the 
individual's immune system is crucial to the risk for development of tuberculosis (TB) 
after infection with Mycobacterium tuberculosis (Mtb). Epidemiological evidence 
suggests an age-related incidence of TB. Furthermore, the prevailing clinical expression 
t ' 
of TB varies between age groups. 
-The aims of this study were to characterise the cellular immune response at different ages 
in TB patients and healthy individuals living in a region highly endemic for TB and to 
relate the findings to the clinical expression of TB in different age groups. 
A total of 150 persons of different ages were included in this study: 50 TB patients, 
(identified on the basis of clinical, radiological and microbiological characteristics), 49 
healthy Mantoux positive (~15mm) and 51 healthy Mantoux negative (<15mm) subjects. 
All patients <12yrs were identified as having primary TB and postprimary TB was only 
diagnosed in patients ~12yrs. 
Haematologic indices were obtained from all the included subjects and found to be age-
related. With the exception of the absolute lymphocyte counts, all indices were 
significantly different in TB patients when compared to healthy controls. 
Whole blood was cultured and stimulated with PHA, PPD and ESAT -6 to measure 
lymphocyte proliferation and IFN-y, TNF-a, IL-2 and IL-10 production in the 
supernatants of the cultures. 
After stimulation with PHA, the production of IFN-y, TNF-a and IL-10 as well as 
lymphocyte proliferation were all age-related. 
After stimulation with PPD, age correlated positively with IFN-y production in healthy 
Mantoux positive subjects< 12yrs. In the age groups <20 yrs, patients produced similar 
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amounts of IFN-y when compared to healthy age-related Mantoux positive controls. 
TNF-a and IL-2 production were not different between patients and controls. In this 
whole blood system, measuring any of these cytokines on their own did not differentiate 
patients from controls at all ages. 
The ratio of PPD stimulated IFN-y to TNF-a production was significantly less in patients 
with primary TB and postprimary TB when compared to Mantoux positive controls, 
irrespective of age. These findings indicate that calculated ratios between several 
cytokines may be useful markers of disease at all ages. 
ESA T -6 stimulated IFN -y production did not result in any significant correlation with 
age, but was significantly less in healthy Mantoux positive subjects ~12 yrs when 
compared to healthy Mantoux positive subjects <12 yrs and TB patients of all ages. This 
finding suggests that a positive immune response to ESAT -6 is indicative of recent 
immunological contact with Mtb. 
Total IgE was measured in serum. In children <12 yrs these values correlated with age 
and were highest in healthy Mantoux positive controls, thereby not confirming any 
inverse correlation between IgE and TB. 
Age should be recognised as a significant variable in quantitative measurements of 
cellular immune responses. 
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Opsomming 
Die immuunsisteem van kinders en volwassenes kan verskillend wees. Die mate van 
immuniteit van 'n individu'is deurslaggewend vir die risiko om tuberkulose (TB) na 
infeksie met die Mycobacterium tuberculosis (M tb) te ontwikkel. Epidemiologiese 
bevindings suggereer dat die insidensie van TB ouderdomgebonde mag wees. V erder 
verskil die voorkomende kliniese beeld van TB ook tussen ouderdomsgroepe. 
Die doelstellings van hierdie studie was om die sellulere immuunrespons op verskillende 
ouderdomme by TB-pasiente en gesonde individue wat in 'n streek met hoogs endemiese 
TB-insidensie woon te vergelyk. Die doel was ook om vas te stel hoe hierdie bevindings 
by die kliniese beeld van TB by verskillende ouderdomsgroepe inpas. 
Daar is 150 persone van verskillende ouderdomme in hierdie studie ingesluit: 50 TB-
pasiente (geidentifiseer op grond van kliniese, radiologiese en mikrobiologiese 
karakteristieke), 49 gesonde Mantoux -positiewe (:2':15mm) en 51 gesonde Mantoux-
negatiewe (<15mm) persone. Alle pasiente <12 jaar is gediagnoseer met primere TB. 
Postprimere TB is alleenlik gediagnoseer in pasiente :2':12 jaar. 
Daar is aangetoon dat. hematologiese indekse van al die persone in hierdie studie 
ouderdomsverwant was. Daar was n beduidende verskil in alle indekse van TB-pasiente 
in vergelyking met die gesonde kontroles met die uitsondering van die absolute limfosiet-
tellings. 
Kulture van volbloed is gedoen en gestimuleer met behulp van PHA, PPD en ESAT -6 om 
limfosiet-proliferasie, IFN-y-, TNF-a-, IL-2- en IL-10-produksie in die supematante van 
die kulture te meet. 
Na stimulasie met PHA was die produksie van IFN-y, TNF-a en IL-10, asook die 
limfosiet-proliferasie ouderdomsverwant 
3 
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Na stimu1asie met PPD het ouderdom positief gekorre1eer met IFN-y produksie in 
gesonde Mantoux-positiewe persone <12 jaar. In die ouderdomsgroep <20 jaar het 
l 
pasiente diese1fde hoevee1hede IFN-y geproduseer as gesonde, ouderdomsverwante 
Mantoux-positiewe kontro1es. Daar was geen verskil tussen die produksie van TNF -a. en 
IL-2 tussen pasiente en kontro1es nie. In hierdie vo1b1oed-sisteem het die meet van nie 
een van hierdie sitokiene op sigse1f 'n verski1 getoon tussen pasiente en kontro1es van 
aile ouderdomme nie. 
Die verhouding van PPD-gestimu1eerde IFN-y- tot TNF-a.-produksie was betekenisvo1 
minder in pasiente met primere TB en postprimere TB in verge1yking met Mantoux-
positiewe kontro1es, ongeag ouderdom. Hierdie bevindings toon dat berekende 
verhoudings tussen verskillende sitokiene waardevoile merkers van 'n siektetoestand 
{TB) by aile ouderdomme kan wees. 
ESAT-6 gestimu1eerde IFN-y-produksie het geen betekenisvoile korre1asie met ouderdom 
getoon nie. Daar was egter betekenisvo1 minder produksie in gesonde Mantoux-positiewe 
persone ~12 jaar as in gesonde Mantoux-positiewe persone <12 jaar, asook in 
verge1yking met TB-pasiente van aile ouderdomme. Hierdie bevinding kan daarop dui dat 
'n positiewe immuun respons op ESAT -6 'n aanduiding van on1angse immuno1ogiese 
kontak met M tb is. 
Tota1e IgE was in serum bepaal. In kinders <12 jaar het hierdie waardes gekorre1eer met 
ouderdomme en die waardes was die hoogste in gesonde Mantoux-positiewe kontro1es. 
Hierdeur is daar nie bevestig dat daar 'n omgekeerde korre1~sie tussen IgE en TB is nie. 
Ouderdom behoort dus as 'n be1angrike veranderlike gesien te word in die kwantitatiewe 
meting van die seilu1ere immuunrespons. 
4 
·< 
Stellenbosch University http://scholar.sun.ac.za
Abstract 
English 
Afrikaans 
Table of contents 
List of abbreviations 
Introduction chapters 
Table of Contents 
Age and the development of the immune system 
Immunobiology of tuberculosis 
Tuberculosis: age as a variable 
Hypothesis: age, immune competence and tuberculosis 
Aims of the study 
Materials and methods 
Results 
Description of study subjects 
Description of laboratory methods 
Methods of analysis 
Introduction to results section 
Results of clinical findings 
Tables of correlations 
All subjects- PHA stimulation 
Patients - PHA stimulation 
"' 
1 
3 
5 
7 
8 
20 
30 
40 
42 
43 
48 
54 
56 
59 
68 
69 
5 
Stellenbosch University http://scholar.sun.ac.za
Healthy controls- PHA stimulation 
All subjects- PPD/ESAT-6 stimulation 
Patients/ Mantoux pos - PPD/ESAT-6 stimulation 
Patients- PPD/ESAT-6 stimulation 
Mantoux pos- PPD/ESAT-6 stimulation 
Results of haematological findings 
Results of lymphocyte proliferation assays 
Results of Interferon-gamma production 
Results ofTNF-alpha production 
Results of IL-2 production 
Results of IL-l 0 production 
Results of IgE production 
Results by disease expression 
Technical problems during the study 
General discussion 
Accountability 
Acknowledgements 
Consent form and information sheet study participants 
References 
·~ 
70 
71 
72 
73 
74' 
75 
87 
97 
112 
119 
125 
133 
141 
155 
160 
172 
173 
175 
177 
6 
Stellenbosch University http://scholar.sun.ac.za
List of abbreviations 
APCs Antigen Presenting Cells 
cpm counts per minute 
CMI Cell Mediated Immunity 
CR Chest Radiograph 
BAL bronchio-alveolar lavage 
DTH Delayed Type Hypersensitivity 
ELISA Enzyme Linked Immunosorbent Assay 
ESAT-6 Early Secreted Antigen Target-6 
IFN-y Interferon-gamma 
IgE Immunoglobulin E 
IL-2 Interleukin-2 
IL-4 Interleukin-4 
IL-10 Interleukin-1 0 
IL-12 Interleukin-12 
LAM Lipoarabinomannan 
Mantoux neg Mantoux negative 
Mantoux pos Mantoux positive 
MHC Major Histocompatibilty Complex 
M.tb Mycobacterium tuberculosis 
NK cells Natural Killer cells 
PBMCs Peripheral Blood Mononuclear Cells 
PPD Purified Protein Derivate 
PHA Phytohaemaglutinin 
TB tuber~ulosis 
TBM tuberculous meningitis 
TGF-~ Transforming Growth Factor-beta 
TNF-a. Tumor Necrosis Factor- alpha 
WBC White Blood Cell Count 
yrs years 
-~ 
7 
Stellenbosch University http://scholar.sun.ac.za
Age and the development of the immune system 
Introduction to the functioning of the immune system 
The immune system keeps a balance between health and disease through its capacity to 
mount a response to a wide variety of stimuli, including foreign pathogens. 
The functioning of the immune system can be outlined through several, not always 
mutually exclusive, pathways: 
Innate vs adaptive immune response is a segregation to differentiate a usually non-
specific response from a more specialized effector function. The key difference lies in the 
fact that genes encoding recognition receptors rearrange in cells of the adaptive immune 
system, thus allowing clonal differentiation and memory, while this does not happen in 
cells of the innate immune system. 1 Cells from the innate immune system 
(polymorphonuclear leucocytes, monocytes and macrophages) respond rapidly, are 
polyspecific and discriminate self from non-self. Antigen presenting cells (macrophages, 
dendritic cells, but also B-lymphocytes) present the adaptive immune system (T and B 
lymphocytes) with antigen in order to activate a specific, memory immune response, 
which evolves at a slower pace than the innate response. 
The adjectives naive vs memory describe T -cells that respond to either antigens never 
encountered before or to antigens for which a memory has been formed through earlier 
encounter( s ). 
A cellular vs humoral immune response discriminates between a response largely 
mediated through direct cell-cell interaction from one that is primarily dependent on 
antibody production. The T-lymphocyte vs the B-lymphocyte lineage are the respective 
main players in these two forms of responses. 
8 
., 
Stellenbosch University http://scholar.sun.ac.za
A type 1 vs a type 2 immune response is distinguished on the basis of the predominant 
cytokines (soluble proteins secreted by immunoregulatory cells) involved in a particular 
effector function. This discrimination was originally described in the mouse model2 and 
subsequently proved to be of use in the understanding of human immune responses in a 
variety of diseases3, including TB. Initially the distinction was thought to be applicable 
primarily to CD4+ T helper lymphocytes, but recent studies have shown that other cells 
of the immune system are also capable of committing- themselves to producing mainly 
type 1 or type 2 cytokines. The most important factor in T cell development towards type 
1 or type 2 is the nature of the cytokines that are present during initial T cell activation. 
By releasing specific cytokines the innate immune system directs the adaptive immune 
system towards a certain type of effector response. 4 Production of IL-12 leads towards a 
type 1 and IL-4 production towards a type 2 direction. Immune responses that are not 
clearly dominated by typical type 1 or type 2 cytokines are called type 0 responses. In 
general type 1 responses are primarily required for elimination of intracellular pathogens 
and type 2 responses for antibody mediated control of pathogens, but most often both 
types are needed for an optimal overall immune response. 
Maturation of the immune system 
Important for the context of this thesis is the notion that the immune system develops 
throughout life, from the early fetal stages to "old age". Normally, the basic requirements 
for development of immune competence are present at birth. However, full expansion of 
the. capacities of the immune system, in resemblance to the central nervous system, 
requires learning. "Maturation" is a qualification used to describe this concept. Essential 
to the learning curve of the immune system is "exposure": only the actual encounter with 
a pathogen will provoke a response and memory for a subsequent encounter. Relating age 
to maturation of the immune system, requires some kind of time-scale. Since exposures 
do not necessarily follow each other in the same order in every individual. or indeed in 
any given population, the general use of a time-scale ~ay be too simplistic. Nevertheless 
epidemiological evidence from around the world suggests that age is an important _ 
-< 
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confounding factor in data on morbidity and mortality. Pabst\ Wilson6 and Holf, authors 
of key review articles on age-related immune competence, argue that research in this field 
will help to provide us with insight in mechanisms responsible for disease susceptibility 
and/or specific expression of disease at given ages. 
Much on the development of the immune system has been learned from mouse models 
and one of the basic questions in the field of immunology has always been how the 
discrimination between self and non-self develops. At some stage(s) in the ontogeny of 
the immune system, the ability to recognize self and non-self is established and it has 
generally been assumed that this happens during intrauterine and neonatal life. In the 
1950s McFarlane-Burnett proposed that developing, potentially self destructive T-
lymphocytes, are removed from the thymus before they can mature. This process is called 
negative selection as opposed to positive selection, when self-MHC restricted 
lymphocytes are selected for survival. The classic experiments by Medawar and co-
workers8 showed that introduction of foreign tissues in neonatal mice, but not in older 
animals, induced tolerance to these tissues. Recently, a series of experiments9• 10• 11 have 
shown that, at least in a mouse model, tolerance induction might also be dependent on the 
dose of a given antigen, the adjuvant in which the antigen is presented and the amount of 
co-stimulatory help from APCs forT-lymphocytes. These studies also suggested that the 
neonatal period is not exclusive in this respect and that, given the right conditions, 
tolerance can be learned at any time during life. The whole original evolutionary concept 
of self, non-self and tolerance induction, which has been a cornerstone in immunology for 
the last decades is currently widely debated by immunologists12, who have not yet found 
a common ground. 
The ontogeny of immunological milestones, in terms of time needed to acquire a certain 
competence, differs between animals 13 and experimental models may not reflect 
adequately the order and circumstances of events in humans. However, it is reasonable to 
assume that the timing of antigen presentation, dosage of antigen as well as the presenting 
mode of a given antigen have short and possibly long term effects on the immune 
response in humans as well. For example, infections in early life may protect against 
10 
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atopy later in life14 and non-conjugated vaccines for polysaccharide encapsulated bacteria 
do, in general, not induce a protective response if given before the age of two years.15 
The degree of endemicity (number of infective bites per year) in a given region dictates 
the main age specific causes of morbidity and mortality from malaria. 16 Natural infection 
with measles virus seems to confer a higher degree of protection against atopic disorders 
when compared to vaccination against measles. 17 
A seemingly wide ranging "physiologic immunodeficiency" with respect to handling of 
infections, has made the neonatal period a comparatively well researched childhood 
period (reviewed by Wilson18), both in experimental and human models. Cord blood 
(easily obtainable material) has been used in most studies on neonates. The notion that a 
healthy neonate comes into the world as an immunologically completely naive subject, 
previously protected in a sterile uterine environment by the mother's immune system, 
cannot be upheld anymore. For example, cord blood lymphocytes of children born from 
mothers residing in Kenya, where helminth infections and tuberculosis are prevalent, 
respond to helminths and mycobacterial antigens in vitro in much the same way as their 
mothers' cells and differently from North American controls. 19 The degree to which cord 
blood represents the actual immune competence of the newborn is not clearly established, 
inasmuch as perinatal stress and maternal factors may well influence the results of studies 
using cord blood. 
In most of the literature, the immune system is regarded as competent around the age of 
five. Adolescence, a period in life where rapid changes in body functioning and 
composition take place, might be interesting from an immunological point of view. 
Adolescence is, however, difficult to model in any experimental setting. Some infectious 
diseases, like measles and varicella, if not encountered during early childhood, may cause 
serious morbidity in adolescents. Others, like schistosomiasis, often present during 
adolescence, while the infection has taken place at much earlier age. The incidence of 
autoimmune diseases rises during adolescence with different expressions of disease and 
preference for a particular sex. Hormones, increasingly known for their potential 
influence on immune processes, are probable role players. One study, focusing on 
immune function in 331 healthy adolescents aged 12-18yrs, found age- (WBC, 
11 
~' 
Stellenbosch University http://scholar.sun.ac.za
phagocytic and bactericidal activity of granulocytes), gender- (lymphocyte subtypes and 
bactericidal activity) and race- (WBC, lymphocyte subtypes, PWM responses) related 
differences in a set of enumerative and functional immune markers.20 
Quantification of immune cells throughout age 
One of the ways to quantify characteristics of the immune system is counting specific cell 
populations, by making use of the flow cytometry technique. In part, the reason for 
evaluating children of different ages with this method has been driven by the HIV-
v 
epidemic. In HIV-infected persons, absolute CD4+-lymphocyte counts relate to immune 
competence and normal values in children have been shown to differ from those in adults, 
depending on the age of the child. The numbers of subjects included in published reports 
on changes in lymphocyte subpopulations over age are not large21• 22• 23 and most of the 
studies published thus far described only absolute numbers oflymphocytes, T cells (CD4, 
CD8), B cells (CD19) and NK cells (CD56) in relation to age. A graphic display of the 
changes over age is shown in the figure below. 
Lymphocyte subpopulations over age 
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Fig: Changes of/umphocyte subpopu/ations over age (adapted from Comans-Bitter et af1) 
12 
-~ 
' 
Stellenbosch University http://scholar.sun.ac.za
Although the age-related trends of change are similar, populations from various regions 
in the world are documented to differ with respect to absolute lymphocyte, CD4+ and 
CD8+ counts.24• 25 These differences are possibly due to varying infectious pressures 
and/or genetic background in different parts of the world. Information on numbers and/or 
phenotypes of cells in relation to age from any body compartment other than blood is 
even sparser. One study found age-related changes in tonsillar lymphocytes similar to 
peripheral blood. Interestingly, this phenomenon was independent of a history of 
recurrent infections. 26 Although there is thus a demonstrable relation between age and the 
development of the immune system, how this relates to the functional aspects of the 
cellular immunity is not always obvious. 
Immune competence throughout age 
Diagnostics 
Over the past decade or two, there has been an impressive expansion of the possibilities 
in diagnostic immunology. Isolated PBMCs, with or without stimulated culture 
conditions, have been widely used to measure cellular immune responses in vitro. 
Important information has been yielded from it. However, the procedure to isolate 
PBMCs may by itself cause alterations in their functioning, and, more importantly, the 
absence of autologous serum factors may limit interpretations with regard to in vivo 
conditions. Furthermore the methods used to measure cytokines are potential sources of 
variations: detecting protein or the corresponding mRNA, the nature of a stimulating 
agent and the presence of accessory cells in a culture system may all result in differing 
conclusions. The use of a whole blood culture system, whereby there is no need for cell 
separation and cells are cultured with all the autologous components of peripheral blood 
has been validated and used increasingly in recent years.27• 28• 29• 30 Advantages of this 
method are a simpler way of processing blood, the possibility of using of smaller blood 
volumes and the probability of better approximation of in vivo conditions. A potential 
disadvantage is that subsets of cells cannot routinely be scrutinized for their functioning. 
Apart from the technical procedures used to evaluate immune competence, d,ifferences in 
study populations (age groups, gender, race and living environment) should be taken into 
13 
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account when comparing study results. Notwithstanding these comparative limitations, a 
number of publications have, quantitatively and/or qualitatively, provided more detailed 
insight in immune competence of selected age groups. 
Naive vs memory cells 
One of the striking age related variations in T cell populations is the ratio of 
CD45RA+RO- (naive type) and CD45RA-RO+ (memory type) subsets in CD4+, CD8+ 
as well as yo T -cells. Naive type cells are involved in the primary immune response after 
an initial encounter. Memory type cells are responsive to recall antigens and their clonal 
expansion is thought to be driven by environmental antigens; adult levels are generally 
attained between 15-20 years of age. The two cell types require different activation 
signals and may secrete other cytokines in response (reviewed by Akbar1). Additionally, 
the availability of co-stimulatory help and the dose and nature of antigens will likely 
prove to differ, as in mouse models.32 Thus, age-related quantitative variations in naive-
and memory- T- populations probably result in different qualitative effector functions. 
Cytokines 
IFN-y 
IFN-y, produced mainly by T cells and NK cells, is regarded as the archetypal type 1 
cytokine. Its major biologic effects are activation of macrophages with respect to 
intracellular killing of pathogens; upregulation of MHC class I and class II expression on 
macrophages; downregulation of type 2 immune responses and induction of isotype and 
class switching by B-cells to produce IgG1, IgG3 and IgE antibodies. It is generally 
accepted that the ability to produce adult-equivalent levels ofiFN-y is not attained before 
the age of 3-5 yrs.7 One of the contributing factors to this phenomenon is the fact that 
naive T cells, if compared to memory T-cells, are deficient in producing this cytokine.33 
Evidence for other mechanisms has, however, been put forward: T -cell clones from 
cultured neonatal cells do not have the adult capacity to produce IFN-f4 and turnover 
rates from naive to memory cells are not the same in neonates and adults.35 While young 
childrens' PBMCs may produce as much IL-2 upon stimulation with PHA, their capacity 
to produce equal amounts ofiFN-y is diminished compared to PBMCs from adults.36 
14 
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TNF-a 
TNF -a, produced by mononuclear phagocytes, T-cells and NK cells, is considered an 
important pro-inflammatory cytokine .. When produced in excess, it is also well known for 
its systemic side effects like fever, cachexia and tissue destruction in a variety of diseases. 
Its production is counter-regulated by anti-inflammatory cytokines like IL-1037• 
Production upon mitogenic stimulation seems to be age related, with neonates producing 
less than older individuals. 18• 38 However under pathologic conditions, like bacterial 
meningitis39 and malarial disease40 young children are quite capable of producing high 
"\c 
levels of TNF -a. Interestingly, a study on cellular responses to N. meningitidis antigens in 
patients and controls of different age groups, found stimulated TNF -a production to be 
age-related in controls (higher in older children), but not in patients after meningococcal 
infection.41 
IL-2 
IL-2 is produced by T lymphocytes upon activation and is a major growth factor for T 
cells, as well as B cells and NK cells. Its production is probably not age dependent under 
most circumstances although naive cells have a higher capacity to produce IL-2 than 
memory cells. Consequently one might expect a relatively high or at least equal 
production in young children.42 On the other hand isolated neonatal T cells produce less 
IL-2 than those of adults. 18 
IL-12 
IL-12 is produced by antigen presenting cells that have been exposed to various microbial 
antigens. Capable of bridging the innate and the acquired immune system, it can directly 
activate NK cell function (killing). Indirectly, via inducing IFN-y production by NK cells 
and T lymphocytes, it promotes effective killing by phagocytic cells. As a strong 
promotor of type 1 immune reactions in general, it may also indirectly inhibit type 2 
responses or even cause a switch from an established type 2 to a type 1 response.43 No 
reports on age related IL-12 production have been published, however IL-12 seems to 
exert differential effects on cord blood naive CD4 cells when compared to adult naive 
15 
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CD4 cells: it promotes the maturation of cord blood naive cells into IFN-y as well as IL-4 
producers.44 
IL-10 
IL-l 0 is produced predominantly by mononuclear phagocytes, but also by CD4+ T cells 
and B-cells. In mice, IL-l 0 is generally classified as a type 2 cytokine. Pathways for 
production in humans are somewhat different in that production is stimulated by IFN-y as 
well as TNF-a and not solely regarded as a type 2 cytokine.45 IL-10 has potent anti-
inflammatory properties and can actively downregulate levels of IFN-y, TNF-a and IL-
12. On the other hand, IL-10 promotes B cell proliferation and differentiation, which 
accounts for its immuno-stimulatory properties. Studies of IL-l 0 production by cells from 
cord blood or young children were studied did not show a low production per se, but most 
of these studies were not designed to address a possible age relation.46' 39 In Pollards' 
study of responses to N.meninigitidis antigens41 an age related production of IL-10 
(higher with increasinR age) was suggested, but did not reach statistical significance. 
TGF-~ 
TGF-~ can be produced by virtually all cells, including immunologically active cells.47 
The three mammalian isoforms seem to have specific functions in vivo and need to be 
activated from their latent form in order to become biologically functional. TGF-~ has 
counter-regulatory effects on proinflammatory cytokines. No studies with regard to age-
related production have been published. 
IL-4 
IL-4, produced by T cells, mast cells and basophils, is one of the cytokines typically 
involved in type 2 immune reactions. It can stimulate B cells to synthesize IgE and act as 
a co-factor in T and B cell growth. Furthermore it can inhibit macrophage functions. IFN-
y is able to antagonize some of the effects of IL-4. Age related production upon 
stimulation with mitogens, lower at younger age, has been elegantly shown in a series of 
experiments by Tang et al.48 They also concluded that the mechanisms responsible for age 
"-
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related production may involve naive/memory subpopulations, as well as inhibitory other 
cellular or serum factors. However, Holt's group has shown that Il-4 production after 
stimulation with specific antigens may well differ in this respect. After stimulation with 
housedust-mite allergen, production of IL-4 was high in non-atopic children and declined 
with progressive age, but was low at birth with a subsequent rise to a sustained high level 
in atopic children.49 
(Knowledge of the age-related production capacity of other cytokines, chemokines and 
growth stimulating factors as well as cytokine-receptors and co-stimulatory molecules, is 
either not available or will be addressed at a later stage in the text of this thesis) 
Antigen presenting cells 
APCs deserve special mention, since so little is known about their function at different 
ages and it has become increasingly clear that they are key players in the type of immune 
response that follows encounter with an antigen. In dendritic cells from the respiratory 
tract of neonatal mice, local hyporesponsiveness to stimulatory signals when compared to 
adult mice has been demonstrated. 50 Various researchers have combined cells from 
subjects of different age groups in vitro. Their experiments were mainly designed to 
clarify if (purified) T -cells were intrinsically incapable of a particular effector function. If 
it was found that with "adult help" (APCs from adults), T cells or leukocytes from 
younger subjects behaved similar to those from adult subjects, it was concluded that 
deficiencies of APCs from younger subjects were the probable cause of this 
phenomenon. 51• 52 Differences in expression of receptors on T cells and/or co-stimulatory 
molecules on APCs, which could explain poorer cross-talking between the cell 
populations have also been found in these studies. The mixing of cells from young 
children with those from adults is, however, not a natural in vivo condition. 
In future, when some of the mechanics involved in deficient antigen presentation in 
young children are unraveled, it will probably have implications for interventional 
strategies like vaccination. The, already mentioned, recent findings on tolerance induction 
in mice (dependency on dose, mode and co-stimulatory help )9• 10• 11 may well prove to be 
of strategic importance for future research in this respect. 
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B cells 
"The" immune response in vivo is determined by all cells· involved and attention towards 
components other than the cellular arm of the immune system is entirely justified, but 
given the scope of this thesis beyond a detailed discussion. The reduced capacity before 
the age of two to produce a sustained and memorised antibody response to so called T-
cell independent antigens (mostly bacterial polysaccharides) is, despite the name given to 
these antigens, at least, in part, likely to be due to insufficient help from T cells.53 This 
illustrates that the cellular and humoral arms of the immune system are seldom totally 
independent of each other. Maturation ofB cells follows, however, a different path than T 
cells. 54 The ability to respond with the production of antibodies of a certain class 
develops quite chronologically with age, reaching adult type levels only after the teenage 
years. 55 Furthermore the different phenotypic characteristics of the B-cell population at 
birth gradually evolve towards adult type over age with a reduction in CDS+ B cells, the 
dominant polyreactive type of B-cell at birth.56• This maturational process has 
implications for the functionality of the antibodies produced: low-affmity/polyreactive at 
young age vs high affinity/specific at older age. 57 
The notion that immune responses at an early age (in mice and man) are more readily 
skewed towards type 2 has been around for some time. However, it has recently become 
increasingly clear that environmental factors, be they of infectious or allergic nature, may 
have considerable influence on the degree to which a skewing towards one or the other 
type of immune response develops from birth onwards.14' 48 Age is probably an 
independent variable in this process, but the quantity and nature of environmental factors 
may prove to be just as instrumental. 57 
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The layered evolution of the immune system 
Much of the literature on the development of the immune system uses terms like 
"deficient" or "immature" when describing differences between young subjects compared 
to adult counterparts, thereby implying that adult immune functions might be superior. 
Herzenberger et al 58 propose that: 
" ... The evolution of the immune system is layered, whereby evolution sequentially gives 
rise to lymphocytes that are similar to their predecessors, but have either lost or gained 
functional capacities. Inasmuch as the evolutionary success of the latest layer in such a 
system depends on its ability to introduce a selective advantage, each new layer can be 
expected to increase the sophistication of the immune system with respect to its ability to 
efficiently protect the animal against challenges from its environment ... " 
The maturation of the individual's immune response throughout life reflects such a 
layered evolution whereby the system evolves from versatile to more efficient, which if 
given the multitude of immunologic challenges shortly after birth, is probably the most 
adequate from an evolutionary perspective. 
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Immunobiology of tuberculosis 
Introduction 
The sequence of possible events that occur within the host after encountering Mtb is the 
result of an active and complex interplay between host and the mycobacterium. Of central 
importance in these events are the host's immune response and the ability of Mtb to 
evade, stimulate or suppress that response. 90% of people infected with Mtb are, during 
their lifetime, able to limit the potential damage triggered by infection with Mtb and 
manage to keep a balance in favor of protection from disease. TB can be considered as a 
disease of the immune system, whereby the trigger and, in part, the ongoing stimulus for 
pathology is provided by Mtb. The cell mediated immune (CMI) response is universally 
regarded as the cardinal role player in any reaction to Mtb from the immune system. 
Macrophages, in their various stages of activation, and T-lymphocytes are considered the 
crucial cells. The functions of dendritic and NK-cells are probably important, but less 
well defined at the moment. Although a role for the humoral immune system, recently 
reviewed by Glatman et al60, can certainly not be ruled out, the nature of such a role is at 
present ill defined and will not be considered in any detail. 
Conflicting results between studies addressing the immune response in TB have been 
obtained. Differences in the models (animal or human in vitro studies), subjects under 
study (animals or humans in vivo) and techniques used, contribute largely to this 
problem. Knowledge gained of immune responses in humans forms the backbone of this 
overview, unless stated otherwise. 
The pathogen: Mycobacterium tuberculosis 
Tubercle bacilli are non-motile rods, measuring between 1 and 4J.lm in length and 0.3 to 
0.6J.lm in diameter, considered Gram positive, although they stain poorly by the usual 
Gram stain procedure. After heating and dye fixation, they resist decolourisation by acid 
treatment (acid-fast bacilli). They are obligate aerobes that grow very slowly, with a 
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doubling time of about 20-24 hrs under optimal conditions. They posses a complex and 
lipid-rich cell envelope, which probably accounts for a number of its unusual 
characteristics: they resist chemical and physical stress and are impermeable to many 
antimicrobials. 61 Furthermore, Mtb has the potential to evade or counteract a number of 
immune attacks by the host relying on a strategy that enables its survival within the host 
cell in the phagosomal vacuole, from where it can secrete antigens into the cytoplasm. 
Lipoarabinomannan (LAM), a cell wall associated lipopolysaccharide produced in large 
amounts by Mtb, has been associated with active induction of cytokine transcription by 
macrophages.62 Phagosome-lysosome fusion within the macrophage normally provides an 
(acidic) environment in which the intracellular killing of bacteria takes place. M tb has 
the ability to block formation of a phagolysosome and produce NH4+, thus making the 
environment non-acidic. Recently it has been suggested that the virulence of a given Mtb 
strain may be related to its speed of replication in macrophages. 63• 64 M tb has the capacity 
to survive in a "dormant" state within the macrophage for as long as the lifetime of the 
human host or become pathogenic many years after the original infection. The 
mechanisms by which the bacillus survives during this period of "latency" are still a 
mystery. Breakdown of this balanced system between immune response and pathogen 
causes "reactivation TB". 
Macro phages 
Macrophages act as the principal effectors of protective reactions of the host, but have, at 
the same time, the dual role of being the preferred biotype for M.tb. They serve as antigen 
presenting cells to T -lymphocytes and can, when activated by T cells, effectively kill 
Mtb. In their end stage of differentiation they form part of the granuloma as giant or 
epitheloid cells. Mtb can enter the macrophage via specific binding to a number of cell 
surface molecules (macrophage mannose receptor, complement receptors CRl, CR3 and 
CR4, signalling receptor CD14, and possibly some Fe receptorst5; phagocytosis follows 
subsequently. The signals for killing, mediated through cytokines and chemokines, are 
provided by lymphocytes as well as the macrophages themselves. 
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T -Lymphocytes 
Of all the T-lymphocytes involved in host defense against Mtb, the CD4+ T-cells are 
probably the major inducers of protection. Mice depleted of CD4+ cells are unable to 
control mycobacterial infection, adoptive transfer of CD4+ cells from sensitized animals 
confers protection66 and humans with diminished CD4+ cell counts have an increased 
susceptibility to tuberculous disease. CD4+ cells amplify the immune response by 
activating effector cells like macrophages and enabling them to kill Mtb. They also 
recruit additional immune cells to the site of disease and are prominently present in the 
lymphocytic layer of the granuloma. Peptide antigens that have been processed by 
phagocytic cells are presented in the context of MHC class II molecules to the a/!3 
receptor on the surface of the CD4+ cell. Little is known about help from co-stimulatory 
molecules in activating the T -cells in TB, but one study in this field67 reported down 
regulation of CTLA-4 expression in TB patients. Memory T cells proliferate and produce 
IFN-y in response to Mtb68 and are presumed to be predominant in local immune 
defences. Human naive T cells have hardly been studied specifically for their potential 
role in the immune response to Mtb, but one study designed to address this issue, found 
that upon priming with Mtb or a subunit antigen (Ag85B) these cells were able to 
produce IFN-y. Interestingly this was not dependent only on IL-12 production, since IL-
12 antibody in this (highly experimental) system did not eliminate all IFN-y production.69 
Mice, deficient in functional CD8+ cells, are more susceptible to mycobacterial infection 
and show enhanced pathology in the lungs. 70 The role for CD8+ cells in human TB is less 
clearly defined. They are present at the site of disease, but in one study successful 
treatment resulted in decreasing numbers of CD8+ cells, while numbers of CD4+ cells 
rose in peripheral blood and BAL fluids from TB patients.71 They do however seem to 
contribute to cytolitic activity of human M.tb infected cells72 as well as IFN-y production 
upon stimulation ofPBMCs with Mtb.13 
In much the same way the role of yf:J T -cells in human TB is inconclusive. Expansion of 
these cells in peripheral blood from healthy Mantoux positive individuals upon 
stimulation with mycobacterial antigens and decreased presence of yf:J T -cells in BALs 
from diseased patients relative to non-TB diseased individuals suggest a role in protection 
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from disease.74 They are probably involved in the initial response to infection and are 
potent producers of IFN-y after mycobacterial stimulation. In a recent review on the 
subjece5 a complementary role to CD4+ cells is suggested for yo T -cells, primarily in and 
around maturing granulomas. 
Cytokines 
Knowledge of the dominant cytokines (type 1 vs 2) produced by particular cells involved 
in the immune response may lead to valuable insight in the pathogenesis of a variety of 
diseases. Over the past decade or so, the role of cytokines in mycobacterial infections, as 
in other infectious diseases, has been widely studied. Production of a type 1 cytokine 
profile by T -cells is crucial for protection from mycobacterial disease, as can be inferred 
from numerous animal and human studies. Whether a type 2 profile is linked to 
susceptibility to disease is less certain in humans as opposed to some animals. 
IFN-y 
A central role for IFN-y in protection from TB is generally assumed on the basis of 
animal and human data. As the main activating factor for murine macrophages to enhance 
mycobacterial killing, it has been well researched in mice models of TB and defmed as 
being crucial to the host's defence. However, human macrophage cell lines are not able to 
kill mycobacteria as effectively in vitro upon activation with exogenous IFN-y. An 
intermediate role for 1,25(0H)2D3 in this respect has been shown.76 Recently a likely 
mechanism by which 1,25(0H)2D3 can enhance mycobacterial killing, namely by 
upgrading nitric oxide production, has been described.77 IFN-y, in conjunction with TNF-
a, does have the capacity to stimulate 1,25(0H)2D3 production by human macrophages in 
vitro through activation of 1-a hydroxylase, the enzyme that converts 25(0H)D3 to 
1,25(0H)2D/8 This link in the pathogenesis of human TB is further strengthened by the 
fact, that alveolar macrophages from TB patients, recovered by BAL, produce more 
1,25(0H)2D3 than control patients suffering from sarcoid.79 
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IFN-y receptor deficiency is now a well established risk factor promoting disseminated 
mycobacterial disease in humans.80• 81 
A number of studies of IFN-y production by PBMCs from adult patients suffering from 
active TB, have found decreased levels if compared to healthy Mantoux positive 
controls82•83 , although this diminished production in the periphery has not always been a 
consistent finding. 84 However, at the site of infection, in pleural and BAL fluids of TB 
patients, the production of this cytokine seems abundant85•86' suggesting 
compartementalisation of the immune response in TB. A potential negative effect of "too 
much" IFN-y at the site of disease might be increased inflammation at the cost of tissue 
necrosis, but this phenomenon has been more widely attributed to TNF -a. 
TNF-a 
Human mononuclear cells and alveolar macrophages produce large quantities of TNF-a 
in response to stimulation with M tb and specific mycobacterial antigens like LAM. 87 In 
vitro, addition of TNF-a to human and animal macrophages enhances mycobacterial 
killing. In vivo, at the site of infection, proper granuloma formation in mice seems, in 
part, dependent on adequate levels of TNF -a. 88 
Symptoms like fever, cachexia and extensive tissue damage in very ill TB patients have, 
on the other hand, also been attributed to excessive amounts of this particular cytokine. 89 
In a rabbit model ofTBM, high TNF-a levels are correlated with more extensive disease 
and clinical detonation of the animals.90 An additional argument for the role ofTNF-a as 
a contributor to immunopathology relates to the finding that thalidomide, a selective 
inhibitor of TNF-a production by monocytes, seems to reverse some of the tissue 
necrosis in mice.91 
IL-2 
IL-2 is a growth factor for expanding antigen-reactive T -cells, thereby increasing 
concentrations of macrophage activating factors. In trials of mice with Mbovis infection, 
humans with lepromatous leprosy and humans with multidrug resistant TB who were 
treated with intra-dermal recombinant IL-2, an enhancement of the antimicrobial response 
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by a reduction in the bacillary load and improvement of clinical status was shown.92• 93 
Interestingly, in cattle infected with virulent and attenuated strains of Mbovis, only the 
virulent strains induced high levels ofiL-2 (and IFN-y) production by PBMCs .94 
IL-12 
IL-12, an important inducer of type 1 T cell responses, has been shown in increased 
concentrations in pleural fluids and lymph nodes of TB patients.95 Cross regulatory 
interactions with IL-10 have been shown in vitro in PBMCs co-cultured with Mtb 
Erdman. 68 Poor granuloma formation in patients with disseminated atypical 
mycobacterial disease has been documented as a result of either a lack of functional IL-
12R complexes, due to a mutation in the IL-12RI31 gene, or a mutation in the IL-12p40 
gene. 96,97 
IL-10 
The anti-inflammatory cytokine IL-10 is produced in response to Mtb in vitro by murine 
and human macrophages and T cells. Furthermore PBMCs from adult TB patients 
produce higher levels of this cytokine than controls98 and elevated serum levels of this 
cytokine in patients with active TB have been described.99 Despite a down-regulating 
effect on inflammatory cytokines like IFN-y and TNF-a., this might be of potential benefit 
at the site of disease in limiting tissue damage. IL-l 0 has been demonstrated at the site of 
pathology in a study of tuberculous pleural fluids86, but not in a recent study where BAL 
fluids from patients with intrapulmonary TB were examined. 85 
TGF-13 
TGF-13 production is induced by Mtb and PPD in blood monocytes and TGF-(3 mRNA is 
expressed in epitheloid and Langhans cells of tuberculous granulomas. 10° Cell wall 
components from Mtb (LAM) and secreted mycobacterial proteins (30-kDa a antigen) 
are also able to stimulate TGF-13 production by monocytes. 101 Higher values of this 
cytokine are measured in the supernatants of monocyte cultures from patients as 
compared to those from healthy tuberculin reactors. This might result in the suppression 
of peripheral T-cell responses in TB patients, by reducing IL-12RI31 and IL-12RI32 
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expression, a phenomenon reversible in vitro by addition of natural inhibitors of TGF -13 
to the culture system.102 At the site of infection there may a potential beneficial effect of 
this protein as an antagonist and down regulator of TNF -a. and thus in limiting 
immmunopathogenic effects. Furthermore TGF-13 can promote fibrosis and 
angioneogenesis. 103 
A variety of other cytokines, chemokines and other soiuble factors have been studied in 
relation to Mtb in a number of experimental models. Thus far information on their role in 
human TB is very limited. Of particular interest in this respect is the function of IL-4, a 
prominent type 2 cytokine in humans and animals and recognized down-regulator ofiFN-
y production. In murine models of TB, lymphocytes from susceptible mice produce 
higher levels of' IL-4 than resistant mice, although mice with disrupted genes for IL-4 
display a normal resistance to infection with Mtb. 104 Nor has it been shown in any 
consistent way that elevated IL-4 production is related to disease in humans, perhaps in 
part due to technical constraints in measuring IL-4. 105 Elevated levels of IL-5, another 
type 2 cytokine produced by lymphocytes and of interest because of its role in helminthic 
infections, have recently been implicated in diminished protection from disease in 
humans. 106 
The granuloma 
Granulomatous inflammation can be defmed as a speCial variety of chronic inflammation 
in which cells of the mononuclear phagocyte system are predominant and take the form 
of macrophages, epithelioid cells and multinucleated giant cells. In addition a mixture of 
other cells, lymphocytes, plasma cells and fibroblasts are usually present. 107 A granuloma 
is usually regarded as a means by which the host defends itself through walling off a 
persistent exogenous or endogenous agent, hence containing it and possibly destroying it. 
Tissue damage during the active phase of inflammation and fibrosis during the healing 
process are frequent results. The tuberculous granuloma is classically characterised by the 
presence of central caseous necrosis in which acid-fast bacilli are present, although 
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neither a non-caseating granuloma nor the abcence of identified acid-fast bacilli exclude a 
tuberculous origin. 
Developmental stages of granuloma formation have been best studied in the rabbit 
models of Lurie. 108 On the basis of these studies two, somewhat different, immune 
responses by the host are recognized. The cell mediated immunity (CMI) reaction is 
responsible for activating macrophages to kill ingested bacillli, through expansion of the 
population of specific T -cells and attraction of monocytes from the bloodstream into the 
lesion. The delayed type hypersensitivity (DTH) reaction kills bacilli-laden non-activated 
macrophages, thereby eliminating the intra-cellular environment so favorable for 
bacillary growth. DTH responses are accompanied by caseous tissue necrosis. A positive 
Mantoux skin test is regarded as a DTH reaction. Both responses, CMI and DTH, are in 
principal complementary and beneficial to the host, but have failed one another when the 
host is diseased. If failing, the DTH reaction in particular can cause important pathology 
within the host. The types of cytokines produced by the cells within the granuloma are 
thought to play an important role in its destiny. This has best been studied in situ in 
leprosy, where type 2 cytokines are predominant in lepromatous leprosy, which is the 
most severe presentation of this disease. 109 In tuberculoid leprosy, the more benign 
variant, type 1 cytokines dominate. Deficiencies in receptor genes for the type 1 
cytokines IFN-y and IL-12 are correlated with a spectrum of defective granuloma 
formation in individual patients with mycobacterial infections. 81 Steroids have been 
shown to influence granuloma formation and disease outcome in experimental models. 
Dehydroepiandrosterone (DHEAS) and cortisol (if given exogenously to mice infected 
with M tb) differentially influence granulomatous pathology with DHEAS favoring a type 
1 and cortisol a type 2 dominant cytokine profile.· However outcome of disease seems to 
depend quite critically on the ratio of their concentrations and timing of administration. 
At appropriate dosages and intervals they may both have beneficial effects. 110 
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Immunobiology of tuberculosis during childhood 
Studies of the immune responses related to TB in children have historically been driven 
by the need for improvement of diagnostic tools and vaccination strategies. Antibody 
mediated responses have been the focus of many of these studies and have, unfortunately, 
yielded very little information in either of these areas. Very few studies involving 
children and their cellular immune responses in relation1o TB have been published. Dieli 
et al111 compared lymphocyte proliferation after stimulation of PBMCs with PPD and a 
peptide derived from the 38kDa Mtb protein (p38G) between children with TB and 
healthy Mantoux positive as well as Mantoux negative children. Stimulation with PPD 
resulted in similar proliferative responses by patients and Mantoux positive controls. 
p38G stimulation however in diminished responses by the patient group. This study was 
also designed to look at potential differences in al3 and yo T cells enumeration's before 
and after stimulation; there were none before stimulation 'and patients and healthy 
controls did not differ in this respect after stimulation. Swaminathan et al112 report on 
cytokine production by PBMCs from children with TB compared to Mantoux positive 
children without TB. IFN-y production was diminished in the TB diseased group, 
whereas IL-12, IL-4 and IL-10 productions were similar in the two groups. In the 
Gambia, studies have been conducted in young infants to measure IFN-y production after 
BCG vaccination. 113 It was found that PBMCs from vaccinated young infants are quite 
capable to produce this cytokine after stimulation with BCG in vitro. Donald et al114 have 
found high levels of IFN-y in cerebrospinal fluids of patients with TBM at diagnosis and 
persisting during 4 weeks on treatment whereas the latter is not a phenomenon commonly 
found in other types of bacterial meningitis. 
Immunodiagnostics for TB 
Immune-based diagnosis of TB has, for a long time, been impeded by the fact that there 
were no reliable methods to measure functional cellular immunity, while antibody-based 
technology proved to be neither sensitive, nor specific enough. Over the past decades, our 
improved understanding of the cellular immune system has resulted in an explosion of 
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techniques to measure cellular immune function, form gene to protein. The urgent need 
for better and faster diagnostic tools in TB as well as identifiable correlates of protection 
from TB, has recently driven the research into human cellular immune responses in TB. 
Results are not always consistent and sometimes confusing, often due to the practical 
constraints of measuring a response to a pathogen that causes disease in only 10% of 
infected persons during their life-time, while having a seemingly comfortable symbiotic 
host-parasite relationship in the other 90%. Furthermore the disease causing mechanisms 
are multi-factorial in origin, the major site of pathology is not easily accessible for 
diagnostic purposes and Mtb shares a substantial number of antigens with other, non-
pathogenic, mycobacterial species. An extensive array of antigens, from mycobacterial 
wall components to culture filtrate proteins, has been used to probe the immune response 
in TB. PPD, prepared by precipitation of proteins from heat-killed Mtb, has been the 
most widely used, but is not specific for Mtb. ESAT-6, a short term culture filtrate 
protein of low molecular mass, is one of the interesting antigens for diagnostic purposes 
and has been quite extensively studied in different populations. Its gene is restricted to 
the tuberculosis complex, including Mbovis but importantly none of the BCG strains, 
and only three environmental mycobacteria (Mkanasii, Mmarinum and Mafricanum). 115 
ESAT-6 stimulation induces IFN-y production by PBMCs from TB patients, but not in 
healthy subjects that have been immunised with BCG. Identified contacts of TB patients 
have been to shown to have variable ESAT-6 responses116, possibly related to their actual 
infection with M tb as has been implied in another study117• 
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Tuberculosis: age as a variable 
Risk for infection 
Although a range of animals can be infected with M tb and become diseased, humans are 
the only known natural reservoir for Mtb. Transmission usually occurs through 
inhalation of infective particles from a diseased individual, who generates these in the air 
by coughing, sneezing or merely speaking. The risk of a person getting infected is 
dependent on a number of known and unknown factors. Infection occurs more readily, 
but not exclusively118, from a source that is sputum-smear positive than from a smear-
negative index case. The number of infective bacilli that are present in the air plays a role 
and consequently the space (size, ventilation) in which one is confined at the time of 
inhalation, as well as the amount of time spent in contact with the infective source.119 
Socioeconomic conditions like poverty, crowding and urbanization are linked to 
increased rates of infection. The virulence of the strain is most probably important, as can 
be postulated from reports on outbreaks.120 Ethnicity may play a role as has been shown 
in a report on residents in nursing homes in Arkansas (US) when twice as many blacks as 
whites became infected121 , but not all studies confirm this122• The ability of a person to 
resist infection may also be dependent on immunological mechanisms, as can be assumed 
from Lurie's experimental rabbit model, in which he showed that natively resistant 
rabbits were less susceptible to the establishment of infection.123 No human homologue 
for resistance to infection has been found to date. 
Whether age as an independent variable influences the risk of getting infected with M tb 
after exposure is uncertain. Certainly the prevalence of infection rises throughout 
childhood and adolescence in any given population124, but most studies have not included 
enough very young children to make a valid statement concerning this matter. Some 
animal data suggest that newborns are more susceptible to infection.125 
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Mantoux Skin testing 
The most sensitive diagnostic tool we have for identifying infected persons is the 
Mantoux skin test, whereby purified protein derivate (PPD, derived from Mtb culture 
filtrates) is injected intradermally. The size of the skin induration at the site of injection, 
caused by a delayed hypersensitivity reaction in the skin, is measured 72 hours after 
injection. The test becomes positive 6-8 weeks after infection. It is used for diagnostic 
purposes in individuals and as an epidemiologic tool to determine the prevalence of 
infection in populations. 
However, despite it being our most sensitive tool for diagnosis of infection, it is an 
inadequate one. There are technical difficulties in performing the test that may raise 
uncertainty over some results. Prior BCG vaccination and exposure to environmental 
mycobacteria may both influence the size of the induration, thus diminishing the 
specificity of the test. An estimated 5% of people are anergic to the test and patient~ with 
TB can revert to a negative skin test during the acute phase of their illness. The positive 
and negative predictive values of the test are dependent on the prevalence of infection 
with Mtb in a given community. 126 Partly for this reason, the cut-off point that is regarded 
as a positive test result varies between countries and populations. Evidence for a recent 
infection in an individual is only provided by a recent skin test conversion from negative 
to positive and previous test results are not always available. Certain conditions, like 
AIDS, can render people non-responsive to PPD. In adult AIDS patients, this non-
responsiveness is related to the number of CD4+ cells in peripheral blood.127 A childhood 
infection like measles may also depress the magnitude of the induration for more than 10 
weeks after the acute disease period. 128 
Age is an aspect to consider in the interpretation of Mantoux skin test results. Children 
have higher rates of anergy than older people do. 129• 13° Furthermore, the length of time 
after BCG vaccination has been shown to have an effect on the magnitude of the 
induration. 131 Under epidemic conditions a positive skin test in a person older than five, 
is not necessarily indicative of a recent infection, because of the high annual risk of 
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infection. The epidemiological context, including that of the country of origin of 
immigrant populations and their relevant risk of infection, has to be taken into 
consideration when results are being interpreted. 
Risk for disease 
The risk of becoming diseased after infection is also dependent on a number of known 
and probably a greater number of unknown factors. Time since infection is a risk factor, 
the risk being highest ( 45%) within two years of infection, while the lifetime risk of 
disease development after infection is estimated at 10%.132 This is, however, dependent 
on the immune status of the infected individual, genetic factors, sex and the age at which 
one is infected. HIV infected persons have an approximate 10% per year risk ofbecoming 
diseased. However that risk varies with their immune status: the lower the CD4+ counts 
the higher the risk of tuberculous disease133 and, interestingly, also the higher the chance 
of getting disseminated, rather than pulmonary types of TB.134 The timing of infection 
with M tb also matters: the risk for tuberculous disease is larger if the infection with M tb 
occurs after HIV infection, rather than the other way around. 132 For other conditions 
influencing the immune system, inCluding immunosuppressive drugs like corticosteroids, 
the increased risk for disease has been much less well quantified. Even without a known 
or demonstrable immunodeficiency, the host's immune response is still arguably the most 
important determinant of disease. But again socioeconomic circumstances are influential 
as well: known risk factors from epidemiological evidence are malnutrition and general 
poor health. Although speculation around certain vitamin and mineral deficiencies as 
contributors to the development of TB exists, unequivocal proof has not yet been 
provided for most of them. Vitamin D deficiency is possibly one such risk factor for 
which at least some in vitro data77•135 support the epidemiological evidence of vitamin D 
deficiency (defined as low 25-hydroxyvitamin D3) contributing to the risk for 
tuberculous disease in parts of the world.136 However, no in vivo study, controlled for 
seasonality, ethnicity and age, has had the power to show this in humans to date. Vitamin 
A deficiency may be common in patients with TB.137 Recently a number of genetic 
factors have been identified in susceptibility to TB. Four NRAMP1 gene polymorphisms 
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have been linked to the development of tuberculous disease in the Gambian population. 138 
In the same population a vitamin D receptor (VDR) polymorphism has been linked to 
disease. 139 The main problem with both these studies is the choice of the control 
population: blood bank donors without known tuberculin status. The function of the 
NRAMP gene in humans is ill defined, while polymorphisms in the murine NRAMP 
genes are related to risk of infection rather than disease140 and the VDR polymorphisms in 
humans relate to bone densities rather than vitamin D status. Much easier to explain from 
a functional point of view, is, as already mentioned in the previous chapter on the 
immunobiology of TB, the vulnerability that persons with a partial or complete 
interferon-y (IFN-y) or IL-12 receptor deficiency have for diseases caused, by 
mycobacterial species.81 
Age has long been recognised as an important determinant for the development of TB. In 
Comstock's large study of skin testing in Puerto Rican children the major risk factor for 
developing disease in tuberculin reactors was age. 141 
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Children under 4 years of age had the highest rates of disease (and the most serious 
complications); a second peak was observed in persons of about 20 years of age. In any 
population children m~der the age of five have relatively high rates of disease after 
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infection, falling to a life time low between the ages of six to about twelve ("the golden 
age of TB"), only to rise again during adolescence. Depending on the prevalence of 
infection in a given population, the incidence of disease continues to rise, peaking at 
about 35 years (under epidemic conditions) or in old age (in low prevalence areas). The 
age-related incidence of disease in the Western Cape (SAY42, an area with a very high 
prevalence of infection, is shown in the figure below: 
TB incidence Western Cape, South Africa, 1989 
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The shape of this curve is similar to others from populations with a high incidence of TB 
and shows remarkable similarity to the age-mortality curves from the pre-chemotherapy 
era as described in the classical paper by WH Frost. 143 The prevalence of infection in any 
given population is arguably the single most important risk for age-related morbidity and 
hence the shape of the curve144, but one cannot escape the notion that age may be an 
independent variable in the relative risk for development of disease after infection with 
Mtb. 
Depending on the age period under study, sex differences are recognised. Boys are 
usually over represented in the very young children.145• 146 During adolescence and early 
adulthood, the incidence of disease in most populations is highest in females. 147 After 
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about the age of twenty-five up to menopause, females consistently have lower rates of 
TB than males. 
Tuberculous disease 
The natural history ofTB is intrinsically difficult to study, not in the least because ofthe 
lifelong risk of disease after infection and the variability of signs and symptoms. 
Furthermore, we have to depend largely on reports from the pre-chemotherapy era. To 
complicate matters not all authors have agreed on termino)ogy for the different 
expressions of disease, something that still hampers present day communications on TB. 
A concise description of the pathology following infection with Mtb is given below, 
~awn from a large number of references of which the seminal book "The pathogenesis of 
tuberculosis" by Arnold Rich148 and a more recent publication written by John McKinney 
et al149 were the most influential. 
The primary focus is the structural change in a tissue at the site of implantation of the 
tubercle bacillus. The primary complex is composed of the primary focus and the 
accompanying regional adenitis. Since the primary focus is nearly always located in the 
lungs, the primarily affected regional lymph nodes are usually also located 
intrathoracically. True congenital TB is one of the rare exceptions with a primary focus in 
the liver and the regional adenitis around the porta of the liver. Most authors also argue 
that a degree of lympho-haematogenous spread of bacilli takes place after establishment 
of infection. The subsequent fate of the primary complex varies greatly and is dependent 
to a large extent on the local and systemic immune response of the host. It is of 
importance to realize that the immune system of the great majority of people deals with 
an infection without any signs or symptoms other than a positive skin test conversion. 
The primary complex may vanish completely before or after calcification. However, in 
conventional thinking, we consider the host sensitized and consequently, at least partly, 
protected from complications of a possible reinfection. Primary TB is, by definition, ariy 
form of tuberculous disease that is the consequence of a primary infection, even if the 
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complication occurs years after the first encounter with the pathogen. Wallgren's 
timetable of primary untreated tuberculosis is still a useful tool to illustrate this150• 
Timetable of primary tuberculosis (A. Wallgren} 
Primary complex 
Miliary & Meningeal 
Bronchial perforation 
Pleural effusion 
Initial fever 
Skeletal 
Renal & skin 
uired resistance 
0 1 2 3 6 9 12 15 18 21 24 
< :X: > 
Greatest risk of local & 
disseminated lesions 
Diminishing risk 
90% in first 2 years 
30 36 60 
Fig: schematic representation ofWal/grens' timetable for primary tuberculosis 
"Postprimary TB", "chronic pulmonary TB" or "adult-type TB" are synonyms for the 
type of TB that becomes the main presentation of disease in late adolescence and 
adulthood. It is characterized by more or less extensive lung parenchym involvement, 
most often in the upper lobes of the lung, with tissue necrosis and characteristically the 
development of cavities. There is little or no lymph node involvement. Cavities with 
central liquefaction and tissue necrosis offer favorable circumstances for the growth of 
Mtb, which is partly the reason why patients with this type of TB harbour many 
organisms. An open communication of a cavity with the airways gives the opportunity to 
cough up organisms and cause transmission of Mtb. It is generally assumed that patients 
with postprimary TB have been in contact with Mtb before, were immunologically 
sensitised to the bacillus and attained a certain degree of immunity to reinfection. There 
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are two pathways by which postprimary TB is thought to develop. Either by reactivation 
of dormant bacilli after a period of latency (endogenous reinfection) or by reinfection 
from a new contact (exogenous reinfection). In both instances the immune system of the 
patie:Qt has failed to protect from disease.· What percentage of the patients with 
postprimary TB have been subject to reactivation or reinfection is open to research and 
debate, but is probably dependent on the epidemiological circumstances. In low 
prevalence areas reactivation is the most likely mechanism, in high prevalence areas 
reinfection is a more likely occurrence. 151 • 152 
The age at which one becomes infected is consequently of great importance to the clinical 
presentation of disease. Primary tuberculosis is the commonest presentation of TB from 
early childhood to the teenage years. Most often the disease is a complication of enlarged 
hilar and paratracheallymph nodes that may or may not cause collaps or hyperinflation of 
a lung segment and/or ulcerative erosion of the bronchi. ( endo- or lympho-bronchial 
tuberculosis). Inflammatory ulceration of the primary focus by itself or aspiration of 
tuberculous material may cause further pathology in the lungs .and in rare instances even 
cavitation might develop as a result. On the chest radiograph, differentiation· of these 
different pathogeneses is not always easy. Extensive bronchopneumonia can occur as a 
result of widespread deposition of tuberculous material from whatever source. A pleural 
reaction may be seen during the course of these events, but large pleural effusions are 
thought to result from a different mechanism: the discharge of tuberculous material in the 
pleural space and a subsequent local hypersensitivity reaction. Large pleural effusions are 
very uncommon in early childhood, but become more frequent during adolescent years. 
The apparent age-related switch from primary to postprimary TB as the dominant form of 
clinical presentation during the adolescent years has been the topic of much speculation, 
but little research. The hypothesis, that hormones, as contributors to the growth spurt and 
sexual maturation of adolescents, might play a role in the changing pathology during this 
age period, has been put forward for quite some time. Recently, research in experimental 
models has revealed the influence of certain hormones on the course of TB and it might 
be apprpriate to investigate this in humans. 153 
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Children are more prone to develop extrapulmonary complications than 
immunocompetent adults. Tuberculous meningitis (TBM) is in general an early 
complication after infection (90% within 1 year). For unknown reasons occurrence of 
TBM is especially prevalent in very young children, under the age of two years. 154 
Treatment 
Although chemotherapeutic agents for TB have had major positive implications for the 
survival rates of patients, "cure" ofTB was possible in the pre-chemotherapy era. Various 
regimens of sunlight, diet and supplements as well as more invasive procedures like 
injecting ergocalciferol, tuberculin or syphillis bacteriae have all been claimed as 
curative, at some point. With hindsight, a number of these therapies could have boosted 
the immune response of patients and may therefore have been beneficial. 
There are however enough data to argue that pulmonary primary TB has a more 
favourable natural history than postprimary TB. The greater chance of surviving 
intrathoracic adenopathy, even with intrapulmonary complications, without important 
long term sequela has contributed to the notion that "childhood" primary TB is a 
relatively benign disease as opposed to the "adult" postprimary form. This does not hold 
true for the forms of primary TB, where haematogenous spread is the prime mode of 
bacterial dissemination, a more frequent event in young children than adults. Tuberculous 
meningitis in particular, is well known for its devastating implications for survival and 
permanent cerebral damage. Thus age is a factor to account for in evaluating cure rates 
and devising consequent therapeutic regimens. 
Prophylaxis 
At present time, two measures for preventing TB are in use: vaccination and treatment of 
latent infection(= prophylactic chemotherapy). 
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Bacille Calmette-Guerin (BCG) is worldwide the most frequently given vaccine, despite 
being the least effective of the currently used range of childhood vaccines. Prevention of 
tuberculous meningitis during ' childhood and protection from leprosy after BCG 
vaccination has quite convincingly been shown in some, but not all, populations. 
Efficacy of BCG appears to be dependent on the population to which it is given, which in 
tum is probably in part determined by latitude and exposure to environmental 
mycobacteria in a given area. 155 Ethnicity and age at which the vaccine is given might be 
other factors, although not well researched in comparative studies. The large English 
MRC trial of vaccination in 14 year olds (conducted in the fifties with a follow-up of 7-
10 years) did show a considerable protection from disease after vaccination with either 
BCG or vole bacillus at that age. 156a The incidence of TB was less in the vaccinated 
group than in a control group already tuberculin test positive upon entry in the study and 
subsequently not randomised for vaccination. 
Preventive chemotherapy after contact with an infective individual is regarded as 
beneficial for recent skin test converters of any age. In most countries where the TB 
incidence is high, this policy is implemented only for children under the age of five. 
Reasons for this are that the most serious complications after infection within the shortest 
period of time occur in this age group. Furthermore, it can be assumed that the contact 
was probably recent. However, one of the few large scale studies that compared 
preventive chemotherapy to no therapy in persons aged 0-24 years, known to be recently 
infected (within the previous year) and skin test positive, showed distinctive differences 
in age related morbidity as a result of preventive therapy. A more significant reduction in 
incidence of disease in the 10-24 yr old group as compared to the younger age groups was 
demonstrated. 156b 
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Hypothesis: Age, immune-competence and tuberculosis 
Exposure toMtb may lead to a "balanced" life-long interplay between host and parasite. 
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Numerous factors may tip one of these balances at any point in life, but they all result in 
the "breakdown" of the hosts ' immunological defence against the baccillus. As such, the 
immune competence of the host at a given time is arguably the most important 
determinant for the development of TB. "At a given time" remains one of the most 
intriguing, but very vague, issues in the pathogenesis of TB. With all the knowledge of 
TB that we have gained over the last century, we are still not able to answer the question: 
"who, when and where". 
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Tragically, the AIDS epidemic has created in many ways a window of opportunity to 
reinvestigate all angles of TB, from pathogenesis to treatment and prevention. AIDS has 
put into focus again the things we knew: that socio-economic circumstances and 
prevalence of infection as well as prompt treatment and proper treatment adherence are 
all important. We have learned in the mean time that CD4+ cells, quantitatively and 
qualitatively, are crucial in the immune response to Mtb as well as the clinical expression 
of TB and that timing of infection in relation to immune.:.competence of the host matters 
for outcome. 132' 133' 134• 
As outlined in the previous chapters, children are known to differ from adults with 
respect to the functioning of their cellular immune system, not only quantitatively with 
respect to cell types, but, most probably, also qualitatively. An adequate cellular immune 
response is a crucial determinant to the risk for development of TB after infection with 
M tb. Age-related differences in susceptibility to and clinical expression of TB are well 
recognised. It may thus be hypothesised that age-related immune competence may be a 
variable in the pathogenesis of tuberculosis. 
Frost revisited: 
After careful examination of the age-related TB mortality rates in the 
Massachusetts area over a period of 50 years (1880-1930), WH Frost noted in 
1935: " ... We are forced then to recognize, as at least highly probable, that the 
predominant factor in the up-and down movement of mortality along the age-
scale is change in human resistance. And this is a complex of which we have 
very little knowledge except the plain fact that age and prior exposure bring no 
such immunity against tuberculosis as they establish against many of the acute 
infections ... ,,143 
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Aims of this study 
1. To characterise the cellular immune response in TB patients and healthy individuals of 
different ages living in a region highly endemic for TB. 
2. To relate the results to the clinical expression ofTB at different ages 
To achieve these objectives a cross-sectional study was designed, whereby the cellular 
immune response of included study subjects was investigated by culturing their whole 
blood and measuring lymphocyte proliferation and cytokine levels after stimulation with 
a mitogen (PHA) and defined mycobacterial antigens (PPD and ESAT-6). 
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Materials and methods 
Description of study subjects 
Demographics 
This study is set in the Western Cape Province of South Africa, where the case load of 
TB was around 1000/100.000 inhabitants in the 1985-1994 period.157 
All the subjects in this study were of "coloured" origin, people who form a distinct 
anthropological entity of mixed Khoi-San, African, Malay and European origin, living 
predominantly in the Western Cape Province. Although from variable socioeconomic 
backgrounds, none of the study subjects were from the affluent sectors of South African 
society. 
Recruitment 
The subjects ofthis study were recruited from May 1998- November 1999 from: 
- The local authority health clinics in the City of Tygerberg (with permission from Dr I 
Toms, Head of Health Services, City ofTygerberg) 
- The paediatric wards of the Tygerberg Hospital (with permission from Prof. PB 
Hesseling, Head of the Department of Paediatrics and Child Health) 
- The paediatric surgical ward of Tygerberg Hospital, prior to routine surgery for non-
infectious diseases (with permission from Prof. SW Moore, Head of the Department of 
Paediatric Surgery, Tygerberg Hospital). 
Consent and ethical approval 
Informed written consent was obtained from every subject 14 years and older or his/her 
caretaker when the participant was younger than 14 years. (Copies of the consent form 
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and patient information sheet are on pp 175 -176) All subjects volunteered to participate 
in this study and did not receive any compensation for participation. 
HIV-test counseling was given to each subject and his/her caretaker. 
The Ethics Committee, Faculty of Medicine, University of Stellenbosch, has approved 
this study (registration number: 98/117). 
Inclusion criteria 
Subjects of three different categories were included in the study: 
I. Patients with tuberculosis (TB) 
TB patients were recruited before initiation of treatment. No patient was known 
with any disease other than TB or on treatment with corticosteroids at the time 
of recruitment. 
After diagnosis of TB, the patients were fully treated with combination therapy 
under direct supervision (DOTs) in accordance with the South African National 
TB Control Programme.158 
A case of TB fulfilled one of the following criteria: 
. A positive sputum-smear for acid fast- bacilli and symptoms ofTB. 
. A positive culture for M tb from sputum, gastric aspirate, cerebrospinal fluid 
or 
lymph node in a person with symptoms ofTB. 
. A history of a recent contact with a known and identified TB patient in 
combination with signs of TB on the chest radiograph and clinical 
symptoms ofTB (cough, weight loss) . 
. A diagnosis of tuberculous meningitis on the basis of clinical fmdings, 
cerebrospinal fluid analysis and CT scan of the brain. 
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II. Healthy control subjects, who had a positive tuberculin skin test (Mantoux) 
(The method used for Mantoux skin testing is described under methods of 
investigation) 
. A person with a Mantoux skin test induration ~ 15mm and no recent history 
or clinical symptoms of any disease . 
. A chest radiograph (CR) was evaluated upon entry in the study to exclude 
radiological signs of tuberculous disease for all persons under the age of 12 
yrs . 
. In accordance with the South African National TB Control Programme, all 
healthy Mantoux pos children under the age of five received supervised 
prophylactic chemotherapy (INH + rifampicin for a period of three months 
for children< 2 yrs, INH for 6 months for children 2-5 yrs) 
III. Healthy control subjects, who had a negative tuberculin skin test (Mantoux) 
. A person with a Mantoux skin test induration <15mm and no a recent 
history or clinical symptoms of any disease. 
Exclusion criteria 
The exclusion criteria for subjects to enter the study were: 
previous TB treatment, including prophylactic chemotherapy 
numerous periods (>3/year) of purulent otorrhea 
skin infection with scabies or eczema at time of recruitment 
asthma if on treatment with oral steroids during the previous 3 months 
measles during the previous 3 months or a measles contact (2 weeks prior to 
recruitment) 
chickenpox or chickenpox contact (3 weeks prior to recruitment) 
oral or intramuscular hormonal contraception 
pregnancy and the 3 months' period after giving birth ifbreastfeeding 
known immune deficiency or a positive HIV-1/HIV-2 test 
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signs of any overt infection other than TB 
fever (>38°C) and/or malnutrition, as measured by weight under the 3rd percentile for 
age for healthy Mantoux pos and mig subjects 
Methods of investigation 
Mantoux skin testing was done with O.lml (STU) Japanese freeze dried tuberculin, 
reconstituted shortly before use and injected intradermally on the volar aspect of the 
forearm by an experienced health care worker. The transverse diameter of induration was 
read 48-72 hours afterwards, with the ballpoint method, by an experienced health care 
worker. The Mantoux skin test was considered positive if the transverse diameter of 
induration was 15mm or more and negative if this measurement was less than 15mm. We 
used a 15mm skin induration as a cutoff value for to discriminate Mantoux negative from 
Mantoux positive subjects in accordance with the South African Tuberculosis Control 
Programme.158 
All the subjects underwent Mantoux skin testing, except the sputum-smear positive 
patients who were older than 20 years. Most adult TB patients in this region exhibit a 
strongly positive Mantoux reaction with considerable discomfort (itching, blistering and 
ulcerating). For ethical reasons it was therefore felt unjust to skin test the adult patients. 
Furthermore when a Tine skin test (used as a screening test in some health clinics) had 
been done and was grade II-IV (n = 4), a skin test was not redone with the Mantoux 
method. 
Chest radiographs (P A and lateral, CR) were read by a team of 3 experienced clinicians 
and classified as: 
Primary TB if there was hilar or paratracheal adenopathy with or without lung-
parenchym involvement. 
Postprimary TB if infiltrating abnormalities in the lung-parenchym mainly affected 
the upper lobes, with or without cavities. 
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Pleural effusion if uni- or bilateral pleural effusion without lung-parenchym 
involvement was seen. 
No TB if there were no abnormalities seen. 
Microbiological confirmation of primary intrathoracic TB is notoriously difficult, due to 
the problems in obtaining sputum from young children and the relatively low numbers of 
bacilli these children harbour. Even modem techniques like PCR on bronchial lavage 
(BAL) specimens159• 160 have not proven to be more sensitive than the "best" we currently 
have: culture of gastric aspirates taken in the morning before feeding and initiation of 
therapy (around 40% sensitivity in children diagnosed with TB161). A large proportion of 
the young patients was recruited from the local health clinics. We felt it was not justified 
to subject them to the (good) practice of obtaining proper early morning gastric aspirates. 
They would have had to be admitted to a hospital and there is no justification for this in a 
region where health care resources are very scarce. Our set criteria for identifying a 
patient as having primary intrathoracic TB are internationally recognised and every care 
has been taken to apply them to each patient. Since hilar adenopathy due to TB can have 
a relatively benign prognosis with few symptoms, we did justify a CR of all the healthy 
positive Mantoux controls under 12 yrs of age to exclude the possibility of asymptomatic 
TB in these children. 
Blood was taken from each subject, between 9.00 and 12.00am for a whole blood assay 
( 5 ml in a sodium heparin tube) and kept at room temperature. Furthermore a routine HB 
and WBC count with cell differentiation was done on each subject and serum was taken. e 
Serology for HIV-1/HN-2 was done on all but 3 subjects, with the use of a MEIA 
(AxSym®, Abbott). None of the subjects included in this study tested positive for HIV-
1/HIV-2. The 3 subjects who were not tested for HIV-1/HIV-2 did not have any risk 
factors for HIV infection. 
Full blood cell counts were done at the Department ofHaematology, Tygerberg Hospital, 
using routine laboratory methods. 
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Total serum IgE levels were measured with a radioimmune assay (Pharmacia, Uppsala, 
Sweden) at the Department of Chemical Pathology, Tygerberg Hospital. 
Description of laboratory methods for whole blood assays 
Whole blood cultures 
Reagents 
All solutions were made and handled under laminar flow conditions. 
1. RPMI-1640 cell culture medium (SIGMA, C/N: R 1383). The solution was prepared 
according to the manufacturers· instruction with the addition of 1 OOmg PenicillinG 
Sodium/Streptomycin Sulphate, (Highveld Biologicals LTD, C/N:2276), 10 mL extra L-
glutamine (200mM; Highveld Biologicals LTD, C/N:2342) and 174j..tL 13-mercapto 
ethanol, at pH 7.2 before filter strerilisation. The medium was kept at 4°C. 
2. PBS (Phosphate Buffered Saline) was made from 8.0g NaCl, 0.2g KCl, 1.15g 
N~HP04, dissolved in 1L destilled H20 and filter sterilised. 
3. PHA-P (Phytohemaglutinin-Sigma, C/N: L-8754, stored at 4°C). 1 mg PHA-P was 
dissolved in 1 mL of PBS (1mg/mL) and filter sterilized, aliquoted in 100j..tL fractions 
and freezed at -20°C before use. Aliquots were thawed shortly before use and diluted in 
RPMI to obtain a stock solution at a concentration of 1 OOj..tg/ml. 
4.PPD (Purified Protein Derivate, kindly provided by Prof. S Ress, Dept of Medicine-
Clinical Immunology, Groote Schuur Hospital, Cape Town at a concentration of 
lOmg/mL) was stored 4°C. Shortly before use, a dilution was made with RPMI to obtain 
a stock solution at a concentration of33j..tg/mL. 
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5. ESAT-6 (kindly provided by Dr P Andersen, Staten Seruminstitut, Copenhagen, 
Denmark) was frozen at -20°C in aliquots of 20J.!l (0.5mg/mL). Aliquots were thawed 
shortly before use and diluted with RPMI to obtain a stock solution at a concentration of 
10J.t.g/mL. 
6. Methyl-3H Thymidine (Amersham, C/N: TRK12D-1mCi). Shortly before use, a 
dilution was made with RPMI to obtain a stock solution at a concentration of25J.!CilmL. 
Culture conditions 
All sodium heparinised blood samples were processed within a maximum of 2-3 hours 
following venous puncture. All processing took place under laminar flow conditions 
Blood samples were diluted 1:10 in RPMI medium. 180J.!l of diluted sample was plated 
per well in aU-bottom 96-well plate. 
20J.t.L of stock solution was added to appropriate wells to obtain the following final 
concentration of stimulants in the wells: 
-PHA: 
-PPD: 
-ESAT-6: 
10J.t.g/mL 
3.3J.t.g/mL 
1J.t.g/mL 
20 wells were incubated with 20J.!L of RPMI to obtain non-stimulated, negative control 
wells. 
The plate was incubated at 37°C in 5% C02 (NAPCO, water jacketted C02 incubator) 
Pulsing of lymphocytes with MethyVH Thymidine (20J.t.L, final concentration 2.5J.t.Ci) 
was done, in triplicate wells, on the following days: 
Day 3 for PHA stimulated wells 
Day 6 for PPD and ESAT -6 stimulated wells 
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Triplicate negative control wells were pulsed on each of these days as well. 
The total pulsing time was 20 hours for each well. 
Collection of pulsed wells, after mixing, was done on: 
Day 4 for PHA stimulated wells 
Day 7 for PPD and ESA T -6 stimulated wells 
The contents of the wells were transferred to 96-well flat-bottomed plates and 
immediately frozen at -20°C for future assaying of lymphocyte proliferation. 
On days 3, 4 and 7 after proliferation, supernatants in the other wells were removed from 
the plates. Supernatants from wells cultured with identical stimulants were pooled, mixed 
and aliquoted in Eppendorf tubes after which they were immediately frozen in -20°C for 
cytokine measurements at a later time. 
Lymphocyte proliferation assays 
The 96-well flat bottomed plates were defrosted shortly before cell harvesting. Harvesting 
was done unto glass fibered filter paper with the help of a Titerteck Cell Harvester. Filter 
discs were placed, after drying, into scintillation vials with 4.5 ml of scintillation fluid 
(Insta-Gel Plus-Biotechnik, C/N: 6013399). Cell counting was done in a !3-counter 
(Beckmann LS6500, multiple scintillation counter). 
Proliferative responses are given as the mean of counts per minute ( cpm) measurements 
of triplicate stimulated wells after subtraction of the mean cpm measurements of triplicate 
negative control wells. 
Cytokine measurements 
Reagents and materials used for the ELISAs: 
- Coating plates: MaxiSorp microtiter 96-welled plates (Nunc TM Brand Products 
C/N:439454) 
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-Coating solutions: IFN-y, TNF-a and IL-2: O.lM Carbonate buffer, pH 9.5 
IL-10: PBS, pH 7.5 
-Blocking buffer: PBS with 1% (IFN-y, IL-2, TNF-a, IL-10) Bovine Serum Albumin 
(BSA, Sigma Chemical Co, USA, C/N: A6003) 
-Wash buffer: PBS with 0.05% Tween-20 
-Reagent diluents: PBS with 1% BSA (IL-10) and 0.05% Tween-20 (IFN-y, TNF-a 
and IL-2) 
-Detection enzyme: HRP-conjugated streptavidin (DAKO A/S, Denmark, C/N: P0546) 
for IL-10 
- Substrate: 
- Stop solution: 
tetramethylbenzidine (TMB) and hydrogen peroxide (TMB 
Microwell Peroxidase Substrate System, Kirkegaard & Perry 
Laboratories INC, C/N: 50-76-00) 
2NH2S04 
Cytokine concentrations of the supernatants from the whole blood cell cultures were 
measured utilizing the antibody sandwich ELISA principle, for which commercially 
available kits and reagents were used. 
IFN-y was measured with a DuoSet for human IFN-y (Genzyme Diagnostics, C/N: 80-
3932-00), IL-2 with a DuoSet for human IL-2 (Genzyme Diagnostics, C/N: 80-3606-00) 
and TNF-a with a DuoSet for human TNF-a (Genzyme Diagnostics, C/N:80-3933-00). 
For IL-10, the capture antibody was a monoclonal rat anti-human IL-10 (Genzyme 
Diagnostics, C/N: 80-4315-01), the secondary antibody a biotinylated anti-human IL-10 
(Genzyme Diagnostics, C/N: 80-5037-01) and the standard a lyophilized recombinant 
human IL-10 (Genzyme Diagnostics, C/N: 2261-01) 
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General principle of the ELISAs:o 
ELISAs were performed according to the manufacturers' instructions. Reagents and 
materials, the general principle and specific conditions and dilutions are briefly described. 
A cytokine specific antibody (capture antibody) in coating solution was bound to a 
microtiter plate by overnight coating at 2-8°C. 
The following day, plates were washed with wash buffer to remove unbound antibody 
and blocked with a blocking buffer for 2 hours at 37°C. Twofold serial dilutions of 
recombinant cytokines were used for each standard curve. After removing the coating 
buffer, supernatant samples (diluted in RPMI), dilutions of standards and blanks were 
added in duplicate on each plate to form a solid phase bound complex. After incubation 
plates were decanted and washed several times. 
The secondary antibody was added to the wells and incubated for 1-2 hours, where after 
decanting and washing of plates. If the secondary antibody was directly bound to the 
detecting enzyme( (HRP-streptavidin), the substrate solution was added after decanting 
and washing procedures. If the secondary antibody was a biotinylated one, an additional 
incubation was performed with HRP-conjugated streptavidin prior to decanting, washing 
and addition of substrate. 
After 10-15 minutes incubation of the substrate solution, at room temperature, the 
reaction was stopped with the stop solution. 
The optical densities (OD) of the substrates in the wells were then immediately read by 
microtiter plate reader (Reader 510 Microwell system, Organon Teknika) at 450nM 
wavelength. 
The values of the mean cytokine concentrations of the samples were calculated from the 
standard curves on each plate using the Prism Graphpad software program. 
Standardisation of the assays was obtained after pilot studies, done twice on the same 
volunteers. 
Time courses for the different cytokines were evaluated to obtain the optimal sample day 
for the various cytokines. 
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Production of IL-l 0 in unstimulated (negative control) supernatant samples was found 
not to be negligible. Consequently the values for this particular cytokine were obtained 
by subtracting the value of negative control samples from the values of the stimulated 
supernatant samples. 
For the specific ELISA conditions and dilutions of each of the cytokines measured: see 
table 
Table: specific conditions and dilutions of the ELISAs per cytokine measured 
If the measured values were higher than the highest concentration of the standard, repeat 
assaying was done, using lower concentrations of the supernatant sample. If the values 
were lower than the lowest concentration of the standard, an assigned value was 1 Opg/ml 
was given (see methods of analysis). 
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Methods of analysis 
Stratification 
On the basis of the age-related incidence ofTB in the Western Cape (jig p 34), subjects 
included in this study were stratified along age into four "age groups": 
0-5 yrs (age 5 yrs not included)) 
5-12 yrs (age 5yrs included, age 12 yrs not included) 
12-20 yrs (age 12 yrs included, age 20 yrs not included) 
20 yrs and older (age 20 yrs included) 
Furthermore subjects were classified on the basis of three categories of "TB status", 
according to their status as: 
patient 
Mantoux positive ("Mantoux pos") 
Mantoux negative ("Mantoux neg") 
Consequently twelve different "study groups" were recognised. 
The "whole study population" refers to all the subjects included in the study. When 
''patients" vs "healthy" subjects are compared, "healthy" subjects include the Mantoux 
pos and Mantoux neg subjects. ''Age" in years, obtained after calculation from date of 
birth to date of venous puncture in up to two decimals, has been used as a continuous 
variable 
'~ 
I, 
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Limitation of the assays 
For all the ELISA assays to measure cytokine production, the lowest concentration on 
each plated standard curve was 15 pg/ml. Because of the sensitivity of these assays, data 
on cytokine production below the lowest point of a standard curve for a given assay plate 
can not be regarded as di;criminative. Therefore every value below the lowest point of 
the standard curve has been given an "assigned value" of 10 pg/ml. 
Statistical analysis 
In this study non-mathematically transformed data were used for analyses with non-
parametric statistical methods. There were low numbers of subjects (minimum 8, 
maximum 21) in each of the recognised twelve study groups, which necessitated non-
parametrical statistical tests. Furthermore non-normal distribution of data in many 
subgroups, which could not all be normalised by mathematical transformation, prompted 
the use of non-parametrical tests. Differences among several independent groups were 
assessed with the Kruskall-Wallis One-Way ANOVA by Ranks test. Differences between 
two independent groups were assessed with the Wilcoxon-Mann-Whitney U test. 
Associations between continuous variable were tested using Spearman Rank-Order 
Correlation Coefficient. 
Statistics were computed throughout using SPSS (version 9.0) software. 
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Introduction to results section 
This study produced more than 3,700 different data points. To present them in a sensible 
and readable format has proved to be a challenging task on its own. I have made choices 
in this respect bearing in mind that: 
- Restriction to the main study objectives helps to focus on issues of importance 
- Consistency in presentation of data makes a thesis like this easier to read 
- Repetitiveness of facts and numbers in a text are unattractive to read 
Restriction to study objectives 
The aim of this study was to characterise the cellular immune response of TB patients 
and healthy individuals of different ages. To this end study subjects were stratified along 
age and healthy control subjects according to their Mantoux skin test response (pos or 
neg) which served as a correlate for infection with M tb. Furthermore the results were 
aimed to be related to clinical expression of disease at different ages. 
The most important question was thus: 
1. Do the data show age-related differences in immunological parameters? 
However, analyses should also be done on a number of issues related to the main focus of 
this study: 
2. Do patients of various ages behave differently from healthy controls in mitogen 
induced responses and do they behave differently after PPD stimulation if compared to 
healthy Mantoux pos controls? 
As can be concluded from the presented data, healthy Mantoux neg subjects did not 
respond to PPD stimulation with any appreciable quantity of measurements. 
3 .Does clinical expression of disease make a difference? 
Patients with primary and postprimary TB were included in this study and they were 
compared with age-related healthy controls. 
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Graphically, the data are presented by boxplots. This format of display allows the clearest 
overview of all the data in relation to age and TB status and describes best the non-
parametric statistical methods that have been used throughout the analyses. Horizontal 
bars represent median values, boxes interquartile ranges (representing 50% of the values) 
and whiskers the highest and lowest values, excluding the outliers. Because non-
parametrical tests are not very sensitive to outlying variables, the outliers have been 
omitted from the graphs for optical reasons. 
Numerically, the data are described in tables. The interquartiles here are the mathematical 
251h and the 75th percentages of all the values per study group. Although they compare in 
most instances to the interquartile ranges in the boxplots, they are not the same. 
The boxplots are more representative of the non-parametric statistical tests that were 
used, the tables better show the actual figures from a mathematical perspective. This may 
cause some confusion when one compares the two forms of display and is most obvious 
in cases where there were a number of outliers or skewed distributions. 
Theoretically, one could assume that there should not be any differences between 
Mantoux pos and Mantoux neg healthy controls in haematologic values or PHA induced 
responses by age group. Analyses of these measurements showed that there were indeed 
no significant differences, although the boxplots might sometimes suggest otherwise. 
Therefore, in the analyses on these particular measurements, patients are compared to all 
the healthy controls per age group (p-value1) and age groups are compared by their status 
as patient or healthy control (p-valui). 
PPD induced responses were very low to negligible in Mantoux neg healthy controls. 
They are represented in the figures and tables for completeness, but it made no sense to 
include them in any statistical analysis. Patients are compared to Mantoux pos healthy 
controls per age group (p-value1) and age groups are compared by their status as patient 
or healthy Mantoux pos controls (p-valui). 
57 
~-• I· 
!'i 
:~,, 
,,, 
lij, 
lj 
~.:1'· 
" 
Iii 
! 
I~ 
,:i 
:I 
' I ,,, 
Stellenbosch University http://scholar.sun.ac.za
Correlations between the different measurements, including age in years, are important in 
this study and are presented in table format as a separate chapter "tables on correlations" 
(pp 68-74), whereby only the significant correlations are given. 
The individual chapters of the results' section start with a graphical display of the data, 
followed by a table and a short text describing some results that cannot be inferred 
directly from the graph and/or table. The chapters in the results' section end with a 
summary on the key findings and a brief discussion. 
Every attempt has been made to streamline the chapters in the same format; where this is 
not the case the reason for the deviations is explained. 
Although it may be the custom in scientific writing to include all data in the actual text 
and not only in the tables, I found that doing so made the text indigestible. Because of the 
extensive use of graphs and tables to display the numerical facts, I have omitted most of 
them largely from the text, including only those that were important and not represented 
in any table. With respect to the correlations between the different measurements: The 
exact p-values and correlation coefficients (p) are all specified in the designated chapter 
mentioned above and the relevant page numbers (p. 68-7 4) noted throughout the text. 
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Clinical characteristics of the study subjects 
In- and exclusion of recruited study subjects 
A total of 168 subjects were recruited for the study. Of these 18 were excluded from 
further analysis for the following reasons: 
5 patients were, according to clinic files, found to have had previous TB 
treatment or chemoprophylaxis 
2 patients and .1 control subject who were HIV positive on ELISA testing 
1 patient had second thoughts on giving consent for HIV testing and was thus 
not included, nor tested for HIV 
1 patient was diagnosed as not having TB but Crohn's disease at follow up 
1 patient had documented complaints of chronic cough, weight loss and CR 
abnormalities, but repeatedly negative sputum smears for Mtb without a 
conclusive diagnosis over the three years prior to inclusion; she was excluded 
on the grounds that she might have an underlying chronic disease of the lungs 
1 patient with concomitant diagnoses of Kwashiorkor and rota-virus infection 
at time of venous puncture 
5 subjects, initially recruited as patients but on reviewing the evidence from 
the data did not meet sufficient criteria to be classified as such 
1 control subject on whom we were unable to get the result of the Mantoux 
skin test 
Consequently, a total number of 150 subjects were included in this study. 
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Numbers and sex of study subjects per age group and TB status 
Table: Numbers and sex of subjects per age group and TB status included in the study 
The larger number of female subjects in the study population was due to their 
overrepresentation in the healthy controls from age groups 12-20 yrs and > 20 yrs. 
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Age per age group and TB status of study subjects 
Table: Median (interquartile range) age ( yrs) of included subjects per age group and TB status 
Patients I Mantoux pos Mantoux neg Total 
Median n 
(SD) (SD) 
- d I (yrs) 
I I 
0-5 I 14 I 1.8 14 3,2 12 2.9 40 2.4 
(1.3-2.6) (2.4-4.2) (1.5-4.0) (1.5-3.4) 
5-12 I 8 I 7.7 14 9.0 10 8.2 32 8.8 
(26.8-43.6) 
*p-value: patients compared to healthy Mantoux pos and Mantoux neg controls by age group 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
I 
I 
p-value* 
.031 
.338 
Patients, aged 0-5 yrs were significantly younger than healthy controls of this age group: 
p = .014 (Mann Whitney U Test) 
Patients, aged 12-20 yrs were significantly older than healthy controls of this age group: 
p = .004 (Mann Whitney U Test) 
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Mantoux size of study subjects by age group and TB status 
Table: Median (interquartile range: IQ) Mantoux size (mm) by age group. TB status and totals 
TB patients Mantoux pos Mantoux neg 
status 
Age Median Median p-value1 Median 
group (IQ) (IQ) . (IQ) 
n n n 
(yrs) 
0-5 12' 16.5 13* 19.2 .131 12 0 
(10.3-20) (16.5-22) (0-2.6) 
5-12 6" 16.8 14 17.8 .458 10 0 
(0-23.5) ( 16.3-20. 7) (0-3.4) 
12-20 16"' 19.5 12 18.3 .470 21 0 
(16.5-24.1) (16-26.3) (0-0) 
>20 # # 8** 26.5 nv 8 0 
(18.3-32) 171> (0-0.9) 
Total 34 18.5 47 18.8 .236 51 0 
(15-20.9) (16.4-22) (0-1.8) 
p-value• .140 .173 .648 
p-value1: Patients compared to healthy Mantoux pos subjects per age group and totals 
(Mann- Whitney U test) 
p-valui: Different age groups per TB status compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
Missing values of Mantoux skin induration in mm: 
#: patients > 20 yrs with smear positive TB were not Mantoux skin tested 
i 
, 0 1 patient had a Tine skin test grade III and was not re-tested with the Mantoux method 
1 patient did not show up on the day scheduled for Mantoux test reading 
, 0 1 patient had a Tine grade II skin test and was not re-tested with the Mantoux method 
1 patient had a Tine grade II skin test, ulcerating, and was not re-tested with the Mantoux 
method 
"'· 
*· 
**· 
1 patient did not show up on the day scheduled for for Mantoux test reading 
3 patients with smear positive TB were not Mantoux tested 
1 control subject had a Tine grade IV skin test 
1 definitely Mantoux pos control subject, whose exact measurement in mm induration was not 
recorded 
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Age (yrs) correlated significantly with Mantoux size (mm) when patients and Mantoux 
pos subjects were analysed as one group (p = .006), but not when the group of patients 
and the group of Mantoux pos subjects were analysed separately. 
Mantoux size (mm) had a significant correlation with cell proliferation after stimulation 
with PPD (cpm) in the whole study population (p < .0001), but not when analysed per TB 
status. 
Mantoux size (mm) had a significant correlation with PPD stimulated cytokine 
production (pg/ml) for IFN-y (p < .0001), IL-2 (p < .0001) and TNF-a (p < .0001) in the 
whole study population. These correlations were not significant when analysed in the 
Mantoux pos group separately. In the patient group only the correlation with IFN-y 
remained significant (p = .029). 
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Characteristics of study patients 
Table: Characteristics ofTB patients per age group 
Age group (yrs) 0-5 5-12 
Principal diagnosis 
17 8 
TBM: Tuberculous Meningitis, CR: Chest Radiograph, sm+: smear positive, cult+: culture positive 
* · 
** · 
§ 
# 
1 patient with a pneumatocele and infiltrate behind the heart on the CR and positive CSF culture 
1 patient with an infiltrate on the CR and weight loss, a known TB contact and a gastric aspirate 
positive for M.tb on culture 
1 patient without abnormalities on the CR, presenting with clinical, cerebrospinal fluid and cranial 
CTscan findings compatible with TBM 
1 patient with hilar adenopathy on the CR and culture positive abdominal TB 
1 patient with hilar adenopathy on the CR and erythema nodosum 
1 patient with a calcification on the CR, presenting with erythema nodosum 
1 patient without abnormalities on the CR, presenting with chronic cough and smear positive sputum 
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Weights of study subjects 
100r-----------------------------~ 
80 
60 
40 
r6 
~ ~ 20 Dpatients ~ I i , I .z:::! . . · · ·-,'"·-N = 12 25 8 23 19 32 7 16 
0-5 yrs 5-12 yrs 12-20 yrs > 20 yrs 
Age group 
Age (yrs) obviously correlated with weight in kilograms (n =142, p = .921, p < .0001). 
Comparing weight between patients and healthy controls by age group gave (Mann 
Whitney U test) the following statistics: 
Age group 0-5 yrs: 
Age group 5-12 yrs: 
Age group 12-20 yrs: 
Age group >20 yrs: 
p = .071 
p= .020 
p = .365 
p = .018 
l 
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Discussion on the clinical characteristics of the subjects included in the study 
There was an overrepresentation of female healthy controls: it proved to be much more 
difficult to recruit healthy male subjects than healthy female subjects, because the males 
were more reluctant to have a venous puncture and participate in the study. That this 
occurred specifically in the two older age groups is a pity, because sex-related differences 
in disease notifications from the age of puberty are well recognised.162 
The significant differences in age within the age groups of 0-5 yrs (patients younger than 
healthy controls) and 12 -20 yrs (patients older than the healthy controls) should be kept 
in mind when interpreting all the results. The comparisons of the recorded weights 
deserve mentioning in view of this. The very strong correlation between age and weight 
implies that in these two particular age groups, where no significant differences in weight 
were found between patients and healthy controls, this finding might well have been due 
to differences in age in both groups. However, stratifying the whole study population by 
any tighter age ranges would have produced study groups with insufficient numbers to 
perform adequate statistical analyses on. 
Our cutoff value of 15mm skin test induration is a high cutoff value compared to the 
custom in many other regions in the world, where 1 Omm skin induration is often taken as 
the discriminative value. This value makes it highly unlikely that positive Mantoux 
reactions are solely based on previous BCG vaccination. 163 The reported BCG 
vaccination coverage in the Western Cape has been more than 90% over the past decades. 
BCG is given directly after birth or soon thereafter. The vaccination method consists of 
spreading the BCG preparation (Tokyo 172) on the skin of the upper arm and 
subsequently injecting it percutaneously with the help of the "Japanese Gun". According 
to the South African guidelines, the vaccination should be repeated if there is no scar 
visible after 6 weeks. Serious doubts about the technique and follow-up of these 
guidelines have, however, been raised. The gun tool is not really developed for the arms 
ofneonates and a local study often found tools to be faulty. 164 Especially in the older age 
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groups, the absence of a visible scar does not necessarily imply lack of a BCG 
vaccination at birth and scars tend to wane over time, specifically when BCG is given in 
the neonatal period. 165 Vaccination and record keeping practices have undoubtedly 
changed over the past 45 yrs and in a study of this type, which includes subjects from 0 to 
44 yrs age-range, there is an obvious difficulty in stratifying subjects along BCG 
vaccination status. 
Although any presentation of TB was regarded as an inclusion criterion to participate in 
the study as a patient, none of the patients under the age of 12 had a postprimary (chronic 
pulmonary) form of disease. This divide largely reflects the local clinical epidemiology, 
although exceptions on this age-related pattern of clinical presentation are certainly seen 
in our study area. At the start of the study, it was hoped that a specific group of TBM 
patients could be recruited, since the incidence of TBM is high in the Western Cape. 
However, during the study period, only 3 patients with TBM proved to be eligible for 
participation, despite considerable effort to recruit them. The main obstacle was the fact 
that most patients had, appropriately, received their first doses of steroids before 
admission to Tygerberg Hospital and this would probably have affected the results of the 
cytokine responses. 
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Table: Median (interquartile range: IQJ Hb (g/dl) of patients and healthy subjects per age group and totals 
TB patients healthy subjects p-value' total 
status (Mantoux pos and neg) 
Age Median Median Median 
(IQ) 
group 
(IQ) (IQ) 
n n n (yrs) 
0-5 14 9.5 26 10.7 • • 012 40 10,3 
(8.9-10.4) (9.5-11.6) (9.1-10.9) 
5-12 8 11.5 22 11.9 .504 30 11.8 
(10.7-12.5) (11.3-12.5) (11.2-12.4) 
12-20 19 10.7 33 12.8 <.0001 52 12.3 
(9.2-12) (12.1-13.3) (10.9-13.1) 
>20 8 11.5 16 12.6 .019 24 12.3 
(10.4-11.7) (12.1 -13.4) (11.4-12.9) 
total 49 10.6 97 12.0 <.0001 146 11.5 
(9.3-11.5) (10.9-12.8) (10.4-12.6) 
p-value2 .004 <.0001 <.0001 
p-value1: Patients compared to healthy subjects (Mantoux pos and neg) per age group and total 
(Mann- Whitney U test) 
p-value2: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
I 
Age (yrs) correlated significantly with Hb levels (g/dl), when analysed for the whole 
study population (p = .429, p < .0001). This correlation remained significant when 
investigated for patients (p = .390, p = .006) and controls (p = .565, p < .0001) 
separately. 
Analysed per age group, the patients groups had significantly lower Hb values than 
control groups, with the exception of the patients from the 5-12 yrs age group, who had 
similar levels of Hb when compared to their age-related healthy controls. 
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Table: Median (interquartile range:IQ) WBC (xi 09 II) of patients and healthy subjects per age group and 
totals 
TB patients Healthy subjects p-value' total 
status (Mantoux pos and neg) 
Age Median Median Median 
(IQ) (IQ) (IQ) 
group 
n n n (yrs) . 
0-5 14 15 26 9.9 .059 40 10.3 
(8.7-17.4) (7.9-12.3) (8.3-15) 
5-12 8 8.9 22 11.8 .980 30 8.7 
(5.5-11.7) (11.3-12.4) (6.6-9.6) 
12-20 19 8.4 33 6.9 .004 52 7.6 
(7.5-12.9) (6.1-8.3) (6.3-9.2) 
>20 8 8.6 16 6.9 .214 24 7.1 
(7-9.8) (5 .5-9.4) (5.6-9.3) 
total 49 9.1 97 8.0 .003 146 8.5 
(7.6-13 .1) (6.4-9.9) (6.6-10.2) 
p-valuez .096 <.0001 <.0001 
p-value1: Patients compared to healthy subjects (Mantoux pos and neg) per age group and total 
(Mann- Whitney U test) 
p-valui: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
I 
Age (yrs) had a significantly inverse correlation with the absolute amount of WBCs 
(x109/l), when analysed for the whole study population (p. 68). The correlation remained 
significant when investigated for patients (p. 69) and controls (p. 70) separately. 
With the exception of the 5-12 yrs age group, patients had higher absolute counts of 
WBCs than healthy controls, but this phenomenon did not always reached significance 
for the individual age groups. 
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Table: Median (interquartile range:IQ) absolute neutrophil count (xUI/1) of patients and healthy subjects 
per age group and totals 
TB patients healthy subjects p-value' total 
status 
(Mantoux pos and neg) 
Age Median Median · Median 
(IQ) (IQ) (IQ) 
group 
n n n (yrs) . 
0-S 13 5.9 26 4.1 .021 39 4.5 
(4.9-8.7) (3.0-5.8) (3.2-6.2) 
S-12 8 3.7 22 3.8 .982 30 3.8 
(2.4-8.0) (3.1-5.3) (3-5.3) 
12-20 19 6.5 33 3.5 <.0001 52 4.2 
(5.1-10) (2.9-4.8) (3.1-6.5) 
>20 8 6.1 16 3.4 .004 24 4.2 
(4.9-7.7) (2.9-4.7) (3-5.9) 
total 48 6.1 97 3.7 <.0001 145 4.2 
(4-8.1) (2.9-4.9) (3.1-5.9) 
p-valuez .555 .686 .634 
. 
p-valu/: Patients compared to healthy subjects (Mantoux positive and negative) per age group and total 
(Mann- Whitney U test) 
p-valui: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
Age (yrs) was not significantly correlated with the absolute number of neutrophils 
(x109/l) when analysed for the whole or any of the individual study groups (p. 68-70). 
Per age group, the absolute amount of neutrophils was significantly higher in patients 
than controls, except in the 5-12 yrs age group. 
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Table: Median (interquartile range:/Q) absolute lymphocyte count (xlrfl)l of patients and healthy subjects 
per age group and totals 
TB patients healthy subjects p-value1 total 
status (Mantoux pos and neg) 
Age Median Median ·Median 
(IQ) (IQ) (IQ) 
group 
n n n (yrs) . 
0-5 14 4.4 26 3.5 .162 40 3.8 
(3.3-5.9) (2.4-4.8) (2.9-5.1) 
5-12 7 2.5 22 2.8 .980 29 2.8 
(2.3-3 .9) (2.3-3.4) (2.3-3.4) 
12-20 19 1.4 33 2.2 .001 52 2,0 
(1.2-2) (1.7-2.4) (1.4-2.3) 
>20 8 1.4 16 2.3 .172 24 2.1 
(1.1-4.2) (1.9-2.8) (1.7-2.8) 
total 49 2.2 97 2.4 .192 l45 2.4 
(1.3-3.9) (2.0-3.4) (1.8-3.4) 
p-value2 <.0001 <.0001 <.0001 
p-value1: Patients compared to healthy subjects (Mantoux positive and negative) per age group and total 
(Mann- Whitney U test) 
p-value2: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
Age (yrs) had a significant inverse correlation with the absolute amount of lymphocytes 
(x109/l) when analysed for the whole population under study (p. 68) as well as for the 
patients (p. 69) and healthy control groups (p. 70) separately. 
Patients and controls, in general, did not differ significantly in their absolute amounts of 
white blood cells, with the exception of the 12-20 yrs age group, where patients had 
significantly lower counts than healthy controls. 
82 
Stellenbosch University http://scholar.sun.ac.za
3.0 
2.5 
2.0 
- 1.5 c :::1 
0 
u 
~@' ~ 1.0 u 0 c 0 ~ Q) -:::1 0 (/) 
.0 0.0 ro 
N= 13 13 12 
0-5 yrs 
Age group 
~ 
7 14 8 
5-1 2 yrs 
Monocytes 
12-20 yrs 
~ -L~ 
TB status 
Dpatients 
0Mant pos 
83 
Stellenbosch University http://scholar.sun.ac.za
Table: Median (interquartile range) absolute monocyte count (xUI/1) of patients and healthy subjects per 
age group and totals 
TB patients healthy subjects p-value' total 
(Mantoux pos and neg) }:>, 
status 
Age Median Median · Median 
(IQ) (IQ) (IQ) 
group 
n n n 
(yrs) . 
0-5 13 0.86 25 0.61 .030 38 0.63 
(0.62-1.07) (0.46-0.8) (0.49-0.92) 
5-12 7 0.5 22 0.55 .500 29 0.54 
(0.37-0.6) (0.46-0.63) (0.46-0.61) 
12-20 19 0.76 33 0.42 <.0001 52 0.5 
(0.5-0.89) (0.33-0.58) (0.37-0.71) 
>20 8 0.69 16 0.41 .016 24 0.51 
(0.55-0.86) (0.31-0.63) (0.33-0. 73) 
total 47 0.68 96 0.50 <.0001 143 0.55 
(0.5-0.88) (0.37-0.63) (0.4-0.72) 
p-value' .040 .011 .022 
p-value1: Patients compared to healthy subjects (Mantoux pos and neg) per age group and total 
(Mann- Whitney U test) 
p-valui: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
Age (yrs) had a weak, but significant correlation with the absolute amount of monocytes 
(x109/l), when analysed for the whole study population (p. 68), but in the healthy controls 
this correlation between was stronger (p. 70). 
Per age group, patients had significantly higher amounts of monocytes than controls, 
except in the 5-12 yrs group. 
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Discussion on the haematologic findings 
In the context of this study an important observation with respect to the haematological 
parameters, is the fact that there are significant correlations between age in years and the 
haemoglobin levels (positive correlation), the absolute white blood cell count (negative 
correlation) and the absolute lymphocyte count (negative correlation). An inverse 
correlation between age and the absolute monocyte colint was also found in the healthy. 
controls. Given the fact that all published normal reference values of these parameters 
have age-ranges these fmdings are not surprising by themselves. However, within the 
perspective of this study it is important to note that these age-related differences are 
maintained irrespective of tuberculous disease. To what degree this finding has 
implications for the interpretation of other results from this study will be discussed later. 
When patients were compared to healthy controls significant differences between the two 
groups were found for Hb, WBC, absolute neutrophil counts and absolute monocyte 
counts, but notably not for the absolute lymphocyte count. Most studies on 
haematological abnormalities in relation to TB have looked at adults and are reviewed in 
a publication by Knox-Macaulay166• Data on haematologic abnormalities in children with 
TB are scarce. One recently published study from our department on this subject167 
compared data from a group of hospitalised children with TB to a similar control group 
consisting of children admitted suspected to have TB, but subsequently found to have 
other diseases. The objective of this study was to investigate if haematological fmdings 
could discriminate between "TB or not TB" and it was concluded that they could not. 
Low Hb, neutrophilia, monocytosis and lymphocytosis or lymphopenia are all seen in 
adult patients with TB.166 The anaemia in TB is generally regarded as an anaemia of 
chronic disease. Although the red cell indices and iron status related measurements in 
serum (serum iron, total iron binding capacity, percentage saturation, ferritin and 
transferrin) might suggest iron deficiency, most of the patients do not have an anaemia 
secondary to iron-deficient erythropoiesis. 168 Disturbances in iron metabolism, 
inappropriate low serum erythropoietin levels and raised cytokine levels in the circulation 
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(specifically TNF-a) have been assumed as possible contributors to the low Hb levels in 
TB patients.166'168'169 The degree of anaemia seems to be related to severity of disease 
and is most pronounced in disseminated disease. There were 4 patients with disseminated 
disease included in this study. Of these, three children had TBM, none of whom were 
anaemic. One patient with disseminated abdominal TB, did have a low Hb of 8.3 g/dl for 
which she received a blood transfusion. 
Our results on the various white blood cells in paediatric TB patients are in accordance 
with published data on adults. It seems peculiar that lymphocytes, the only circulating 
white blood cells well recognised to be of importance in TB pathology are the only cells 
not to differ significantly in patients from healthy controls. Lymphopenia, lymphocytosis 
and normal lymphocyte counts in TB have all been described to the degree that no 
consistent statement can be made on this subject. However neutrophilia and monocytosis 
seem to be more constant findings. Both cell types are ill defined in the pathogenesis of 
TB, although they are both active phagocytic cell types, present in granulomas and 
possible producers of a variety of cytokines. 
The main reason for doing full blood counts on all the included study subjects was to 
evaluate them in the light of the results from the stimulated cell proliferative and cytokine 
responses in whole blood. Any conclusions on specificity or sensitivity of the 
haematologic findings with respect to a diagnosis of TB or severity of illness cannot be 
made. The number of study subjects is relatively small and, as Wessels' study167 has 
shown, the findings are not specific for tuberculous disease. One can conclude however, 
that, except for the 5-12 age group, TB patients do differ significantly from age related 
healthy controls for most haematological data. That the only age group where no 
haematological differences at all were found between patients and controls was "the 
golden age of TB" is a curious fmding, but in view of the small number of subjects within 
this age group, not even speculative reasoning seems to be justified. 
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Lymphocyte proliferation assays 
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Table: Median (interquarti/e range: IQJ lymphocyte proliferative response (cpm) of whole blood 
stimulated with PHA (1 Opglml) on day 4 (after subtraction of unstimulated proliferation on day 4) of 
patients and healthy subjects by age group and totals 
TB patients healthy subjects p-value• total 
status 
(Mantoux pos and neg) 
Age Median Median Median 
(JQ) (JQ) 
. 
(IQ) 
group 
n n n (yrs) 
0-5 12 33855 25 46110 .151 37 43859 
(20363-59274) (35173-61694) (29367-60924) 
5-12 8 30104 23 62073 .026 31 56104 
( 11906-68650) ( 4 7821-80452) (321 08-79630) 
12-20 17 16356 28 40458 <.0001 45 31595 
(9182-29456) ; (28787-58692) (14770-44035) 
>20 7 30677 17 43612 .383 24 40660 
(20857-57031) (21936-68469) (21731-58861) 
total 44 26952 93 46699 <.0001 137 40710 
(13245-42277) (34030-65842) (23795-60943) 
p-value~ .034 .047 .005 
p-value1: Patients compared to healthy subjects (Mantoux positive and negative) per age group and total 
(Mann- Whitney U test) 
p-value2: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wal/is One-Way ANOVA by Ranks test) 
When analysing the whole study population, there was a weak, just significant, inverse 
correlation between age (yrs) and PHA stimulated lymphocyte proliferation (cpm) (p. 
68). The correlation became stronger and positive for the subjects under 12 years of age: 
p = .039 for all subjects under 12 yrs (n = 68, p = .250) and p = .021 for the healthy 
subjects under 12 yrs of age (n = 45, p = .451). No significant correlations were found 
between age and PHA induced lymphocyte proliferation in subjects older than 12 yrs. 
Although PHA stimulated lymphocyte proliferation was overall significantly less in the 
patients than in the controls, this phenomenon only reached significance in the individual 
5-12 yrs and 12-20 yrs age groups. 
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I 
PHA stimulated lymphocyte proliferation (cpm) showed a significant positive correlation 
(p < .0001) with the absolute amount oflymphocytes (x109/l) (p. 68). 
Correlations between lymphocyte proliferation ( cpm) and cytokine production (pg/ml) 
after stimulation with PHA were significant for IL-2, TNF-a and IL-10 (p. 68). However, 
any significant correlation between lymphocyte proliferation and IFN-y production was 
notably absent. 
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Lymphocyte proliferation after stimulation with PPD 
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Table: Median (interquartile range: IQ) lymphocyte proliferative response (cpm) after stimulation of whole 
blood with PPD (3.3,ug/ml) on day 7(afler subtraction of unstimulated proliferation on day 7) by age group 
and TB status 
TB patients Mantoux pos Mantoux neg 
status 
Age Median Median p-value1 Median 
group (IQ) (IQ) . (IQ) 
n n n n (yrs) ; 
0-5 12 12605 12 16025 .198 12 2672 37 
(1946-26126) (11114-30022) (175-7264) 
5-12 8 23825 13 56132 .020 10 572 28 
(8061-32276) (32794-70071) (127-8733) 
12-20 17 2447 12 36638 <.0001 15 491 44 
(1401-7799) (7098-85196) (82-6360) 
>20 7 8984 8 37063 .142 9 734 23 
(2747-23350) (5146-54675) (482-5379) 
Total 44 5346 46 32824 <.0001 45 668 132 
(1810-17661) ( 12082-57636) (141-5232) 
p-valuel .047 .062 .712 
p-value1: Patients compared to healthy Mantoux positive subjects per age group and totals 
(Mann- Whitney U test) 
p-valui: Different age groups per TB status and totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
total 
Median 
(IQ) 
8795 
(2405-20729) 
23098 
(3055-563 78) 
3913 
(1119-15120) 
5253 
(1483-31695) 
6707 
(1383-24387) 
.069 
PPD stimulated proliferative lymphocyte responses (cpm) did not correlate with age (yrs) 
in the whole population under study, but the correlation was strong in the healthy 
Mantoux pos subjects younger than 12 years (n = 25, p = .649, p <.0001). 
Upon stimulation with PPD, lymphocyte proliferation in the patients was significantly 
less than in Mantoux pos healthy subjects, but when analysed per age group this only 
reached significance in the 5-12 yrs and 12-20 yrs groups. Patients younger than 12 yrs 
proliferated significantly better than patients older than 12 yrs (p = .030), while there was 
no such difference between Mantoux pos subjects < 12 yrs when compared to Mantoux 
pos subjects> 12 yrs. 
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There was no correlation between PPD induced lymphocyte proliferation ( cpm) and the 
absolute amount oflymphocytes (x109/l). 
There was a very strong and positive correlation between PPD stimulated lymphocyte 
proliferation (cpm) and IL-2 production (pg/ml) in patients (p. 73) and Mantoux pos 
subjects alike (p. 74). In healthy Mantoux pos subjects, but not in patients, the 
correlations between PPD stimulated lymphocyte proliferation and IFN-y production as 
well as TNF-u production were positive and significant (p. 74). 
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Lymphocyte proliferation after stimulation with ESAT -6 
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Table: Median (interquartile range: IQ) lymphocyte proliferative response( cpm) after stimulation of 
whole blood with ESAT-6 (l,ug/ml) on day 7 (after subtraction of unstimulated proliferation on day 7) of 
subjects per age group, TB status and totals 
TB patients Mantoux pos Mantoux neg total 
status 
Age Median Median p-value1 Median 
group (IQ) (IQ) . (IQ) 
n n n n (yrs) 
0-5 8 2722 II 1661 .657 7 87 26 
(828-5906) (175-6692) (-76-198) 
5-12 5 2611 4 1495 .730 7 36 16 
(-31-10865) nv* (14-333) 
12-20 17 404 5 65 .249 14 86 36 
(41-1351) (-275-1514) (10-153) 
>20 3 1064 9 449 .727 8 93 20 
nv* (82-3999) (-13-806) 
Total 33 790 29 607 .762 36 57 98 
(83-3131) (58-3197) (-10-157) 
p-valuez .247 .293 .807 
p-value1:Patients compared to healthy Mantoux positive subjects per age group and totals 
(Mann- Whitney U test) 
p-valui: Different age groups per TB status and totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
*nv: interquartile ranges are given as non valid (nv) if the number of subjects is less than 5 
There was a weak, inverse correlation between age (yrs) and ESA T -6 stimulated 
lymphocyte proliferation (cpm) in the patient group (p. 73). 
Median 
(IQ) 
942 
(112-3486) 
77 
(18-2931) 
108 
(15-704) 
272 
(-13-1244) 
178 
(17-1504) 
.157 
There was a positive and significant, but weak, correlation between lymphocyte 
proliferation (cpm) and IFN- y production (pg/ml) after ESAT-6 stimulation in the patient 
and Mantoux pos group combined (p. 74). 
Because of the small numbers of subjects in some of study groups and large variations in 
values, any other statistical analysis is rather meaningless and probably invalid. 
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Discussion on lymphocyte proliferative assays 
Lymphocyte proliferation assays are used to measure the blastogenesis of lymphocytes, a 
basic requirement of their immunologic function, in response to defined antigens. The 
system relies on the incorporation of a radioactive nucleoside ell-Thymidine) into the 
cellular DNA of dividing lymphocytes during chromosomal replication. By its nature, it 
is an in vitro method that assesses antigen responsiveness rather than functional quality of 
the immune response. The technique can be used for the purpose of measuring antigen 
responsiveness on its own and, in relation to cytokine measurements from harvested 
supernatants of stimulated cell cultures, as a positive control measurement. It is however 
a rather laborious technique for larger scale studies especially if no automated cell 
counter is available. 
There are various ways in which lymphocyte proliferative responses are expressed in the 
literature: as a stimulation index (stimulated response/unstimulated response) or as a net 
value (stimulated response-unstimulated response). 170 When proliferative responses from 
this study were analysed by stimulation index, the results did not differ in any important 
way from the analysis by net value, as presented in this thesis. When the data were 
analysed by "normalising" for the absolute lymphocyte count (proliferative response-
unstimulated response/absolute lymphocyte count at time of venous puncture) the 
comparisons of results by study group were also similar to the ones shown in the 
preceding graphs and tables on lymphocyte proliferative responses. 
The fact that the lymphocyte proliferative responses after stimulation with PHA and PPD 
correlated well with IL-2 production signifies the importance of IL-2 as a growth factor 
for T -cells and, in a way, validates the outcomes of our proliferation studies. 
Overall, there was a decreased lymphocyte poliferative response in patients when 
compared to Mantoux pos subjects and this has been found by others.171 • 172 
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The different relation between lymphocyte proliferation and IFN-y after stimulation with 
PHA (significant correlation) or PPD (no correlation), indicates that the dynamics of 
lymphocyte proliferation in relation to cytokine production depend on the nature of the 
antigen. Others have found a similar discordant relationship between PPD stimulated 
lymphocyte proliferative response and IFN-y production.84 
These findings indicate that antigep responsiveness (as measured by lymphocyte 
proliferation) is not necessarily the correlate for a functional antigen response by the 
active T cell repertoire (as measured by- cytokine production). The function of 
lymphocyte proliferation assays as "a" positive control measurement for cytokine 
responses is probably not entirely justified. I doubt if the technique is of any use in a 
non-research setting, considering its time-consuming nature and need for expensive and 
fractious equipment. 
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IFN-y Production 
IFN-y production after stimulation with PHA 
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Table: Median (interquartile range:IQ) of IFN-y production (pg/ml) on day 4 after stimulation of 
whole blood with PHA (JO,ug/ml) in patients, healthy controls and totals 
TB patients healthy subjects p-value1 total 
status 
(Mantoux pos and neg) 
Age Median Median Median 
(IQ) (IQ) (IQ) 
group n n . n 
(yrs) 
0-5 14 1789 26 10719 .021 40 9576 
(543-11841) (4512-29751) ( 1456-16986) 
5-12 8 34011 24 10232 .454 32 11670 
(3027-65977) ( 4534-27213) ( 4534-36438) 
12-20 20 34284 33 39052 .349 53 38079 
(17570-69261) (17570-69261) (16027-61355) 
>20 8 14211 17 41262 .043 25 35197 
(5745-44792) (25086-65635) (16971-61355) 
total 50 15203 100 26616 .086 150 18371 
(2077-48273) (9575-53566) (5659-52175) 
p-value2 .011 <.0001 <.0001 
p-value1: Patients compared to healthy subjects (Mantoux pos and neg) per age group and total 
(Mann- Whitney U test) 
p-value2: All age groups of patients, healthy subjects or totals compared 
(Kruskal-Wal/is One-Way ANOVA by Ranks test) 
Age (yrs) correlated significantly with PHA stimulated IFN-y production (pg/ml) within 
the whole study group (p. 68). This correlation was stronger when the healthy subjects 
were analysed separately. In the patient group the correlation between age and IFN-y 
production (pg/ml) remained significant only when analysed for the all patients younger 
than 20yrs (p = .484, p = .001) due to the diminished production of IFN-y in the age 
group > 20 yrs. The 0-5 yrs age group (patients and healthy controls) produced 
significantly less IFN-y after stimulation with PHA than all the older age groups. 
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Patients from the youngest and oldest age groups produced significantly less IFN-y upon 
stimulation with PHA than their age related healthy controls. 
IFN-y production showed a significant inverse correlation with the absolute counts of 
white blood cells, monocytes and neutrophils, but notably not in any way (positive or 
negative) with the absolute counts oflymphocytes (p. 68). 
PHA stimulated IFN-y production correlated significantly with PHA stimulated IL-2, 
TNF-a and IL-10 production (p. 68). These correlations remained significant when 
analysed for patients and healthy subjects separately. 
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Table: Median (interquartile range: IQ) IFN-yproduction ( pglml) on day 7 after stimulation of whole 
blood with PPD (3.3,ug/ml) of subjects per age group, TB status and totals 
TB patients Mantoux pos Mantoux neg 
status 
Age Median Median p-value1 Median 
group (IQ) (IQ) (IQ) 
n n !} n (yrs) 
0-5 14 8853 14 7460 .769 12 1200 40 
(1747-13620) (2946- 16999) (10-9771) 
5-12 8 15905 14 23693 .707 10 383 32 
(2571-46187) (I 1243-36421) (10-4574) 
12-20 20 15937 12 16923 1.00 21 1447 53 
(5790-31991) (5 196-36563) (10-4152) 
>20 8 2417 9 15608 .034 8 1022 25 
(408-9566) (5507-33409) (10-2146) 
Total 50 8139 49 15355 .208 51 1328 !50 
(2843-234 12) (4762-30010) (10-3599) 
p-valuez .025 .222 .765 
p-value1: Patients compared to healthy Mantoux positive subjects per age group and totals 
(Mann- Whitney U test) 
p-valu/: Different age groups per TB status and totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
total 
Median 
(IQ) 
7178 
(I 265- I 3544) 
9772 
(985-29907) 
5734 
(I 589-23824) 
2978 
(10-12151) 
5627 
(1301-17723} 
.235 
Age in years did not correlate with PPD stimulated IFN-y production for the whole study 
population. However, in patients and Mantoux positives up to 12 yrs of age a significant 
correlation between age and PPD stimulated IFN-y production (n = 50, p = .406, p = 
.003) did exist. In the group of Mantoux positives this correlation was even stronger (n = 
28, p = .604, p = .001). The healthy Mantoux positive controls 0-5 yrs old produced 
significantly less IFN-y than the older healthy Mantoux positive subjects (p = .001). 
Patients of the oldest age group (> 20 yrs) produced significantly less IFN-y than their 
Mantoux positive controls (p = .034) contrary to patients from the three other, younger 
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age groups who did not produce significantly lower amounts of IFN-y if compared to 
age-related Mantoux positive controls. 
There were significantly inverse correlations between IFN-y production with the absolute 
amounts of neutrophils and monocytes, but not with absolute amounts of lymphocytes (p. 
72). 
PPD stimulated IFN-y production correlated significantly with PPD stimulated IL-2, 
TNF-a and IL-10 production (p. 72). These correlations remained significant with IL-2 
and TNF-a, but not with IL-10, when analysed for patients and healthy subjects 
separately (p. 72 and p. 74 respectively). 
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IFN-y production after stimulation with PPD compared to Mantoux skin testing 
The Mantoux skin test is an imperfect tool to determine "status of infection". Currently, 
efforts to develop an alternative in vitro method are based on IFN-y responses to 
mycobacterial antigens. 173' 174 Here, I have used our data to assess the use of PPD-
induced IFN-y levels for its potential in identifying. Mtb. infected people of different 
ages. 
All the study subjects, patients and healthy controls, were stratified along their positive or 
negative Mantoux status with 15mm skin induration as the cut-off value. The two groups 
were compared for their PPD induced IFN-y responses. Furthermore, the correlation 
between Mantoux size (mm) and IFN-y level (pg/ml) was determined in the Mantoux 
positive subjects by age group. 
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Table: Median (interquartile range: IQ) PPD stimulated (3.3p:g/ml) /FN-y production (pglml) of study 
subjects stratified along Mantoux positive (> 1 5mm) or Mantoux negative (<1 5mm), by age group 
Hrt1Age group (yrs) I " Mantoux pos (~15mln) Mantoux neg (<15mm) ,,,, !10: 
study subjects study subjects p-* 
'>. 
·:'· n Median n Median 
OQ) (JQ)' 
0-5 20 7796 17 1533 .033 
W· (2688-16274) .•.• _(199-889~ 
5.:.12 .... 18 21948 .. !'! 12' " 383 <.0001 (6230-36421) (10-5837) 
12-20 l;w;28 16923 
'" 2}:n 1447: <I'' 
····· < .0001 
· Mvn· (5269: 33491) 1(l0-4f52) +iqH ... 
>20 8 19823 8 1022 .006 
' 
'" ( 4975"3527Zl_.f[ {I0-247ll_ _B!l'i;, '_;£ '_;£ 
Tl>tal ., '74 13250 58 \i 1383' <.0001 
(4975-31190) (10-4962)_ 
*: (Mann Whitney U test) 
Table: Correlation coefficients (p) plus significance values (p) between /FN-yproduction (pg/m/) after 
PPD stimulation(3.3p:g/m/) and Mantoux skin test induration (mm) by age group. 
Age grotip(yrs) ';\ p* 
0-5 37 .397 .015 
5-12 .561 . ·' .001 
12-20 49 .583 <.0001 
>20 • / .16 .813 <.0001 
-
Total "' · ~cc -: 
''132 .577 <.ooot · 
*: Spearmann Rank-Order Correlation test 
The graph and tables show that there were significant differences in IFN-y production 
between Mantoux positives and Mantoux negative persons in each age group. 
Furthermore the correlation between the magnitudes ofiFN-y production (pg/ml) and size 
of Mantoux skin test induration (mm) per age group were also good (relative exception: 
the 0-5 yr age group) and significant. It should be remembered here that we did not 
perform Mantoux skin testing on the patients older than 20 years of age and they are 
therefore not included in these analyses. 
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Validating a new test requires comparison with a "gold standard". The only "standard" 
we have at the moment for discriminating infected vs non-infected persons is the 
Mantoux skin test and calculations for sensitivity, specificity and positive predictive 
values come from the following 2x2 table. 
Table: 2x2 table of IFN-yresponders and IFN-r non-responders after PPD stimulation x Mantoux pos and 
neg subjects from study subjects; I Opg/ml IFN-yis used as the cut-off value to discriminate non-
responders from responders 
Sensitivity, i.e. the percentage of people that have a positive PPDIIFN-y response of 
whom we know they have a positive Mantoux: 72174 = 97% (3% false negatives) 
Specificity, i.e. the percentage of people that have a negative PPDIIFN-y response of 
whom we know they have a negative Mantoux: 20/58 = 90% (10% false positives) 
Positive predictive value, i.e. the proportion of all PPDIIFN-y responders who are truly 
Mantoux positive: 72/110 = 65% 
Negative predictive value, i.e. the proportion of truly Mantoux negatives out of all 
PPDIIFN-y non-responders: 20/22 = 91% 
For the sake of the argument, calculations the other way around, with a positive IFN-y 
response as the "gold standard" would give the following values: 
Sensitivity, i.e. the percentage of people that have a positive Mantoux of whom we know 
they are PPD/ IFN-y responders: 65% (35% false negatives) 
Specificity, i.e. the percentage of people that have a negative Mantoux of whom we know 
they are PPDIIFN-y non-responders: 90% (10% false positives) 
Positive predictive value, i.e. the proportion of all Mantoux positives who are truly 
PPDIIFN-y responders: 97% 
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Negative predictive value, i.e. the proportion of truly PPDIIFN-y non-responders who are 
Mantoux negative: 34% 
The 50 patients in this study were classified as having TB on the basis of clinical 
(including radiological and microbiological) parameters and not on Mantoux skin test 
induration. Of the patients 3 out of 50 (= 6%) were PPDIIFN-y non-responders. Of the 
patients on whom we had a Mantoux skin test 7 out of 27 (= 26%) were Mantoux 
negative and 1 out of27 (= 3%) was a PPDIIFN-y non-responder. 
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Table: Median (interquarti/e range: IQ) IFN- yproduction in pglml on day 7 after stimulation of whole 
blood with ESAT-6 (3.3pg/ml) of subjects per age group, TB status and totals 
TB patients Mantoux pos Mantoux neg 
status 
Age Median Median p-value1 Median 
group (IQ) (IQ) (IQ) 
n n n n 
(yrs) . 
0-5 10 1285 12 5987 .254 9 10 31 
10-3743 136-12291 10-109 
5-12 6 2370 4 8340 .476 7 10 17 
10-9993 nv* 10-10 
12-20 19 1916 6 10 .176 20 115 45 
264-7818 10-48555 10-935 
>20 2 856 5 57 .571 6 10 13 
nv* 10-854 10-1~ 
Total 37 1416 27 1140 .437 42 10 
214-4313 10-9170 10-244 
p-value1 .216 .005 
.... . .. .... 
p-value1: Patients compared to healthy Mantoux positive subjects per age group and totals 
(Mann- Whitney U test) 
p-value2: Different age groups per TB status and totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
total 
Median 
(IQ) 
943 
10-6811 
32 
10-7584 
355 
10-2852 
10 
10-176 
215 
(10-2819) 
.066 
*nv: interquartile ranges not valid because number of subjects in the study group too small 
Age did not correlate in any way with IFN-y production (pg/ml) after ESAT-6 
stimulation. 
IFN-y production after stimulation with PPD and ESAT-6 were positively and 
significantly correlated in patients as well as healthy Mantoux positive controls (p. 73-
74). However, the paucity of numbers, notably in the two oldest control groups, may 
cause some misinterpretation .. 
108 
Stellenbosch University http://scholar.sun.ac.za
Discussion on IFN-y production 
The subjects included in this study produced IFN-y in abundant quantities. So much so 
that I have repeatedly rechecked if we had not miscalculated by a factor 10, but that was 
not the case. A large subgroup of subjects (around 50%, mainly consisting of the very 
high producers) have been checked for unstimulated background levels and these values 
were all below the detection limit of the assay (<15pg/ml). 
Stimulation with the mitogen PHA resulted in different age-specific responses when 
compared to stimulation with antigens PPD or ESAT -6. The strongly positive correlation 
between age in years and PHA stimulated IFN-y production was lost when PPD or 
ESAT -6 were used as a stimulant. However, when the Mantoux positive healthy study 
groups were analysed, there was still a rather strong correlation between age in years and 
PPD stimulated IFN-y production in the healthy Mantoux positives under 12 years of age. 
Furthermore, the 0-5 · yrs age group produced significantly less IFN -y compared to the 
older age groups after stimulation with both PHA and PPD. For a discussion and the 
possible implications of these findings I refer to the general discussion. 
Mitogen induced IFN-y responses from patients may be affected if compared to healthy 
controls, as shown in the data for the 0-5 and >20yrs age groups, but the other data show 
that this fmding is t:tot a general rule. One can only speculate on the reasons for this 
discrepancy. A possible explanation would be that patients of some age groups were in a 
compromised physical condition, whereby the comparison of weights between sick and 
healthy persons may serve as a proxy for physical condition. However, although the 
patients in the oldest age group were significantly lighter than their age-related healthy 
controls, this comparison did not reach significance in the 0-Syrs group where the 
patients were moreover younger than their age-related controls. Furthermore, the patients 
from the 5-12yrs age group were significantly lighter than their age related controls, but 
produced equal amounts ofiFN-y upon stimulation with PHA. Another speculation could 
evolve around "severity of disease", but we have no unified and standardised 
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classification at our disposal to compare patients with primary as well as postprimary by 
degree of disease severity. 
In Mantoux-negative subjects, stimulation with Mtb related antigens like PPD and 
ESAT-6, does not result in appreciable amounts ofiFN-y, compared to Mantoux positive 
subjects. There have been a number of studies suggesting that quantified PPD induced 
IFN-y production might be a valid and more sensitive substitute for Mantoux skin testing. 
173
•
174 The problem with these studies, as with this one, is that there is no "gold standard" 
for identifying Mtb infected individuals other than the Mantoux test. Consequently the 
Mantoux test, for which a substitute is wanted, is being used as the gold standard for 
validation of a possible substitute. Methodologically flawed as this may be, it is hard to 
come up with another study design for this particular question. This study was not 
designed to examine if PPD induced IFN-y responses may replace Mantoux skin testing, 
but speculations on this issue are interesting enough in view of the results. Furthermore, 
the published studies on this subject have all been on adults and our data are therefore the 
first from a group of children. It should be noted that although the tables on p-values and 
correlation coefficients for the different age groups show very satisfactory and significant 
values, they are slightly misleading. Because there were relatively few subjects with 
Mantoux skin test indurations between 0 and 14.9 mm (11 %), the/ significance of the 
correlations is, in part, caused by the fact that most of the skin indurations had extreme 
values of Omm (32%) or> 15mm (56%). 
In the evaluation of an individual patient, there may well be an added value of measuring 
IFN-y after PPD stimulation, since the Mantoux test was more frequently negative in 
these subjects than the IFN-y response (26% vs 6%). 
For larger scale studies, especially in low incidence countries, the calculated positive 
predictive values are not good enough. Higher cut off values for PPD induced IFN-y 
responders does improve the positive predictive value, be it at the cost of lower 
sensitivity and specificity. 
We only obtained the ESAT-6 antigen when the study was already underway, which is 
why we have relatively few data in some study groups on ESAT-6 stimulated IFN-y 
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production. Any statistical analysis in view of the results is, in my view not valid in this 
section, but an analysis of these data from the perspective of disease expression later in 
this thesis proved interesting. 
Because IFN-y is such a crucial cytokine in mycobacterial infection and quite extensively 
studied in adults, but rarely in children, our results deserve a more elaborate discussion 
than that given in this chapter, for which I refer to the general discussion at the end of the 
thesis. 
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Table: Median (interquartile range) ofTNF-aproduction (pg/m)l after stimulation of whole blood with 
PHA (JO,ug/ml) in patients, healthy controls and totals 
TB patients healthy subjects p-value1 total 
status (Mantoux pos and neg) 
Age Median Median Median 
(IQ) (IQ) (IQ) 
group 
n n n (yrs) 
. 
0-5 13 215 26 199 .670 39 200 
(10-421) (25-342) (10-331) 
5-12 7 397 22 356 .980 29 361 
(212-547) (170-532) (196-510) 
12-20 20 297 33 370 .045 53 334 
(157-386) (228-908) (215-642) 
>20 8 242 17 1016 .023 25 508 
(50-613) (331-1442) (242-1351) 
total 48 262 98 343 .020 146 310 
(45-421) (192-820) (164-563) 
p-valuez .556 <.0001 <.0001 
----- - ----
p-value1: Patients compared to healthy subjects (Mantoux positive and negative) per age group and total 
(Mann- Whitney U test) 
p-valui: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
Age (yrs) had a significant correlation with PHA stimulated TNF-a production (pg/ml), 
in the healthy controls (p. 70), but not in the patients. 
In the two oldest age groups, patients produced significantly less PHA stimulated TNF -a 
than healthy controls. 
PHA stimulated TNF -a production (pg/ml) did not show any significant correlation with 
the total amount of lymphocytes in any group, but a significant inverse relation with total 
amounts of neutrophils and monocytes (p. 68). Correlations with other cytokines 
produced after stimulation with PHA were positive and significant for IFN-y, IL-2, and 
IL-10 (p. 68). 
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TNF-a. production after stimulation PPD 
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Table: Median (interquartile range: IQ) TNF- a production ( pg/ml) after stimulation of whole blood with 
PPD (3.3pg/ml) of subjects per age group, TB status and totals 
TB patients Mantoux pos Mantoux neg 
status 
Age Median Median p-value1 Median 
group (IQ) (IQ) - (IQ} 
n n n n (yrs) 
0-5 13 172 14 86 .094 12 10 39 
(90-227) (10-187) (10-85) 
5-12 7 92 14 116 .255 8 10 29 
(16-226) (80-155) (10-18) 
12-20 20 132 12 113 .346 21 10 53 
(85-215) (28-159) (10-57) 
>20 8 90 9 10 .370 8 10 25 
(32-262) (10-101) (10-22) 
Total 48 109 49 97 .088 49 10 146 
(64-184) (10-150) (10-10) 
p-valuez .330 .294 .794 
p-value1: Patients compared to healthy Mantoux positive subjects per age group and totals 
(Mann- Whitney U test) 
p-valui: Different age groups per TB status and totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
total 
Median 
(IQ) 
85 
(10-173) 
83 
(10-140) 
91 
(10-136) 
10 
(10-101) 
81 
(10-135) 
.088 
Age did not correlate in any way with TNF-a production after stimulation with PPD. 
On the whole, patients tended to produce more TNF-a upon stimulation with PPD, but 
this did not reach significance. 
There were no significant correlations with any of the absolute amounts white blood cells 
and TNF-a production after stimulation with PPD. 
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PPD stimulated IFN-y production correlated with TNF-a production in patients and 
healthy Mantoux pos controls (p. 73-74). However IL-2 correlated with TNF-a only in 
the healthy controls (p. 7 4), but not in the patients. The correlation between IL-l 0 and 
TNF-a was weak and only just significant in the healthy controls (p. 74) . 
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Discussion on TNF-a. production 
Although the quantities in pg/ml of TNF-a. that were produced were rather small, the 
virtual absence of any production after stimulation with PPD in the healthy Mantoux 
negative group is an indicator that analyses of differences are valid. However, neither 
PHA nor PPD seem very good stimulants of TNF-a. production in this whole blood 
model. Nor did PHA stimulation result in very large differences in the quantities ofTNF-
a. when compared to PPD stimulation, in contrast to some of the other cytokines we 
measured {IFN-y and IL-10). TNF-a. was measured in all the non-stimulated samples of 
day 3 and day 7 and these values were below the minimal detection value ( 15pg/ml) of 
the assay; thus unstimulated background levels did not influence the results. It may be 
that soluble TNF receptors, known to be present in serum of adults with active TB before 
treatment175, have influenced the results in this whole blood system. 
The positive correlation between age in years and PHA stimulated TNF-a. production in 
healthy controls is perhaps in itself not a remarkable finding. Cord blood cells have been 
shown as deficient producers of TNF -a., partly because of their reduced sensitivity to 
IFN-y. 176 Elsasser-Beile et al177 found significant differences in PHA induced TNF-a. 
production of whole blood in relation to age with fewer numbers of children than we 
included. This latter study is the only one in this field where comparable methods to ours 
have been used. One study into age related TNF -a. production after stimulation with 
PHA, using PBMCs, found higher values in children than adults, however the age range 
for their group of children was rather wide (0.6-16.5 yrs)178 Few other studies have 
reported on healthy children's TNF-a. responses to antigenic stimulation, one exception 
being Pollard's study41 , who found age related values in controls (higher in older 
children), but not in patients after meningococcal infection upon stimulation with 
menigococcal antigens. For a cytokine that is implicated is so many severe pathologic 
conditions, it is perhaps surprising that few normal age-related reference data exist. 
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The correlation between age and PHA stimulated TNF-a. production is lost upon 
stimulation with PPD in all the study groups. Apparently the type of antigen is a 
determinant for a relation between age and TNF-a. production. 
Why patients from the groups older than 12 years were affected in PHA, but not in PPD 
stimulated production of TNF-a. when compared to age-related controls is unclear. 
However, what is perhaps more interesting in this context, is the fact that healthy controls 
of all ages produced relatively larger amounts of TNF-a. upon stimulation with PHA 
compared to stimulation with PPD, while this was not the case in all patient groups. This 
suggests that it is easier to induce TNF-a. production with PPD in patients than in healthy 
controls. 
Clinical and experimental data in animals and humans suggest a dual role for TNF -a. in 
the immune regulation of TB. On the one hand its beneficial contribution to granuloma 
formation 179 but on the other hand its detrimental effect leading to cachexia and fever89 
are well recognised consequences that are most probably dependent on its relative 
production in various stages of the immune response to M.tb. In the context of this study, 
the phenomenon is further explored in the chapter on cytokine responses in relation to 
expression of disease. 
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Table: Median (interquartile range:/Q) of /L-2 production (pg/ml) after stimulation of whole blood with 
PHA (JOpg/ml) in patients, healthy controls and totals 
TB patients healthy subjects p-value1 total 
status (Mantoux pos and neg) 
Age Median Median Median 
(IQ) (IQ) (IQ) 
group 
n n n 
(yrs) 
. 
0-5 14 155 26 127 .747 40 127 
(56-331) (49-225) (49-235) 
5-12 8 187 24 178 .404 32 178 
(17-331) (85-349) (76-328) 
12-20 20 92 33 236 .028 53 195 
(62-300) (99-642) (78-543) 
>20 8 107 17 226 .110 25 139 
(22-162) (112-438) (81-381) 
total 50 120 100 193 .020 150 157 
(46-263) (87-387) (68-337) 
p-value1 .841 .217 .321 
.. 
---------- - ---
p-value1: Patients compared to healthy subjects (Mantoux positive and negative) per age group and total 
(Mann- Whitney U test) 
p-valui: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
I 
Age (yrs) had a weak correlation with PHA stimulated IL-2 (pg/ml) production in the 
healthy subjects (p. 70), but not in the patients. 
On the a whole, the patient group produced less IL-2 than the healthy control group, but 
after stratification by age group this difference proved only to be significant in the 12-20 
years group. 
PHA stimulated IL-2 production was not related to the absolute lymphocyte counts. 
Correlations were positive and significant between PHA stimulated IL-2 and IFN-y, 
TNF-a and IL-10 (p. 68). 
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IL-2 production after stimulation with PPD 
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Table: Median (interquartile range: IQ) IL-2 production (pg/ml) on day 3 after stimulation of whole blood 
with PPD (3.3pg/ml) of subjects per age group, TB status and totals 
TB patients Mantoux pos Mantoux neg 
status 
Age Median Median p-value1 
-
Median 
group (IQ) (IQ) (IQ) 
n n n n 
(yrs) 
0-5 14 102 14 153 .804 12 44 40 
(68-941) (10-451) (10-138) 
5-12 8 194 14 337 .238 10 10 32 
(106-481) (209-670) (10-10) 
12-20 20 35 12 133 .209 21 10 53 
(10-224) (16-549) (10-38) 
>20 8 60 9 128 .423 8 10 25 
(37-161) (40-452) (10-40) 
Total 50 79 49 213 .055 51 10 150 
(33-24) (58-469) (10-42) 
p-value2 .015 .167 .040 
p-value1: Patients compared to healthy Mantoux positive subjects per age group and totals 
(Mann- Whitney U test) 
p-valui: Different age groups per TB status and totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
total 
Median 
(IQ) 
102 
(32-404) 
189 
(10-371) 
10 
(10-135) 
47 
(10-175) 
60 
(10-253) 
.009 
Age (yrs) had a significant inverse correlation with IL-2 production (pg/ml) after 
stimulation with PPD in the patients (p. 72), but not in the healthy Mantoux pos controls, 
in which group however, the correlation with age tended to be negative. 
The difference in PPD stimulated IL-2 production between patients and Mantoux positive 
healthy controls was nearly significant with median values in each age group lower in 
patients than controls. Patients< 12 yrs produced significantly more IL-2 than patients> 
12 yrs (p = .001), while there was no difference between the healthy controls< 12 yrs vs 
> 12yrs. 
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IL-2 production did not correlate significantly with absolute lymphocyte counts in the 
patient group, nor in healthy Mantoux pos group, but there was a weak correlation 
between IL-2 and lymphocytes when these two groups were analysed together (p. 72). 
Correlations with the other PPD stimulated cytokines were significant for IFN-y, TNF-a ( 
in Mantoux pos controls (p. 74). However, in the patients IL-2 production did not have a 
significant correlation with TNF-a. 
Stellenbosch University http://scholar.sun.ac.za
-·--~·-·-.,~---.~·=. * ,. ;::::; Q Mi4i) WW 
Discussion on IL-2 production 
As with the stimulated TNF -a production the quantities of stimulated IL-2 in pg/ml were 
not very large. There were, however, a few very distinct and significant differences 
between groups. As a growth factor for lymphocytes, rapid IL-2 production is probably 
needed for specific cytokine responses. Indeed IL-2 production was maximal early in the 
time course of our cell cultures and we therefore harvested on day 3 for both PHA and 
PPD stimulated cultures, while PPD stimulated IFN-y and TNF-a levels were maximal 
on day 7. 
Since it is well recognised that nai"ve T cells invariably produce only IL-2 upon 
stimulation and the younger the child the more nai"ve T -cells are demonstrated, one would 
expect higher IL-2 production at younger age. However there is evidence that naive T-
cells35 as well as antigen presenting180 cells from young children and adults differ in that 
respect and this might explain the fact that increased IL-2 production has not been 
demonstrated in any consistant way in studies involving T cells from children. 
Diminished capacity to produce IL-2 in cord-blood and neonates has been described32, as 
well as equal production by cord blood and children of different ages42 or lower 
production by the younger children in a small study of children aged 2-15 yrs. 181 
The level of IL-2 production is likely to depend on previous antigen exposure. However, 
in the patients we found a negative correlation between age in years and PPD stimulated 
IL-2 levels. The relatively high level of IL-2 in patients< 12 yrs might explain some of 
the comparatively good production of IFN-y in patients of the 0-5 and 5-12 yrs age 
groups. 
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IL-10 production 
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Table: Median (interquartile range: JQ) IL-10 production (pglml) after stimulation of whole blood with 
PHA (10pg/ml) on day 3 (after subtraction of unstimulated IL-10 production on day 3) of patients and 
healthy subjects by age group and totals 
TB patients . healthy subjects p-value1 total 
status (Mantoux pos and neg) 
Age Median Median Median 
(IQ) (IQ) (IQ) 
group 
-n n n (yrs) 
0-S 13 518 26 734 .848 39 610 
(142-1658) (199-1488) (203-1408) 
S-12 8 641 23 1478 .110 31 1187 
(235-1769) (959-2933) (658-2301) 
12-20 20 713 33 1598 .009 53 1217 
" 
(136-1758) (619-3303) (388-2981) 
>20 7 1298 16 2432 .341 23 2402 
(316-3200) ( 1344-3195) (677-3136) 
total 48 597 98 1392 .004 146 1095 
(161-1715) (580-2751) (319-2485) 
p-value2 .827 .002 .005 
p-value1: Patients compared to healthy subjects (Mantoux positive and negative) per age group and total 
(Mann- Whitney U test) 
p-value2: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
There was a significant positive correlation between age (yrs) and PHA stimulated IL-10 
production (pg/ml) in the healthy subjects (p. 70), but not in the patient group when 
analysed separately. Furthermore the subjects of the youngest age group produced 
significantly less IL-10 upon stimulation with PHA than all the other age groups (in the 
healthy subjects: p = .013 for 0-5yrs vs 5-12yrs; p = .002 for 0-5yrs vs 12-20 yrs; p = .001 
for 0-5 yrs vs > 20 yrs). This was not due to differences in unstimulated values between 
any of the study groups. 
On the whole, patients produced less than healthy controls, but after stratification for age 
this was not significant for any of the individual age groups, except for the 12-20 years. 
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There were weak, but significant correlations with the absolute amounts of neutrophils 
and monocytes within the whole study population (p. 68), but they did not hold when 
patients and healthy subjects were analysed separately. No correlation with the absolute 
amount of lymphocytes was found. 
~ 
Correlations between PHA stimulated IL-l 0 and other cytokines were significant for: 
IFN-y, IL-2 and TNF-a (p. 68). 
~ 
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Table: Median (interquartile range:IQ) /L-10 production ( pglml) after stimulation of whole blood with 
PPD (3.3,ug/ml) on day 3 (after subtraction of unstimulated production on day 3) per age group, TB status 
and totals. 
TB patients Mantoux pos Mantoux neg 
status 
Age Median Median p-value1 Median 
group (IQ) (IQ) . (IQ) 
n n n n (yrs) 
0-5 11 -6 10 61 .426 6 2 27 
( -66/131) (0/196) (-39/ 123) 
5-12 7 182 13 11 .088 7 68 27 
(9/295) (-36/83) (-13111538) 
12-20 20 114 12 -28 .004 20 10 50 
(8/169) (-110119) (-30/58) 
>20 6 0 3 49 .572 5 55 14 
(0/256) (-60/197) (-150/487) 
Total 43 75 37 2 .032 38 3 118 
(0/168) (-62/86) (-59/69) 
p-valuel .206 .126 .963 
- --- ---- --- --- - ---- ----
..___ 
p-value1: Patients compared to healthy Mantoux positive subjects per age group and totals 
(Mann- Whitney U test) 
p-value2: Different age groups per TB status and totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
total 
Median 
(IQ) 
10 
(-60/125) 
26 
(-41/1 46) 
14 
(-34/118) 
0 
(-57/317) 
12 
(-40/ 123) 
PPD was a poor stimulant for IL-l 0 production in most groups. Negative values were the 
result of higher unstimulated than stimulated background values. 
If analysed by responder (PPD stimulated IL-l 0 production > unstimulated IL-l 0 
production) to non-responder (PPD stimulated IL-10 production <unstimulated IL-10 
production) status, the following counts were obtained: 
Total 
18 63 
19 55 
37 118 
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In all age groups there were as many responders as non-responders in the Mantoux 
negative subjects. 
Age did not correlate with IL-l 0 production after stimulation with P~D in any of the 
subgroups. 
The patient group seemed to produce significantly more IL-l 0 than Mantoux pos healthy 
subjects, but the 12-20 yrs age group was the only age group where this was of any real 
significance. 
There were no significant correlations between IL-l 0 production and any of absolute 
counts of white blood cells, nor with any of the other PPD stimulated cytokines. 
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Discussion on IL-10 production 
IL-l 0 is often regarded as a cytokine that is produced late in the immune response to a 
pathogen. 182 After stimulation with the mitogen PHA, we found in the pilot studies that 
day 3 was the optimum time point of IL-l 0 production. Production after PPD. stimulation 
started at day 3 and remained detectable, albeit at lower levels, on day 7. I have made 
some mistakes with the ELISAs for IL-l 0, which resu1ted in fewer data available for 
analysis from day 7 than from day 3. In addition the values from day 7 were in general 
even lower and I have therefore discarded the day 7 values from the results. 
The very distinct and significant age-related difference in PHA stimulated IL-l 0 
production between the subjects younger than 5 years and the older subjects, is 
interesting and, as far as I know, not previously described. IL-10 production has however 
been found defective in cord blood mononuclear cells when compared to mononuclear 
cells from adults. 183 Stimulated IL-l 0 production furthermore has been measured in 
young children with various diseases,49• 184 but conclusions on an age-relation per se are 
rarely mentioned in these publications, with the exception ofPollards' study41 who found 
a non-significant trend to higher production at older age. The correlation with PHA 
induced IL-10 levels was significant, for IFN-y, TNF-a and IL-2 in our study and one can 
therefore hypothesise age-related regulation between these cytokines, but not necessarily 
age-related contra regulation. 
The importance of IL-l 0 in the human immune response to M tb has been demonstrated 
in a number of studies that, however, differed greatly in their methodology to highlight 
this issue. IL-10 has a down-regulating effect on IFN-y and TNF-a production and is 
therefore regarded as anti-inflammatory. Two studies have proved the point that IFN-y or 
TNF-a production can be down-regulated by adding recombinant IL-10 to monocyte cell 
cultures stimulated with mycobacterial antigens.68• 185 One important study in this field98 
found higher levels of IL-l 0 in the supernatants of PBMCs stimulated with mycobacterial 
antigens from patients if compared to healthy household contacts, however without any 
differences in mRNA expression ofiL-10 between these two groups. No difference in IL-
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10 mRNA expression was found between patients and healthy controls in a study by 
Zhang et al82, who, contrary to Torres et al98, could not demonstrate a difference in IL-10 
production by PBMCs either. 
In our study IL-l 0 production after stimulation with PPD on day 3 was very low in all the· 
study groups. The table on the responders and non-responders serves to illustrate the 
point that there were as many responders in the Mantoux negative as in the Mantoux 
positive group. In comparison to the other cytokines we measured after stimulation with 
PPD, this finding raises the question if PPD stimulation was at all specific. It should 
perhaps rather be regarded as a non-specific stimulant for some IL-l 0 production in 50% 
(healthy Mantoux pos and neg subjects)-60% (patients) of the whole population under 
study. The only study I could find where PPD was used as a stimulant of whole blood and 
IL-l 0 measured afterwards, was by van Creve! et al30 who studied healthy skin test 
positive and negative individuals, but no patient group. They could not measure any IL-
l 0 production either after stimulation with PPD, while they could measure IL-l 0 after 
stimulation of whole blood with PHA or LPS. On the basis of these arguments, I have 
decided to regard the results on the PPD stimulated IL-l 0 production as non-specific in 
our study, thereby disregarding the fact that there was a significant difference between 
patients and Mantoux pos controls, especially in the 12-20 yrs age group. Why PHA and 
LPS, but not PPD, seem to be effective inducers of IL-l 0 in whole blood cultures is an 
intriguing issue, that would be interesting to study further in some detail. Plasma factors 
are likely candidates, since the phenomenon seems not to be apparent in studies with 
PBMCs. The fact that IL-l 0 can be measured in serum from TB patients, and in 
significantly higher amounts than in healthy Mantoux positive controls99 indicates that, 
with respect to TB, serum IL-l 0 has some role in vivo. 
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Table: Median (interquartile range:/Q) of serum /gE (in KU/1) levels in patients, healthy controls and 
totals 
TB patients healthy subjects p-value• total 
status 
(Mantoux pos and neg) 
Age Median Median Median 
(IQ) (IQ) (IQ) 
group 
n n n 
(yrs) 
0-5 8 44 20 247 -.150 28 144 
(20-299) (68-606) (43-477) 
5-12 8 310 21 627 .301 29 529 
(101-1045) (252-1882) (200-1076) 
12-20 17 191 33 254 .690 50 164 
(51-910) (62-530) (52-788) 
>20 8 251 16 124 .214 24 145 
(56-1005) (16-303) (20-350) 
total 41 157 90 239 .794 131 217 
(47-781) (63-690) (52-758) 
p-valuez .216 .004 .006 
... . --
p-value1: Patients compared to healthy subjects (Mantoux positive and negative) per age group or total 
(Mann- Whitney U test) 
p-valui: Age groups of patients, healthy subjects or totals compared 
(Kruskal-Wallis One-Way ANOVA by Ranks test) 
Age (yrs) had no correlation with total serum IgE levels (KUIL), although the various age 
groups had significantly different levels of serum lgE. 
There were no significant differences in serum IgE levels between patients and healthy 
controls 
Serum lgE levels (KUIL) did not correlate with any of the produced cytokines (pg/ml) 
that we measured, after stimulation of whole blood with PHA or PPD. 
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Serum IgE levels in children under 12 years of age 
As can be inferred from the boxplot graph on total serum IgE levels in all age groups, 
there were more distinct differences in serum lgE levels in the subjects under 12 years of 
age than in the older subjects, which is why the children < 12 yrs will be analysed in 
some more detail. 
Under the age of 12 years, there was a significant correlation between age in years and 
serum lgE levels (n =57, p = .444, p = .001), when all the subjects of this age were taken 
into account. 
lgE was the only measurement where, at least in the children under 12 yrs of age, there 
were differences between both patients and healthy Mantoux pos controls (significant) as 
well as between Mantoux pos and Mantoux neg healthy controls (nearly significant). 
Graph: Total serum IgE (KU/1) in children under 12 yrs of age by TB status 
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The corresponding p-values (Mann-Whitney U test) of this analysis were: 
. difference in serum lgE levels (KU/L) of patients vs Mantoux pos: p = .028 
. difference in serum IgE levels (KU/L) of patients vs Mantoux neg: p = .906 
. difference in serum lgE levels (KU/L) of Mantoux pos vs Mantoux neg: p = .055 
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There were no correlations between serum IgE levels (KUIL) and produced cytokines 
. (pg/ml) that we measured, after stimulation with PHA or PPD in children under 12 years 
of age. 
There was no correlation between lgE levels (KUIL) and Mantoux size (mm) in the 
patients < 12 yrs. There was however a, just significant, correlation between lgE levels 
(KUIL) and Mantoux size (mm) in the group of healthy controls, Mantoux pos and neg 
combined (n = 40, p = .321, p = .044). 
136 
I 
li 
! 
Stellenbosch University http://scholar.sun.ac.za
Discussion on total serum IgE measurements 
We measured serum IgE levels in our study subjects to obtain a "proxy" or surrogate 
marker -for type 2, as opposed to a type 1, immune activity. In general, it is acknowledged 
that a type 2 immune response is driven by type 2 cytokines like IL-4, Il-5, Il-6, IL-13 
and IL-l 0, resulting in a dominant humoral immune response. Cross-regulatory 
interactions between IL-4, IL-13 and IFN-y are well ·described.186 Increased levels of 
serum IgE are associated with high Il-4 and/or IL-13 production and IL-4 seems an 
essential factor for IgE synthesis187. We attempted to measure IL-4 in the supernatants of 
the stimulated whole blood cultures, but the levels of this cytokine were mostly below the 
detection levels of the assays. This may have been due to technical constraints in 
measuring IL-4105 and/or a real absence of IL-4 derived biological activity in the human 
immune response to TB. A good number of groups studying the human immune-
pathogenesis of TB have failed to demonstrate IL-4 by a variety of techniques, although 
others were able to show an increased frequency of IL-4 producing cells in TB 
patients. 84•188 
Total IgE levels in serum may be a reflection of polyclonal, non-specific IgE and/or 
antigen specific IgE. High serum IgE levels are associated with a number of pathologic 
conditions amongst which atopy and helminthic infections are the most common. In both 
these conditions high IgE levels may be found with or without elevated antigen specific 
IgE. 
In recent years, there have been a number of reports and opinionating articles supporting 
the hypothesis that helminthic infections, whiCh are so very prevalent in resource-poor 
tropical regions of the world, contribute to the rapid spread of diseases like TB and AIDS 
in these populations. 189 Helminths may drive the hosts' immune response towards high 
polyclonal serum IgE levels as well as elevated helminthic specific IgE. Complicated 
cross-talk with all elements of the immune system is the result, reviewed in an instructive 
paper by Maizels et al 190• Furthermore this cross-regulation is not only helminth species 
specific, but also dependent on the stage of the parasite's life cycle and the organ of the 
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host in which the worm resides. Within this interplay, genetic factors are probably 
important, illustrated by the fact that in most populations ''wormy people" are identified, 
i.e. persons who seem to have a predisposition favoring recurrent high burdens of 
helminthic infestations, despite treatment and preventive measures. High lgE may be an 
indication of past or present helminthic infection. 191 As such IgE is not only an indicator 
of infection but may be an expression of protection from infection as well. 192 Changes in 
mean worm burden typically follow a convex curve with the age of peak intensity in the 
host depending on life expectancy of the parasite, intensity of transmission and 
behavioral factors of the host. 190 
Age-prevalence curves of Ascaris lumbricoides infections rise steadily with age from 
young childhood to a peak in early teenage years and tail off thereafter. In our study, 
there was a significant correlation between age in years and total serum lgE levels in 
children younger than 12 years as well as a convex curve with age thereafter, which may 
very well be a reflection of endemic infection with Ascaris lumbricoides in the region. 
According to a 1993 study from the area of our study, Ascaris lumbricoides and Trichuris 
trichuria infections were already prevalent in 54% of creche attendees (children aged 12-
69 months), despite the availability of free anti-helminthic treatment. 193 Ascaris 
lumbricoides worms are of interest to our IgE data, because of their propensity to induce 
high serum IgE levels and perhaps, on a speculative note, because of their transient life-
stage in the lungs. We have previously published a study where we showed that a group 
of adolescent TB patients, at time of diagnosis, did not have different levels of total 
serum IgE as compared to a group of Mantoux positive healthy controls.194 ·Our study 
presented here confirms this finding for that particular age group (12-20 yrs). However, 
our findings from the children younger than 12 years are different. There were significant 
differences in lgE between patients and both healthy Mantoux- positive and negative 
controls. It would be attractive to hypothesise that an ongoing type 1 response against 
Mtb, as can be postulated a TB patient might exhibit despite it being not entirely 
effective against TB, lowers the total serum IgE. Even more speculative, but interesting, 
would then be the assumption that children infected with Ascaris lumbricoides have a 
lowered local pulmonary defense against infection with Mtb, caused by the migration 
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phase of Ascaris lumbricoides through the lungs. The infection with M.tb would then lead 
to a positive Mantoux skin test, but not necessarily disease in these children. However, 
none of the other data from this study can support these postulates. 
Atopy and TB have been "linked" by a number of authors, in particular Shirakawa et al195 
who, in a much quoted study, argue that a decrease in exposure to Mtb (as measured by 
mm of Mantoux skin induration) is related to an increase in atopic conditions in Japanese 
school children.· Fascinating as the retrospectively obtained data in this report are, the 
authors do not consider in their discussion that atopic conditions may be instrumental in 
diminished DTH skin reactions and thus the cause rather than the effect of the proposed 
association. In atopic persons high serum IgE levels are a reflection of the atopic 
condition and, with exceptions, elevated· allergen- specific IgE levels indicators of 
clinical allergy for a particular antigen. Clinical allergy may, however, also be present 
without demonstrable elevated (specific) serum IgE. Although we are readily inclined to 
make the link "IgE-worms" when debating IgE levels in people from tropical climates, 
we often tend to forget that in these climates TB is an important disease of the urbanised 
poor, who live under shallow conditions in settlements favorable to allergens like house-
dust mite. Indeed, allergic conditions are rising in the cities of Africa and frequently 
encountered in the Cape Town area, where a high and rising prevalence of house dust 
mites in mattresses (coupled to skin-prick test sensitivity) and asthma has been shown.196 
None of the children included in our study were known to have any clinically important 
manifestations of asthma or eczema, but if the high IgE levels in the healthy Mantoux 
positive children were related to atopic conditions, our data argue against those found in 
the Japanese study. 
In the considerations of a possible inverse relation between "infections" and atopy, the 
type 1/type 2 paradigm may not prove to be very helpful in any way. High polyclonal IgE 
levels, caused by infections with helminths may saturate FeE receptors on mast cells and 
in this way competitively inhibit binding of other allergen-specific lgE.197 Children with 
Schistosoma haematobium infections had lower skin test reactivity to house dust mite in a 
recent study fro~ Gabon and this finding correlated with high schistosome-specific 
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antigen mediated IL-10 responses. 198 These fmdings prompted Holt199 in an invited 
commentary to cite the authors of a 197 6 published study on IgE levels: " .... atopic 
disease is the price paid by some members of the white community for their relative 
freedom from diseases to viruses, bacteria and helminths ... ". 
Thus, . in the light of the reasoning on an "inverse" relation between lgE and TB, the 
fmdings of our study do not support any such hypotheses. However, we could not obtain 
IgE on all our study subjects, nor did we measure specific IgE to any allergen or examine 
stools to determine worm load. Furthermore, this is a relatively small study, so any 
definitive conclusions in this respect cannot be drawn. 
One conclusion is very much warranted in my opinion, namely that future studies into the 
relation of infectious diseases and changing IgE levels by any cause, should take into 
account age factors and the dynamics of the prevalent regional helminthic infections 
and/or atopic conditions in the population under study. 
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Age-related expression of disease 
Introduction 
The aims of this study were to analyse the cellular immune response in healthy 
individuals and persons with TB at different ages and to relate the findings to clinical 
expression of disease at different ages. 
Two distinct expressions of disease after infection with M tb are generally recognised: 
1. "Primary TB", which is a direct consequence of an infection with Mtb, occurring in 
immunologically naive persons who have not been previously sensitized with Mtb. The 
most common clinical phenotype of primary TB is hilar adenopathy, with or without lung 
parenchymal involvement as a consequence of bronchial obstruction or seeding of M tb 
through eroded bronchi. Any form of disseminated disease is also regarded as a clinical 
expression of primary TB. 148 
2. "Postprimary TB" whereby, after a variable period of latency, endogenous or 
exogenous re-infection results in a disease principally of the lung parenchym, mostly 
affecting the upper lobes and classically with cavity formation. 
To be able to classify patients as having primary or postprimary TB, their clinical 
characteristics have to be evaluated. Usually, the mode of presentation, which includes 
the findings on the CR, is sufficient ground to make a distinction between primary and 
postprimary TB, along the above described criteria. 
The model of the following analysis was, in part, inspired by a number of findings in the 
preceding chapters of results: 
Mantoux negative healthy subjects of different ages did not produce appreciable 
amounts of cytokines in response to PPD or ESA T -6 when compared to Mantoux 
positive healthy subjects. 
Although there were significant differences between patients and Mantoux positive 
healthy subjects in certain age groups and a number of interesting trends, no single 
cytokine result stood out statistically as highly significant in any of the four age 
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groups individually. This may have been entirely the consequence of the relatively 
small numbers of subjects per group and the need to use non-parametrical tests 
throughout the analyses. The only way to single this factor out is to study larger 
groups of subjects. 
Furthermore, the suggestion has been made by Ellner et aeoo that a profile, i.e. ratios 
between different cytokines, made up from cytokine responses to mycobacterial antigens 
might be more indicative in distinguishing patients from ·controls of all ages. 
Methods 
All the patients and Mantoux positive healthy controls of this study were eligible for this 
analysis. The Mantoux negative healthy controls were excluded, since they did not have 
any quantity of mycobacterial specific responses that were worth comparing to the other 
two groups. 
Patients were stratified as having primary or postprimary disease on the basis of the 
following characteristics: 
Primary TB: Hilar adenopathy with or without lung parenchymal involvement. 
Posprimary TB: 
Disseminated disease, with or without abnormalities on the CR. 
Infiltrating abnormalities of the lung parenchym with or without 
cavities in the presence of a positive smear for acid-fast bacilli 
and/or positive sputum culture for M.tb. 
The subjects' individual results on lymphocyte proliferation and cytokine production, 
obtained from the original study, were used for the analyses. 
Non-parametrical statistical methods, as described before, were used. 
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Results 
Clinical characteristics of included subjects 
22 patients could be classified as having primary TB and 25 patients could be classified 
as having postprimary TB and their diagnostic characteristics are presented in the 
following table. 
Table: Diagnostic characteristics of patients with primary or postprimary TB 
TBM: Tuberculous Meningitis 
CR: Chest Radiograph 
* . 
** · 
1 patient with a pneumatocele and infiltrate behind the hart on the CR and culture positive TBM 
1 patient with an infitrate on the CR, loss of weight, a known contact and a gastric aspirate positive 
for Mtb on culture 
1 patient without abnormalities on the CR, presenting with clinical, cerebrospinal fluid and cranial 
CT scan findings compatible with TBM 
Three patients from the original study were excluded from the analysis. One, because he 
presented with a pleural effusion and a positive smear for TB, but was subsequently lost 
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to follow up and from his CR at presentation, it could not be established with certainty if 
the effusion was accompanying primary or postprimary TB. One was excluded because 
he had symptoms of chronic cough and a positive sputum smear for acid-fast bacilli, but 
no abnormalities on his CR. One, because she presented with erythema nodosum and 
only a calcification on the CR without a known contact with an index case. Erythema 
nodosum, mostly regarded as a hypersensitivity reaction to M.tb, is a well-known 
presentation ofTB, but I could not classify her in any of the two patients groups. 
All the patients with primary TB turned out to be younger than 12 years of age, all the 
patients with postprimary disease were older than 12 years. 
The Mantoux positive healthy controls were stratified along age,< 12yrs or> 12yrs, and 
thus four study groups, displayed in the following table were formed. 
Table: Median (/nterquartile range: /Q) age in years and Mantoux skin test (mm) of the patients with 
primary TB or postprimary TB and their age-related healthy (<1 2yrs or > 1 2yrs) Mantoux pos controls 
There was a significant difference in age (yrs) between the group of patients with primary 
TB and the group of age-related healthy controls < 12 yrs (p = .002). 
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PPD stimulated lymphocyte proliferation 
Table: Median (interquartile range: IQ) lymphocyte proliferative response (cpm) after stimulation of whole 
blood with PPD (3.3j.!glml) on day 7 (after subtraction of unstimulated proliferation on day 7) from 
patients with primary TB or postprimary TB compared to age-related healthy Mantoux positive controls 
*p: patients compared to age-related healthy controls 
(Mann Whitney U test) 
Patients with primary and postprimary TB had significantly lower lympho-proliferative 
responses compared to their age-related controls. Patients with primary TB tended to 
have higher responses than patients with postprimary TB, but this was not a significant 
finding (p = .056). There was no difference in lymphocyte proliferation between the two 
healthy control groups. 
Age (yrs) had a strong positive correlation with PPD stimulated lymphocyte proliferation 
in the healthy Mantoux pos controls < 12 yrs (p = .649, p < .0001) and this correlation 
was weaker, just significant, but inverse in the healthy Mantoux pos controls> 12 yrs (p 
= -.461; p = .036). There were no significant correlations between age and lympho-
proliferation in any of the patient groups 
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PPD stimulated cytokine responses 
PPD stimulated IFN-y, TNF-a and IL-2 responses of whole blood in the 4 study groups 
were as follows: 
Table: IFN-y, TNF-a and /L-2 production (interquartile ranges: IQ) after PPD stimulation (3.3pg/ml) 
stimulation of whole blood from patients with primary TB or pestprimary TB compared to age-related 
healthy Mantoux pos controls 
* p-values: patients compared to age-related healthy controls 
(Mann- Whitney U test) 
(30-465) 
There was no single cytokine that significantly differentiated patients from age-related 
healthy controls, although the difference in IL-2 production between patients with 
postprimary disease and their age-related healthy controls was nearly significant. 
Differences in IL-2 production were significant when patients with primary TB were 
compared to patients with postprimary TB (p < .0001). 
In the healthy control group< 12 yrs, age (yrs) had a strong correlation with IFN-y (p = 
.604, p = .001) and a nearly significant correlation with IL-2 (p = .341, p = .052). 
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Ratios between PPD stimulated cytokine levels 
Ratios of cytokine levels were calculated by dividing the measurements (in pg/ml) of two 
single cytokines in response to PPD from each included subject. Such a calculation 
should approximate the balance between the two cytokines in the culture supernatants 
after stimulation with PPD, whereby it must be remembered that the IL-2 levels were 
measured on day 3 after culture with PPD, while IFN-y and TNF-a were measured on 
day 7. 
Table: Ratios of cytokine levels after stimulation of whole blood with PPD (3.3pg/m/) from patients with 
primary or postprimary TB compared to healthy age-related Mantoux positive controls 
ratio ratio 
,. 
IFN-y/ TNF-a P* IFN-y/IL-2 
Iii 
n (IQ)c n 
.· .. ' 
:;' ~rimaryTB 20 66:,::::::';; 22 22 
'!! '~C'' 
(38-195) (10-103) 
Healthy 28 191 .023 28 28 
<12 yrs (108-325) (18-240) 
Postprimary 25 88 25 175 
.TB (29-217) (64-786) 
' 
'Healthy 21 266 ,,, .011 21 158 . 
. '<"-"'n'·-·' 
·,7l!;!,~; yrs (157-475) ·(30-312) 
*: p-values: patients compared to age-related healthy controls 
(Mann- Whitney U test) 
ratio 
P* IL-2/TNF-a P* 
n (IQ) 
20 3.09 
(.91-6.40) 
.211 28 2.53 .917 
(1.16-9.24) 
25 .40 
(.13-1.00) 
.316 21 2.64 .001 
(.91-~.78) 
; 
Irrespective of age or expression of disease, patients had lower IFN-y/ TNF-a ratios than 
their age-related healthy controls. Furthermore patients with postprimary TB had a 
significantly lower ratio of IL-2/TNF-a when compared to age-related healthy controls. 
If patients with primary TB were compared to patients with postprimary TB the 
differences in IFN-y/ IL-2 ratios (p = .002), as well as the differences in IL-2/TNF-a 
ratios (p = .001) were significant. 
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Of the calculated ratios, IFN-y/ IL-2 had a significant inverse correlation with age (yrs) in 
patients with postprimary TB (p = -.647, p < .0001). None of the calculated ratios had a 
significant correlation with age in any of the other 3 groups. 
There were three children with TBM in the group of patients with primary TB. Two of 
these did not have any outlying values for the ratios between the different cytokines 
presented in the preceding table. One of them did have an abnormal low IFN-y/ TNF-a 
ratio of 32, while her IFN-y/ IL-2 (11) and IL-2/TNF-a (3) ratios fell within the 25th 
percentiles of the values from the other patients with primary TB. Her IFN-y response to 
PPD (530 pg/ml) was well below the normal range for her age. The same was true for her 
PPD stimulated TNF-a (18 pg/ml) and her IL-2 (50 pg/ml) production, which explains 
why she had normal ratios for IFN-y/ IL-2 and IL-2/TNF-a. Unfortunately her 
lymphocyte proliferation values are not available due to a technical problem. Her IFN-y 
response to PHA (1331 pg/ml) was, however, normal for her age. It must be said that this 
patient had far more extensive involvement of her brain with residual neurological 
damage at follow-up compared to the other two patients with TBM. 
This example does illustrate the fact that calculated ratios need to be interpreted only 
after examination of the individual cytokine responses. "Little" divided by "little" results 
in "little" and cytokine ratios of Mantoux negative healthy controls were thus also 
significantly lower than those of Mantoux positive healthy controls. 
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ESAT-6 stimulated IFN- yproduction 
The relatively small amount of subjects we could analyse for their ESAT-6 induced IFN-
y production (due to the later acquisition of ESAT -6) prevented a meaningful analysis by 
age group and TB status in the earlier analysis on ESAT-6 stimulated IFN-y responses. 
Pooling of study subjects by phenotype of disease enabled an analysis that was more 
worth wile. 
Table: Median JFN-y production (interquartile range:JQ) on day 7 after stimulation with ESAT-6 (lpg/ml) 
in patients with primary TB or postprimary TB compared to age-related healthy Mantoux pos controls. 
n 
·primary TB 16 
t ? 
healthy subjects <12 yrs 16 
postprimary TB 18 
healthy subjects >12 yrs 11 
' '{>., 
*: p-values: patients compared to age-related healthy controls 
(Mann-Whitney U test) 
IFN-y (pglml) 
(IQ) P* 
1518 
(10-4849) 
5897 .166 
(193-10431) 
1069 
(217-6955) 
10 .025 
qQ,-3018) 
While patients with primary TB did not produce significantly different amounts of IFN-y 
after stimulation with ESAT -6 when compared to their age-related controls, patients with 
postprimary TB produced significantly more than their age-related controls. Furthermore, 
healthy Mantoux pos subjects < 12 yrs produced significantly more IFN-y than healthy 
Mantoux pos subjects> 12 yrs (p = .028). 
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Graphic displays of the findings on cytokine ratios 
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Discussion on age related expression of disease 
This is, as far as I know, the first study where immune responses of patients with primary 
or postprimary TB are compared to age-related healthy Mantoux positive controls. 
Results of these analyses were specific for PPD stimulated cytokine responses. Ratios of 
PHA induced measurements were not different between the 4 groups under study, with 
the exception of PHA stimulated ratio between IFN-y and TNF-a., where patients with 
postprimary TB had significantly higher (not lower) values than their age-related healthy ~~ 
controls. The analysis as presented here, is focused on differences between patients and 
their age-related healthy controls. Differences between primary and postprimary disease 
are interesting, but in view of the results where lympho-proliferative, IFN-y and IL-2 
responses were age-related in some important subgroups, I cannot exclude that any 
significant differences were possibly influenced by age. The values of the measurements 
could not be normalised by mathematical transformation, which makes a regression 
analysis difficult to defend. 
Although the lympho-proliferative responses differentiated both patient groups from their 
age-related healthy controls, this finding is questionable, because of the strong age-
related values in the healthy controls < 12 yrs and the significant difference in age 
between the patients with primary TB and these controls. That these proliferative 
responses tended to be higher in patients with primary TB than in those with postprimary 
TB is notable. Wilkinson et al. 172 studied adult patients with various clinical phenotypes 
of disease for their lymphocyte responsiveness to a set of mycobacterial antigens, 
including PPD, and found that patients with peripheral tuberculous lymphadenitis had 
higher proliferative responses when compared to patients with pulmonary TB (78% with 
postprimary TB). 
The ratios of IFN-y to TNF-a. after PPD stimulation were significantly lower in both 
patient groups compared to controls, although we found no significant differences in PPD 
stimulated production of IFN-y or TNF-a. separately. A number of studies have found 
lower PPD stimulated IFN-y production in patients compared to healthy Mantoux 
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positive controls, but the finding has not been very consistent. 188' 200 This apparent 
discrepancy of results from different studies may be due to different techniques for 
measuring IFN-y, distinct sites for sampling mononuclear cells, varying patient 
characteristics or any combination of these factors. With respect to TNF -a. there have 
been equally conflicting results87, although patients tend to produce more than healthy 
controls. The revealing calculation of the IFN-y to TNF-a. ratio suggests that, whilst this 
ratio is lower in healthy controls following infection with Mtb, patients suffer from the 
immunopathological effects of a different balance between these two (pro-) inflammatory 
0 
cytokines. 
Another key finding is a striking difference in the positive IFN-y responses to ESAT-6 of 
healthy Mantoux positive children under twelve years of age as compared to lower such 
responses of the older healthy subjects. Both groups of patients responded well to ESAT-
6. ESAT-6, as a Mtb specific antigen has, until now, only been evaluated in adults using 
PBMCs. Its promise as a more specific antigen than PPD in the immune diagnosis of 
TB115 is confirmed in this analysis for subjects older than 12 years. However, in the age 
group where primary TB is far more common, stimulation with ESA T -6 did not help in 
discriminating patients from healthy Mantoux positive controls in this study. For young 
children with a positive Mantoux skin test, it is reasonable to assume that first infection 
with Mtb is of relatively recent date. As the annual risk for infection is 3.4% in the area 
where this study was done (N Beyers, submitted for publication), a considerable time may 
have elapsed since first infection with Mtb in our older controls. Recently, a study 
showed that IFN-y production after ESAT-6 stimulation decreased during antituberculous 
chemotherapJ01 , implying that reactivity may wane. Our data suggest that a positive 
IFN-y response to ESAT-6 is indicative of recent active immunological contact with 
Mtb, but not necessarily of disease, since every healthy control under the age of twelve 
had a normal CR. 
Recombinant IL-2 has (riL-2) been used in some settings as an additional therapeutic 
agent to anti-tuberculous therapy93, whereby an enhancement of the antimicrobial 
response was observed (decreased sputum bacillary loads). The basis for this strategy has 
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been the observation that patients with lepromatous leprosy showed microbiological 
improvement when treated with intradermal riL-2.92 
Patients with postprimary TB in our study produced less IL-2 than age-related healthy 
controls, they furthermore produced less IL-2 than patients with primary TB. Patients 
with postprimary TB are likely to have much higher bacillary loads compared to patients 
with primary TB. Although highly speculative, it is an intriguing thought that the 
relatively good production of IL-2 upon PPD stimulation in young patients reflects their 
relative capacity to limit bacterial growth. The differences between patients with primary 
TB and those with postprimary TB with respect to the IFN-y/ IL-2 ratio and the IL-
2/TNF -a ratio are by themselves interesting, but possibly solely dependent on the age-
related difference in IFN-y and IL-2 production. They need confirmation from studies in 
adolescents and adults of different ages with different clinical phenotypes ofTB. 
In conclusion, in a whole blood model, the ratio of IFN-y to TNF-a in response to PPD 
differentiates active disease from asymptomatic infection, regardless of age. Furthermore, 
our results suggest that a positive IFN-y response to ESAT-6 is indicative of recent 
infection and therefore does not discriminate between infection with M tb and disease in 
young children. 
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Technical problems during the study 
IL-12p40 and TGF-fJ 
This study was set up to report on IL-12 and TGF-13 levels after stimulation with PHA 
and PPD in the same way as on the other cytokines. There have, however, been a number 
of technical problems with the measurements ofiL-12 apd TGF-13. 
Halfway through the study the biotechtechnical company Genzyme Diagnostics merged 
with R&D Systems. Although from the start of the study, we had purchased enough kits 
to perform all the analyses on the other cytokines with DuoSet kits from Genzyme 
Diagnostics for the whole study, we did not have enough kits for IL-12 and TGF-13 to do 
all the samples. Genzyme Diagnostics was not able to supply us with anymore IL-12 or 
TGF-13 kits at the time of the merger and, despite a concerted effort, no other research 
group could be found that might be able to provide us with any of their spare kits. 
Subsequently we had to wait until R&D Systems was able to deliver IL-12p40 and TGF-
13 kits, by which time the initially envisaged total number of study subjects had been 
recruited. 
Since we found in the pilot studies that the background levels of these two cytokines 
were not always below detection levels of the assays, unstimulated background levels of 
IL-12 and TGF were routinely measured in all the study subjects. 
When we received the kits from R&D Diagnostics and measured the IL-12p40 values, it 
became clear that in the group of study subjects included from end of March 1999 until 
June 1999, the background levels ofiL:-12p40 were significantly higher than those from 
the previous group. Although there had been no changes in the lab routines and no 
differences could be found in any of the other cytokines, I decided to reopen the study 
and recruit new subjects in order to substitute those recruited from March '99 until June 
'99. Unfortunately, I found that the newly recruited subjects, from the period June 1999 
until November 1999, again had high unstimulated background levels ofiL-12p40. 
(See graphs) 
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Graphs: Unstimulated levels of IL-12p40 and TGF-P on day 4 of study subjects included before and after 
March 1999 
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The primary measures taken to investigate and prevent possible sources of contamination 
upon the initial finding of high background values were: 
. All the incubators, the destilled water systems and hoods were checked for 
sources of contamination and nothing was found . 
. RPMI, which was previously made from powdered extract, diluted in destilled 
water and sterilised, was now purchased in sterilised solution from the manufacturer . 
. Measures to prevent contamination were reinforced. 
The subjects that had to be newly recruited in June 1999 were predominantly patients 
between 5-12yrs (n=3) and 12-20yrs (n=9), Mantoux positive controls of 0-5 yrs (n=4) 
I 
and Mantoux negative controls of 12-20 yrs (n=9). In total, the 59 subjects recruited as 
from the end of March 1999 until November 1999 were: 
-1 patient, 9 Mantoux positive subjects and 1 Mantoux negative subject aged 5-
12yrs 
-6 patients and 3 Mantoux positive subjects aged 5-12 years 
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-17 patients, 2 Mantoux positive subjects and 19 Mantoux negative subjects aged 
12-20 yrs 
-1 patient aged over 20 years 
This was such a diverse group, that it is very difficult to come up with any reasonable 
explanation that the high background values might have been "natural", but this 
possibility cannot be rejected completely. Nevertheless I have decided that the IL-12p40 
and TGF-f3 results we obtained were not to be trusted completely and therefore they have 
not been included in the results from this study. 
Other cytoldnes by period of inclusion 
From the start of the study unstimulated data were also routinely obtained for cell 
proliferation and IL-l 0 levels, because they were equally found to be potentially higher 
than the detection limits of the assays in the pilot studies. As can be inferred from the 
graphs below there were no differences in these values before and after March 1999. The 
boxplot of the background cell proliferative responses on day 7 has exactly the same 
outlook as the one displayed for day 4 and is omitted. 
Graphs: Unstimulated /L-10 (pglm/) on day 3 and unstimulated lymphocyte proliferation (cpm) on day 4 
before and after March 1999 
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We thought that LPS could be responsible for the high background values of IL-12p40. 
LPS is a strong stimulant for both IL-12p40 and its downstream effector cytokine TNF -a.. 
The background levels of TNF -a. in all the unstimulated supernatant samples from the 
whole study population were subsequently measured, but they were all below detection 
level (15pg/ml) of the assay. Equally, a large subgroup ofunstimulated supernatants from 
before March 1999 and all the unstimulated samples from after March 1999 were 
checked for unstimulated IFN-y levels and these were also negative. Because our storage 
system for samples was such that we alliquoted supernatants in small volumes, we could 
check these background levels ofTNF-a. and IFN-y from samples that had not previously 
been thawed, so any loss of cytokine activity due to repeated freezing and thawing in 
these samples was unlikely. 
The values of TNF -a. after stimulation with PHA or PPD did not differ between the two 
periods as shown in the following graphs 
Graphs: Display ofTNF-alevels (pglml) after stimulation with PHA on day 4 and PPD on day 7 before 
and after March 1999 
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Although no satisfactory reason has been found for the high unstimulated background 
values of IL-12p40 and TGF-~, I have found no reason to disregard either the results of 
the other cytokines or those of the lympho-proliferative cell responses. 
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General discussion 
The definite question in a final discussion must surely be: "SO WHAT .... ?". 
The appropriate answer would probably start with: "that is a good question ...... !" and 
then the researcher will put forward the likely advantages of the methodology used, 
summarise the interesting findings, shed some favourable light over the possible 
implications and propose that further research in this field is needed. And that is exactly 
what I am going to do. 
We used a whole blood technique to investigate cellular immune responses from TB 
patients and healthy subjects in an area highly endemic for TB. As already mentioned in 
one of the introductory chapters, there are clear advantages in the use of this method if 
compared to the use of PBMCs: lesser volumes of blood are required and there is no 
need for separation of cells from autologous serum. One of the difficulties in 
interpreting results from whole blood culture methods is the fact that there are no fixed 
amounts of white blood cells in the wells on the culture plates. When comparing 
children to adults in vitro this phenomenon is further accentuated by the age- related 
differences in white blood cell counts per volume of blood. In one important validation 
study for the use of whole blood vs PBMCs in people of different ages177, the authors 
"normalised" their cytokine results to the blood samples' initial absolute amount of 
mononuclear cells. Although in that specific study, because of its aim for validation, 
such an exercise was necessary, one may argue that the use of the initial amount of 
white blood cells is not correct. White blood cells proliferate upon stimulation and thus 
the number of cells after proliferation might be a better denominator. I have done the 
calculations both with the initial amount of lymphocytes as well as the amount of 
lymphocytes after proliferation, but either way the results were comparable or, 
sometimes, more significant. (I took absolute amounts of lymphocytes rather than the 
absolute amounts of white blood cells, because pulsing with Methyl- 3H Thymidine 
only incorporates lymphocytes.) However I chose not to present the results in this way, 
160 
\ 
Stellenbosch University http://scholar.sun.ac.za
because I feel that one of the reasons why we chose the whole blood method, namely 
the better approximation of in vivo conditions, does not justify such "normalisations". 
Inter-person and intra-person variabilities in cytokine measurements are well 
recognised. 202 In healthy persons, serum cytokine concentrations vary at different time 
points during the day.203 To what degree variations in serum concentrations over the day 
matter to blood cultures after several days of incubation is not known. It is conceivable 
that serum concentrations of cytokines at the tinie of venous puncture influence the 
results after stimulation and proliferation. The fact that all the blood samples were taken 
between 9 and 12 am has ensured some standardisation with respect to the 24-hour 
differences. However, a weakness of this study with respect to inter person variability is 
the fact that we did not do serial measurements of the included subjects. With respect to 
the patient groups, such an exercise might not have validated the study any better: only 
a few weeks of therapy is known to have an effect on immune responses to 
mycobacterial antigens. 
Patients were investigated at time of diagnosis before start of therapy and thus 
presumably had an ongoing immune response towards their illness. Consequently, the 
"immune state" of the patients may have been skewed towards a certain type of 
response at the moment of venous puncture. Furthermore compartmentalisation of cells 
at the site of disease may have taken place and therefore lower numbers of 
representative immunologically active cells may have been present in the periphery. The '-
general condition of the patient and stage of disease are also known to influence the 
immune response?04• 205 However, if one wants to study patients there are few 
conceivable ways to control for these possible confounders. A large, prospective, 
longitudinal study of healthy persons of whom a subset may present with disease at a 
point in time would be the best model for a study into the immune pathogenesis of TB. 
The practical problems of doing such a long-term study are enormous and I doubt if any 
research group will come up with the courage and funding to do it. The cross sectional 
method, as we used, is probably the method that will be favoured by most groups, but 
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its limitations are clear. The choice of appropriate cases and controls as well as the 
number of subjects included in a study of this type largely define limits of its 
interpretation. With regard to the choice of patients, I can say that they were 
consecutively recruited over the study period, whenever we got word of there being a 
possible candidate for the study, via the hospital or one of the participating community 
health clinics. Not all the information necessary for inclusion in the study was always 
available at time of diagnosis, but in line with good clinical practice, treatment of the 
disease was not postponed. The quite rigorous inclusion criteria necessitated exclusion 
of a substantial proportion of patients, initially regarded as suitable for study entry, later 
on. The controls were all living and/or working in the area where we recruited most of 
the patients. There are however recognised differences in TB notifications in this 
relatively small catchment area. 157 What obviously is not known, is if any of the 
controls will develop disease in the future, which is not inconceivable in such a high 
incidence area. None of our healthy Mantoux positives has developed disease 1 year 
after inclusion in this study, but of these, the children younger than five ·an received 
prophylactic treatment. 
The major drawback of all studies of this kind where cytokine responses are measured 
from blood or its components, is that peripheral immune responses may not be 
representative of the actual events at the site of inflammation. The studies that have 
used BAL or pleural fluids as well as peripheral cells to measure cytokine production 
have indeed found that within the same patient different balances ·or cytokines may be 
measured when site of disease is compared to periphery. 85• 86• It can therefore be argued 
that measuring peripheral responses to mycobacterial antigens in humans is primarily to 
be used for the evaluation of diagnostic correlates of disease rather than speculation on 
the pathogenesis of human TB. However, most of us cannot resist the temptation to do 
the latter as well. 
This was a relatively small study. The number of study subjects and the non-normal 
distribution of the majority of findings did not permit statistical analysis with other than 
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non-parametric tests. Although mathematical transformations did normalise 
distributions for a subset of findings and, more sensitive, parametric methods could 
have been used for these, I chose not to do that for three reasons. Firstly, comparison of 
the various results would be more cumbersome. Secondly I appreciate the preference of 
any researcher in this field to value cytokine production in actual pg/ml and not in log 
transformed pg/ml. Thirdly the uniformity of the format-of presentation would be lost. 
In this study, TB patients, Mantoux positive and Mantoux negative healthy controls of 
different ages were investigated for their cytokine response to mitogens and 
mycobacterial antigens. Age (in years) was a significant variable in levels (in pg/ml) of 
all the PHA stimulated cytokine responses that we measured. Most published studies 7 
on age-related PHA induced cytokine responses have been performed on PBMCs, 
whereas the results from this study are derived from PHA stimulation of whole blood. 
PHA is a mitogen for lymphocytes and the absolute amount of lymphocytes per unit of 
whole blood was strongly, but inversely, correlated with age. Except for the lymphocyte 
proliferative response to PHA, it should be noted that neither the proliferative response 
to PPD, nor 'any of the cytokine levels correlated with the absolute amount of 
lymphocytes initially present in the blood sample. Thus, at younger age, even with more 
lymphocytes per unit of blood, less amount of cytokine is produced after stimulation 
withPHA. 
The results of the PPD stimulated cytokine responses in relation to age are less straight 
forward. They were, on the whole not correlated with age, with one very notable 
exception: PPD stimulated IFN-y production in healthy Mantoux positive children 
younger that 12 years of age was strongly correlated with age. ESAT-6 stimulated IFN-
y production was not related to age in any (sub) group. Apparently the nature of the 
. 
antigen determines if there is a relationship between age and the magnitude of a 
cytokine response. It should then be concluded that for any individual antigen-
stimulated cytokine response, normal reference values have to be examined for a 
possible relationship with age. In a way, this is a rather daunting prospect for 
researchers who study paediatric populations. Even though less blood is required for 
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studying cellular immune responses with a whole blood based- than with a PBMC based 
technique, recruiting enough healthy children of different ages to obtain meaningful 
results for any given antigen is a cumbersome exercise. 
Our findings support the notion that lymphocytes from young children under 5 yrs are 
deficient in their capacity to produce IFN-y, to a number of antigens when compared to 
older persons. That this phenomenon is solely the consequence of the young child's. 
relative higher number of na'ive T cells seems unlikely. Given the fact that the same 
relative deficiency to produce IFN-y after PHA stimulation was found after stimulation 
with PPD and Mantoux negative subjects did not produce appreciable amounts of IFN-
y. I therefore presume that specific memory T cells were primarily involved in the PPD 
driven IFN-y response. Furthermore the relatively higher PPD stimulated IL-2 
production in the young children indicates that the capacity to expand specific 
lymphocytes is not deficient either. A role for antigen presenting cells, as proposed in 
some studies51 • 52, in the lesser cytokine production in young children is a possibility. 
Antigen-responsiveness, as measured by lymphocyte proliferation to PPD was very 
much age-dependent in the healthy Mantoux pos control group younger than 12 yrs. On 
the other hand, in the youngest age group the level of IFN-y production after PPD 
stimulation was essentially not different from production after stimulation with PHA 
and mitogen induced lymphocyte responses are not as dependent on the qualities of 
antigen presenting cells. Thus, even when charged with "meniory", young children may 
be deficient in production of IFN-y and speculation upon which other factors might be 
responsible for this phenomenon is open for debate and, preferably, further studies. 
Children with J'B have been rarely studied for their cellular immune response. In the 
study by Swaminathan et al112, their methodology was different from ours in the sense 
that they stimulated PBMCs and our results are based on whole blood stimulation, but 
otherwise this is the only study in this field, worth comparing. In that study PPD and 
Mtb (Erdman strain) induced IFN-y production was significantly lower in patients than 
in healthy Mantoux positive controls of comparable age (mean~6yrs). Their patients 
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produced similar amounts of IL-10 and IL-12 as compared to controls. Interestingly, 
their study included 24 patients of which 41% were malnourished and 22 "healthy" 
controls of whom 59% were malnourished. The authors do not mention if this was an 
intentional "matching" for malnutrition (defined as <75% of body weight for age). PHA 
stimulated IFN-y production was measured in 8 patients and controls (no differences 
between patients and controls found), while IFN-y mRNA expression after stimulation 
with M tb. was lower in 5 patients compared to 5 controls. Support as to why their 
results (lower IFN-y after PPD stimulation) are "real" and specific to children with TB, 
are argued on the basis of these additional experiments, albeit from less than a third of 
their original study group. They do inform us that malnourished patients produced less 
IFN-y after PPD stimulation than patients who were in good nutritional health and that 
there were no such differences between malnourished and well nourished healthy · 
controls. They do not inform us how they chose that small subgroup to do some 
additional experiments on. Nevertheless, the differences between their results and ours, 
with respect to PPD induced IFN -y production, should not be disregarded off hand 
solely on the basis of technical methodology and numbers, but underline the need for 
further studies in paediatric populations. The one other study known to me206 where 
cytokines were measured in children of different ages with and without TB was, in my 
opinion, methodologically completely flawed and the publication so riddled with 
mistakes that I will not discuss it in any detail., Furthermore they could not measure any 
IFN-y in the supernatants of the cell cultures. Dieli et al 111 studied lymphocyte 
proliferation after stimulation with PPD and their patients had equal responses when 
compared to the Mantoux positive controls (mean age -7 yrs). The cut-off point for a 
positive Mantoux test in this study from Italy was a response of 5mm to 1 U PPD and 
this may have influenced the results; it is likely that a number of their healthy controls 
were sensitised by mycobacteria other than Mtb.Z07 
Previous "exposure" to the actual antigen, as described in the introduction chapter on 
age and the development of the immune system, came out as an important variable also 
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in this study. The immunological responses to PPD that we measured were negligible in 
the Mantoux negative subjects when compared to the Mantoux positive subjects. This is 
an important finding for three reasons. Firstly it validates the specificity of the PPD 
induced responses in the patients and healthy Mantoux positive groups. Secondly it 
gives a handle to the prospect of evaluating infection with Mtb by way of an in vitro 
test, rather than a skin test in children. The restrictions. for drawing such a conclusion 
from this study are already mentioned: the study was not designed to investigate this 
aspect and we had few subjects with intermediate (0-15mm) reactions. Further studies 
in this field are clearly needed. Thirdly, PPD induced responses were apparently not 
dependent of BCG vaccination. Apparently, because we did not have proven records of 
BCG vaccination in any of the included subjects and, unfortunately, insufficient BCG 
scar notifications to make a valid statement. Recently the method of using BCG scars as 
a reliable indicator of BCG vaccination has been questioned anyway, at least in persons 
vaccinated BCG at very young age, where the scar seems to vanish with time in about 
25% of persons. 165 There is a high coverage of BCG in this population (more than 
90% ), but the timing of vaccination is in the neonatal period. It has been argued many 
times that responses induced by PPD are not specific enough for Mtb, because PPD 
shares many proteins with other mycobacterial species, including BCG. I do not dare go 
against this argument, if only for theoretical reasons, but on the assumption that at least 
70% of the Mantoux negative subjects from our study were vaccinated with BCG, BCG 
exposure did not result in PPD induced cytokine responses of any important magnitude. 
The research group in the Gambia has shown that in 2 months' old children, vaccinated 
with BCG at birth, PPD induced IFN-y production (by PBMCs) in the first months of 
life period was ·not different from adults with a BCG scar who were vaccinated "in 
childhood" 113• 208 A potentially important difference in the vaccination technique is that 
children in South Africa until now have been vaccinated via the percutaneous route and 
children in the Gambian study via the intra-dermal route. The percutaneous route is 
potentially less immunogenic if the magnitude of skin test induration and the presence 
of a BCG scar are taken as clinical correlates for immunogenicity. 209 Studies into the 
route of vaccination as a potential determinant of the quality of TB related immune 
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responses are currently under way in the Cape Town region, while South Africa is 
planning intra-dermal vaccination. Other differences that make our results difficult to 
compare with the findings from the Gambia are related to the fact that we had only 1 
child under the age of 1 yr in our Mantoux negative study group. We have not yet been 
informed on the longer term follow-up of the Gambian children and perhaps BCG 
' induced PPD responsiveness wenes, as· a percentage-of BCG scars do, when BCG is 
given in the neonatal period. 
The virtual absence of ESAT-6 stimulated IFN-y production in the Mantoux positive 
healthy controls older than twelve years, while being vigorous in the younger controls, 
suggests that, with time, weaning of specific antigen responses does occur. Since this 
was a cross sectional study and not a longitudinal study, the finding is only suggestive: 
it is not known if any of the Mantoux positive healthy controls were ever capable of 
mounting a response to ESAT -6. It may well be that the incapacity to mount a response 
to ESAT -6 will prove to be prognostic for a propensity to develop TB at a later time 
point. Studies on healthy household contacts have shown variable ESAT-6 responses116, 
ranging from negative to higher than the index cases. Longitudinal follow-up of these 
contacts. will be very valuable for interpreting the (prognostic) value of a positive 
ESAT -6 response. From our study, one may conclude that a positive ESAT -6 response 
in children younger than twelve years does not have an added value above a PPD 
ind:uced response or, for that matter, a positiv~ skin test (> 15mm). However, since our 
/ 
patients and Mantoux positive controls had median Mantoux skin indurations well 
above 15mm, it would be interesting to study responses from children with intermediate 
skin test results (5-15mm). 
A uniform classification system for primary and postprimary TB by severity of disease 
does not exist and thus was not an option in comparing patients with primary and 
postprimary disease. Classification of patients along any severity scale heavily depends 
on the time of presentation to the doctor: today's patient with minor disease is probably 
tomorrow's patient with major disease. Based on the extent of radiological 
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abnormalities, a grading system for classifying severity and predicting outcome of 
disease is in use for adults with postprimary TB. A staging scale for TBM, based on 
clinical findings, is also in practice and mostly used to predict neurological outcome of 
disease.210 No such official classification system exists for primary intrathoracic TB, 
although clinicians tend to relate the type and extent of radiological abnormalities in 
combination with clinical findings to a prognosis. In our study, where patients with 
fundamentally different types of disease are compared, any personal attempt at 
stratification by "degree of illness" seemed a pointless operation to me. However, the 
notion that primary intrathoracic TB in children is a relatively benign disease has been 
shown in studies from the pre-chemotherapy era. One of the most instructive of these is 
from the child contacts clinic of the Brompton Hospital in London212 where 2377 
children followed up for a mean of 9 years from 1930 till 1952. 50% of their mortality 
was in children with disseminated miliary and meningeal TB (mostly children younger 
than 5 yrs). The other 50% died from" adult type" postprimary TB (only 6% of their 
children with postprimary disease were younger than 1 0 yrs ). The relative good 
production of IFN-y compared to age-related controls in our children with primary 
disease might well be a reflection of the relatively benign nature of this illness. 
The analysis on cytokine ratios by expression of disease is an important part of this 
' 
thesis for several reasons. Firstly, the increase in numbers per newly stratified age-group 
did not significantly change the results on single cytokine responses when compared to 
those obtained by analysing along the initial stratification by age, whereby each group 
~ . 
contained smaller numbers of subjects. Secondly, because the suggestion, made by 
Ellner et al200, to use cytokine ratios to obtain a more universal indicator of disease, 
rather than only the variable IFN-y production in response mycobacterial antigens, 
indeed did result in a significant difference between TB patients and healthy Mantoux 
pos subjects, regardless of age. Lastly, and most importantly to me, it puts into focus the 
somewhat artificial division into "good" and "bad" cytokines with respect to TB. Over 
the last decade, we have grown accustomed to the use of "type 1" vs "type 2" when 
talking about immune regulatory pathways. The origin of this distinction stems from 
168 
Stellenbosch University http://scholar.sun.ac.za
research into experimental models of disease in inbred mice, living under laboratory 
conditions. I have no doubt that the divide is conceptually very useful, especially when 
the notion of "cross-talk" between the two types of responses is introduced. Effectively 
this leads to a more balanced view of the immune system, whereby we are forced to 
acknowledge that most reactions in nature are contra-regulated by another to produce a 
stationary phase, whereby life is made easier. In the· particular case of TB, there is 
enough reason to assume that type 1 immune responses are beneficial for outcome of 
disease, given the evidence that containment of mycobacterial infections is deficient in 
people with INF-y and IL-12 receptor abnormalities.81 A definite role for a relative 
overproduction of type2 cytokines in the pathogenesis of human TB is less clear either 
peripheral or at site of disease2n, although, certainly; a number of studies have shown 
increased TGF-~, IL-4 and IL-10 production by PBMCs in TB patients as compared to 
healthy controls. But if an imbalanced type 2 immune response is cause or effect in 
human disease has not been convincingly shown, not even in murine models!04 TNF-a. 
is primarily regarded as a pro-inflammatory cytokine, but also implicated in type 1 
immune pathways. INF-y, the archetypal type1 cytokine, can be a potent amplifier of 
TNF-a. production. 179 Most researchers in the field agree that either too much, (resulting 
in tissue necrosis, wasting and fever) or too little (no proper granuloma formation) of 
TNF-a. is detrimental to the host: the principle of the balance. When our patients were 
compared to healthy controls; the balance (ratio) of a "good" cytokine (IFN-y) and a 
potentially other "good" cytokine (TNF -a.) showed a "bad" imbalance, without any type 
2 cytokine in the calculation. 
The findings of this study underline the necessity to include age as a variable in 
immunological investigations. This in itself is no surprise, as we have long known 
about age-dependent values for white blood cells and immunoglobulins. Specific 
responses to defined antigens are clearly not only dependent on age, but also on 
previous exposure and the subsequent development of lasting memory. Unfortunately 
there is much work to do in obtaining normal age-related values for all the antigen 
induced immune responses that we might be interested in. In light of the urgent need for 
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new diagnostic tool in childhood TB as well as an improved vaccine (-strategy), this is a 
particular cumbersome fact, demanding rationalisation in the choice of antigens to 
study. In view of our results, I would argue, that more culture filtrate antigens would not 
be my first choice for further exploring the immune response to M.tb in children, but 
rather cell wall components of Mtb (focexample LAM). They are known to be potent 
macrophage activators and involved in the early encounter of M tb with the immune 
system. The results we obtained in this study obviously need confirmation in other, 
possibly larger studies, of this kind and preferably in different populations. However, it 
seems doubtful from this study and work by others200•113 that, as crucial as IFN-y may be 
for protection from mycobacterial disease, measuring only IFN-y production will 
provide us with a diagnostic tool in children. 
Smith et al 213 have proposed that the ontogeny of cellular immunity could parallel the 
immunobiology of tuberculosis in children at different ages. Without any tuberculosis 
specific data from children available at the time of publication, they put forward a well-
founded hypothesis that the vulnerability of young children, under the age of 2-5 yrs, to 
develop TB might well be related to the relative immaturity of their cellular immune 
system as a whole. The cross-sectional design of our study does not allow any answer 
with regard to susceptibility to disease, but if absolute levels of low IFN-y production 
prove to be a measure of susceptibility, the results of our study might well support their 
hypothesis. 
The perils of paediatric research are multifold. The limited amount of blood often 
available poses technical constraints for a variety methods. Ethical c~nsiderations are 
complex and obtaining informed consent from parents to let children participate in 
research projects difficult. However, if one wants to know more about childhood 
diseases, there is ultimately no other way than to set up studies that involve children. 
The fact that age must be a consideration, is often a confounder and sometimes a 
characteristic is fortunately well known to paediatricians. 
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Epilogue 
" .... Consumption, which in the commencement is easy to cure and difficult to 
understand, but when it has neither been discovered in due time nor treated 
upon proper principle, it becomes easy to understand and difficult to cure ... " 
is a citation from the political scientist Machiavelli who lived from 1469-1527. 
Since his life time the origin of TB has been discovered, the pathogenesis of 
disease is better defined and curative strategies have been developed. However, 
can we rightfully claim that we solved this problem in 2001? 
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Consent Form to participate in a research project on Tuberculosis 
Project: "The influence of age on the cellular immune response in patients with Tuberculosis", 
regnr ............. approved by the Ethics Committee of the University of Stellenbosch 
Patient Details: 
Name: 
First Names: 
Date of Birth: 
Address: 
I, the undersigned doctor/nursing sister ................................. hereby declare that I have informed the patient 
or his/her parent and/or legal guardian on the nature, purpose, risks and possible consequences of the 
research project in his own language. I will take full responsibility if the study results of this person need 
follow-up in terms of treatment and/or counseling 
(Signature of doctor/nursing sister) (Date) 
I, the undersigned ................................................... , (in my capacity as .................................... ), 
(Name of person giving consent) (Nature of relation) 
hereby give consent for the inclusion of ...................................................... .in the above 
(Name of person included in the study) 
research project, the nature of which has been explained by .................................................... . 
(Name of doctor/nursing sister) 
1. The nature of the project has been explained to me 
2. I understand the implications of the research and the risks involved 
3. The following procedures may be carried out as part of the project: 
i) Drawing of 12 ml ofblood 
ii) Tuberculin skin testing 
iii) Chest radiograph if deemed necessary by the doctor 
iv) HIV testing 
4. I understand that I can withdraw at any stage from the project without influencing my or my child's 
medical treatment. 
5. I understand that there will be no financial rewards 
(Signature of person giving consent) (Date) 
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Information for persons or parents of children participating in the research project 
"The influence of age on the cellular immune response in patients with 
Tuberculosis" 
Tuberculosis (TB) is a major health problem in the world and especially in the Western 
Cape. It is a disease that can be cured with medication, but we need more scientific 
information on the nature of the disease to be able to come up with better ways of 
diagnosis, prevention and treatment. We also need more information on the manner in 
which persons of different ages react to TB. For this purpose we ask your permission to 
include you/ your child in a research project to investigate this. 
We need to ask you some questions on the health of you/your child, do a physical 
examination, do a Mantoux skin test and draw blood for testing of the immune system, 
including an HIV test. The proceedings and the meaning of doing a HIV test will be 
explained to you. 
The amount of blood drawn will be 12ml (2,5 teaspoons), devided over three tubes. This 
is not an amount that poses any dangers to you/your child. If, by any chance, there are 
signs in the blood test suggesting that you/your child need to be seen by a specialist 
doctor we will arrange an appointment. If the HIV test should be positive we will refer 
you to the Infectious Disease clinic of Tygerberg Hospital 
The Mantoux skin test will be done with a small needle, whereby a little amount of fluid 
will be put into the skin. After 2-3 days we will read the skin test to see if it is positive. If 
positive, which means that you/your child has been in contact with TB, we will arrange 
for you or your child to have a chest radiograph taken, so that we can look if there are any 
signs of lung disease. If there are signs of disease we will refer you to the local health 
clinic for further treatment. 
The procedures mentioned are not dangerous for your health and the only side-effect is a 
possible positive skin reaction that can be itching or ulcerating for which we can give you 
a s~eroid cream to be used for a couple of days until the reaction has stopped. 
You are completely free to choose whether or not you decide to take part in this study. 
Refusal to participate will not involve any penalty or change in the standard of medical 
attention in the hospital or clinic. You will not receive any fmancial reward for 
participating in this study. 
All personal information obtained from this study will be strictly confidential. The results 
ofthe study will be published in medical journals, but without mentioning the name of 
any person on whom blood was taken. 
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